Roles of periplasmic chaperones and BamA in outer membrane protein folding by Schiffrin, Robert
Roles of periplasmic chaperones 
and BamA in outer membrane 
protein folding 
 
 
Bob Schiffrin 
Submitted in accordance with the requirements for the degree of 
Doctor of Philosophy 
The University of Leeds 
Faculty of Biological Sciences 
September 2016 
The candidate confirms that the work submitted is his own, except where work 
which has formed part of jointly-authored publications has been included. The 
contribution of the candidate and the other authors to this work has been explicitly 
indicated below. The candidate confirms that appropriate credit has been given 
within the thesis where reference has been made to the work of others.   
This copy has been supplied on the understanding that it is copyright material and 
that no quotation from the thesis may be published without proper 
acknowledgement.
 
 
ii 
Jointly authored publications 
Throughout this thesis the work directly attributable to the candidate is as follows: 
(i) Literature research and compilation of the manuscript stated above. 
(ii) The candidate performed all the experimental work and data analysis 
unless otherwise stated. 
Chapters 3 and 4 contain work from the following publication: 
Schiffrin, B., Calabrese, A. N., Devine, P. W. A., Harris, S. A., Ashcroft, A. E., 
Brockwell, D. J. & Radford, S. E. Skp is a multivalent chaperone of outer-membrane 
proteins. Nat Struct Mol Biol 23, 786–793 (2016). 
In this publication B. Schiffrin designed and performed the kinetic experiments, 
computer modelling and molecular dynamics simulations. A. N. Calabrese designed 
and performed the mass-spectrometry and cross-linking experiments. P. W. A. 
Devine designed and performed initial in vacuo apo-Skp simulations. S. A. Harris 
assisted and supervised the molecular dynamics simulations. S. E. Radford, D. J. 
Brockwell, A. E. Ashcroft and S. A. Harris provided help with scientific discussions, 
data interpretation and manuscript preparation. 
  
 
 
iii 
Acknowledgements 
Firstly, I would like to thank my supervisors, Prof Sheena Radford and Dr David 
Brockwell for always generously sharing their expertise, and their unwavering 
support, encouragement and enthusiasm for this project. Everyone in the 
Radford/Brockwell lab has been kind, friendly and ready with advice on any 
technique. The expertise of Dr Sophia Goodchild in lipids and fluorescence was very 
helpful. There was great solidarity and encouragement in the early molecular biology 
stages of the project from Dr Chris Wilson and Rhys Thomas. I am also grateful to 
Rhys for letting me use his meticulously collected list of reagent manufacturers, 
saving me a time consuming, and not amazingly exciting, job. Many thanks also to 
Dr Theo Karamanos for all his encouragement and advice throughout my PhD, in 
particular on computational matters. Lab manager Nasir Khan has fed me bananas 
and curry to keep me going at just the right times, as well as sorting out a huge 
number of technical problems for me, and just generally being a model human 
being. 
I’m also grateful to Dr Sarah Harris for all her assistance with the molecular 
dynamics simulations, and her infectious enthusiasm for the Skp:OMP project. 
Thank you also to Dr Emanuele Paci for all his training and help with molecular 
dynamics simulations. I would like to thank everyone in the High Performance 
Computing (HPC) team at the University of Leeds whose assistance was invaluable, 
particularly when our reviewers wanted additional (very computationally expensive!) 
simulations to be performed. 
Part of the current project was performed in collaboration with mass spectrometrists 
at the University of Leeds. I am grateful to Prof Alison Ashcroft and Dr Anton 
Calabrese for a very fruitful collaboration. I have learned an enormous amount from 
Anton, and I thank him for always making time for helpful discussions and advice. 
I am also grateful to those who have previously worked on outer membrane protein 
(OMP) folding in the lab. Dr Gerard Huysmans and Dr Alice Bartlett were very willing 
to help out with this current project. I owe a huge debt of gratitude to Lindsay 
McMorran who gave me a huge amount of her time and expertise; her guidance on 
all scientific matters in the early stages of this project was invaluable. Thanks to 
Tom Crosskey who made a great contribution to this project, and the lab, during his 
year as a master’s student. Also, a big thanks to all the OMP team: Tom Watkinson, 
 
 
iv 
Anton Calabrese, Julia Humes, Anna Higgins, Matt Iadanza, and Jim Horne. It’s 
been a joy to see the team grow and strengthen as my project has progressed. 
As part of my PhD training I had the opportunity to spend a great three months at 
the Research Complex at Harwell, Oxford. I am grateful to Dr Stephen Carr and Prof 
Simon Phillips for this opportunity, and all in the Carr group. In particular, a big 
thanks to Dr Avinash Punekar, who looked after me during my time in Oxford. 
The Astbury Centre for Structural Molecular Biology at the University of Leeds is a 
fantastic research environment, and I am grateful to all members for creating such a 
supportive and inspiring place to learn and develop scientific ideas. I am also 
grateful to the BBSRC for funding my studentship, thereby making what follows 
possible. It’s a real privilege to have the opportunity to try and put your brick in the 
wall of knowledge. 
My parallel life as a musician has been a welcome distraction during my studies, so 
thank you to all my musical friends, for helping me to relax and have fun away from 
the lab. The joy of playing music with people has definitely contributed to sanity 
maintenance. In particular, a big thanks to members of Biscuithead and the Biscuit 
Badgers for being so much fun on our adventures around the country. Also, thanks 
to DJ Wonky Chris who provided weird analogue synth music to accompany 
molecular dynamics simulations of the Skp chaperone. 
I have discovered that doing a PhD is a difficult thing, which I guess should not have 
come as a surprise. Given this, the love and support of those friends and family 
close to me has, as always, been invaluable. Thanks to my mum, dad and sister for 
their (lifelong!) love, support, and encouragement. The help and advice of my 
brilliant sister Mandy Schiffrin (Moo), in particular her wise words of encouragement 
to get writing up, meant that I, thankfully, didn’t have to pull an all-nighter to get it 
done in the end! Finally, thanks for all the support from my amazing wife Joyce Lee 
Nga Ya, who, by making me happy every day, has contributed immeasurably to this 
work. 
  
 
 
v 
Abstract 
A defining feature of living things is that they have an inside and an outside, and in 
order for all living cells to survive, whether they are part of a blue whale or a 
unicellular microscopic organism, they must have mechanisms to mediate exchange 
with their environment. Food and energy enters the cell, and material must also 
leave, such as the waste products of metabolism, or virulence factors from 
pathogenic organisms. Lipid membranes define these boundaries, but it is 
membrane proteins that mediate the exchange. Although lipid bilayers can self-
assemble in vitro, the assembly of complex biological membranes containing 
proteins requires energy and careful coordination. 
The work presented in this thesis examines the biogenesis pathway of -barrel outer 
membrane proteins (OMPs) in Gram-negative bacteria. OMPs are synthesised on 
cytosolic ribosomes, translocated across the inner membrane, then chaperoned 
across the periplasm, before folding and insertion into the OM. While OMPs can fold 
spontaneously into lipid membranes, this process is too slow to be biologically 
relevant, so a dedicated folding catalyst, the -barrel assembly machinery (BAM) 
complex, is required at the OM. Recent genetic, structural and biochemical 
investigations have increased our understanding of OMP assembly, but key 
questions remain, including: How do periplasmic chaperones bind and release OMP 
substrates? What are the roles and interactions of BAM subunits? What is the 
molecular mechanism by which BAM folds and inserts OMPs? 
Here, an assay was developed to monitor OMP folding kinetics in vitro using intrinsic 
fluorescence in low concentrations of urea (0.24 M). This allowed comparison of the 
real-time folding behaviour of different OMPs under the same conditions for the first 
time (Chapter 3). The assay was then successfully extended to include OMP 
assembly factors, including the periplasmic chaperones Skp and SurA, and BamA, 
the principal component of the BAM complex, to obtain the following key results: 
Investigations into the interactions between Skp and OMPs of varying size (tOmpA, 
PagP, OmpT, OmpF and tBamA) revealed that greater Skp:OMP ratios are required 
to prevent the folding of 16-stranded OMPs compared with smaller 8-stranded 
OMPs. Supported by ion mobility spectrometry-mass spectrometry (IMS-MS) data, 
computer modelling and molecular dynamics simulations, the results imply a new 
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mechanism for Skp chaperone activity involving the coordination of multiple copies 
of Skp to protect a single substrate from aggregation (Chapter 4). 
Addition of further folding factors to the assay demonstrated that the model OMP 
tOmpA can be released and folded from its complex with Skp by BamA, possibly 
recapitulating an in vivo assembly pathway. BamA consists of a -barrel membrane-
embedded domain and soluble periplasmic domains, and while the release activity 
was shown to located in the membrane domain, the activity was greatest when full-
length BamA was present. By contrast, SurA was not able to release tOmpA from 
Skp under the conditions employed, arguing against a sequential chaperone model 
(Chapter 5). 
Next, kinetic studies were used to investigate the mechanism of OMP folding 
catalysis by the BAM complex. The effect of hydrophobic mismatch between the 
BamA -barrel and the membrane was examined by monitoring the folding of 
tOmpA into liposomes containing lipids of different chain lengths in the presence or 
absence of BamA. The results showed that BamA has a greater catalytic effect in 
lipids with longer chain lengths, with the largest rate enhancement achieved in 
bilayers with a hydrophobic thickness close to that of the OM. The results establish 
the importance of hydrophobic mismatch in the mechanism by which OMPs are 
folded in vivo, which may be influenced by local thinning of the membrane and 
increases in lipid disorder in the vicinity of the BAM complex (Chapter 5). 
Finally, based on the results obtained in this project, and consideration of the 
currently available literature, a new ‘barrel elongation’ model is proposed for the 
mechanism of OMP assembly by the BAM complex (Chapter 6). 
The OMP assembly pathway is an attractive target for novel antibacterials given that 
it is surface located, highly conserved, and essential in clinically important 
pathogens. Understanding the molecular mechanisms of OMP biogenesis factors 
will facilitate the development of drugs targeting this pathway. The work described in 
this thesis provides new insights into the mechanisms of OMP assembly, using a 
wide range of biochemical and biophysical techniques, thereby contributing to the 
development of this fast-moving and fascinating field. 
  
 
 
vii 
Table of Contents 
Jointly authored publications ..................................................................................... ii 
Acknowledgements .................................................................................................. iii 
Abstract .................................................................................................................... v 
Table of Contents ................................................................................................... vii 
List of Figures .......................................................................................................... xi 
List of Tables .......................................................................................................... xv 
Abbreviations ......................................................................................................... xvi 
1 Introduction ........................................................................................................ 1 
1.1 Life is defined by membranes ...................................................................... 1 
1.2 The Gram-negative cell envelope ................................................................ 2 
1.2.1 Outer membrane proteins (OMPs) ......................................................... 7 
1.2.2 The OMP biogenesis pathway ..............................................................10 
1.3 Folding in the periplasm ..............................................................................12 
1.3.1 Skp .......................................................................................................12 
1.3.2 SurA .....................................................................................................17 
1.3.3 DegP ....................................................................................................22 
1.3.4 FkpA .....................................................................................................23 
1.3.5 PPIases and disulphide isomerases .....................................................24 
1.4 The BAM complex .......................................................................................25 
1.4.1 BamA ....................................................................................................28 
1.4.2 BamB ....................................................................................................34 
1.4.3 BamC ...................................................................................................36 
1.4.4 BamD ...................................................................................................38 
1.4.5 BamE ....................................................................................................40 
1.4.6 Structural insights into the whole BAM complex ....................................41 
1.4.7 Models of β-barrel folding and insertion by the BAM complex ...............45 
1.5 In vitro studies of OMP folding ....................................................................47 
1.5.1 PagP .....................................................................................................54 
1.5.2 Studies of BAM complex function in vitro ..............................................60 
1.6 Current questions ........................................................................................62 
2 Materials and Methods ......................................................................................63 
 
 
viii 
2.1 Materials and Reagents ..............................................................................63 
2.1.1 General chemicals ................................................................................63 
2.1.2 Lipids ....................................................................................................63 
2.1.3 Molecular Biology Materials ..................................................................64 
2.1.4 Protein Chemistry Materials ..................................................................64 
2.2 Molecular Biology ........................................................................................65 
2.2.1 E. coli Bacterial Strains .........................................................................65 
2.2.2 Growth media .......................................................................................65 
2.2.3 Agarose gel electrophoresis .................................................................66 
2.2.4 Preparation of competent cells ..............................................................66 
2.2.5 Transformation of E. coli strains ............................................................67 
2.2.6 Polymerase Chain Reaction (PCR) .......................................................67 
2.2.7 Agarose gel DNA extraction ..................................................................68 
2.2.8 Plasmid preparation ..............................................................................68 
2.2.9 Restriction Digests ................................................................................69 
2.2.10 Plasmid vector descriptions.................................................................69 
2.2.11 DNA sequencing .................................................................................71 
2.2.12 DNA ligations ......................................................................................71 
2.2.13 Cloning of OmpF, tBamA and OmpT ...................................................71 
2.3 General protein methods .............................................................................76 
2.3.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) .............................................................................................................76 
2.3.2 Trichloroacetic acid (TCA) precipitation of proteins ...............................78 
2.3.3 Determination of protein concentration .................................................79 
2.4 Outer membrane protein expression and purification ..................................72 
2.4.1 Expression and purification of untagged outer membrane proteins .......72 
2.4.2 Expression and purification of His-tagged OmpT ..................................73 
2.5 Expression and purification of BamA POTRA domains ...............................74 
2.6 Expression and purification of Skp ..............................................................75 
2.7 Expression and purification of His-tagged Skp ............................................75 
2.8 Expression and purification of His-tagged SurA ..........................................76 
2.9 Protein expression yields ............................................................................76 
2.10 Characterisation of PagP in DLPC liposomes (Chapter 3) .........................80 
2.10.1 Liposome preparation .........................................................................80 
 
 
ix 
2.10.2 SDS-PAGE band shift assays .............................................................81 
2.10.3 Fluorescence emission spectra ...........................................................81 
2.10.4 CD spectra ..........................................................................................81 
2.11 Preparation of liposomes ...........................................................................82 
2.12 CD spectroscopy of folding factors ............................................................82 
2.13 BamA band shift assays in DLPC, DTPC and DMPC ................................83 
2.14 Kinetic folding assays ................................................................................83 
2.14.1 Kinetic assays in DUPC liposomes (Chapters 4 and 5) .......................83 
2.14.2 Kinetic assays for tOmpA in DLPC, DTPC and DMPC in the presence 
and absence of BamA (Chapter 5) ...................................................................85 
2.15 Fluorescence emission spectra (Chapter 4) ..............................................86 
2.16 Temperature denaturation of BamA and OmpA.........................................87 
2.17 Mass Spectrometry ...................................................................................88 
2.18 Modelling of Skp-OMP complexes .............................................................89 
2.19 Molecular Dynamics Simulations ...............................................................89 
2.20 Microscale thermophoresis (MST) binding experiments ............................91 
2.20.1 Labelling of tOmpA with Alexa Fluor 488.............................................91 
2.20.2 MST protocol ......................................................................................91 
2.20.3 MST data fitting to a quadratic binding equation..................................92 
3 Development of a fluorescence assay for the study of OMP folding kinetics in 
low urea concentrations ..........................................................................................95 
3.1 Introduction .................................................................................................95 
3.1.1 Expression and purification of PagP .....................................................98 
3.1.2 Effects of lipid chain length on PagP folding yields in PC liposomes ... 100 
3.1.3 Effects of lipid chain length on PagP folding kinetics in PC liposomes 102 
3.2 Extension of the OMP folding kinetics assay to additional OMPs .............. 103 
3.2.1 OMP selection .................................................................................... 103 
3.2.2 Subcloning of FadL ............................................................................. 106 
3.2.3 Cloning of tBamA ................................................................................ 107 
3.3 Expression and purification of additional OMPs ........................................ 108 
3.4 Kinetic assays in the absence of lipids ...................................................... 109 
3.5 Highly reproducible exponential kinetics for tOmpA, PagP, OmpF and tBamA 
under identical conditions .................................................................................. 111 
 
 
x 
3.6 Discussion ................................................................................................ 114 
4 Skp is a multivalent chaperone of outer membrane proteins ........................... 118 
4.1 Introduction ............................................................................................... 118 
4.2 Higher Skp:OMP ratios are required to prevent folding of larger OMPs ..... 120 
4.3 ESI-MS reveals differing Skp:OMP stoichiometries according to OMP size
 125 
4.4 Insights into the structure and dynamics of Skp:OMP complexes using ESI-
IMS-MS ............................................................................................................. 128 
4.5 Modelling of larger OMPs in complex with two copies of Skp gives structures 
with different architectures ................................................................................ 133 
4.6 Investigation of Skp:OMP complex models by molecular dynamics 
simulations ........................................................................................................ 135 
4.7 Discussion ................................................................................................ 141 
5 Effects of periplasmic chaperones and membrane thickness on BamA catalysed 
OMP folding .......................................................................................................... 145 
5.1 Introduction ............................................................................................... 145 
5.2 BamA has a catalytic effect on OMP folding in DUPC liposomes .............. 149 
5.3 Release and folding of tOmpA from its complex with Skp is dependent on the 
-barrel domain of BamA .................................................................................. 156 
5.4 SurA cannot release tOmpA from its complex with Skp ............................. 158 
5.5 The catalytic effect of BamA is dependent on membrane thickness .......... 160 
5.6 Discussion ................................................................................................ 166 
6 Conclusions and final thoughts ........................................................................ 172 
References ........................................................................................................... 184 
 
  
 
 
xi 
List of Figures 
Figure 1.1: The three major lipid species in E. coli. .................................................. 3 
Figure 1.2: LPS biogenesis pathway in E. coli. ........................................................ 5 
Figure 1.3: Pathways for the biogenesis of inner membrane proteins (IMPs), outer 
membrane proteins (OMPs) and lipoproteins. .......................................................... 7 
Figure 1.4: Examples of β-barrel outer membrane proteins from different Gram-
negative organisms. ................................................................................................. 8 
Figure 1.5: Sequence alignment of the C-terminal residues of ten OMPs from E. coli.
 ...............................................................................................................................11 
Figure 1.6: Electrostatic surface potential of the Skp chaperone. ............................14 
Figure 1.7: Crystal structure of SurA. ......................................................................18 
Figure 1.8: Structure of SurA highlighting the C-terminal β-strand essential for 
chaperone activity in vivo. .......................................................................................19 
Figure 1.9: SurA has hydrophobic patches across the whole of its structure and in 
vivo cross-links map to the N-terminal domain. .......................................................21 
Figure 1.10: Model of a DegP 12-mer based on a cryo-EM reconstruction. ............23 
Figure 1.11: Crystal structure of the FkpA dimer. ....................................................24 
Figure 1.12: Schematic of the E. coli BAM complex. ...............................................26 
Figure 1.13: E. coli BamA domain organisation. .....................................................28 
Figure 1.14: E. coli BamA POTRA domains in ‘bent’ and ‘extended’ conformations 
showing flexibility in the hinge between POTRAs 2 and 3. ......................................30 
Figure 1.15: Crystal structures of BamA. ................................................................32 
Figure 1.16: Lateral opening of the BamA barrel is essential in vivo. ......................33 
Figure 1.17: Putative substrate exit pore in the BamA β-barrel domain. ..................34 
Figure 1.18: Crystal structure of BamB from E. coli. ................................................35 
Figure 1.19 – Domain organisation of BamC. .........................................................36 
Figure 1.20 – Crystal structure of the E. coli BamC C-terminal domain. ..................37 
Figure 1.21: Crystal structure of the BamCD complex. ...........................................37 
Figure 1.22: Crystal structure of BamD from E. coli. ...............................................39 
Figure 1.23: Proposed BamD binding pocket for OMP C-terminal targeting 
sequence. ...............................................................................................................39 
Figure 1.24: NMR structure of BamE from E. coli. ...................................................41 
Figure 1.25: Crystal structures of BamACDE and BamABCDE complexes from E. 
coli. .........................................................................................................................42 
Figure 1.26: Cryo-EM structure of the E. coli BAM complex. ...................................44 
 
 
xii 
Figure 1.27: Interactions between BamA POTRA 3 and BamD and the detergent 
micelle in the cryo-EM structure of the BAM complex. ............................................45 
Figure 1.28: Four models of β-barrel assembly by the BAM complex......................46 
Figure 1.29: Model for BamA-mediated OMP biogenesis proposed by the 
Buchannan group. ..................................................................................................47 
Figure 1.30: Structures of the OmpA N-terminal β-barrel domain and the C-terminal 
soluble domain. ......................................................................................................49 
Figure 1.31: Proposed OmpA folding reaction pathway. .........................................50 
Figure 1.32: Reaction catalysed by PagP. ..............................................................55 
Figure 1.33: Native PagP forms an 8-stranded barrel with a 19-residue N-terminal 
helix. .......................................................................................................................56 
Figure 1.34: Chevron plot of PagP kinetic data. ......................................................58 
Figure 1.35: Φ-value analysis of PagP folding in DLPC LUVs.................................59 
Figure 2.1: Schematic of HT-MBP-TEV-POTRAs construct. ...................................74 
Figure 3.1: Purification of PagP. .............................................................................99 
Figure 3.2: Characterisation of PagP folding in DLPC liposomes at pH 8.0. .......... 100 
Figure 3.3: Phosphatidylcholine lipids used in folding assay optimisation. ............ 101 
Figure 3.4: PagP folding yields in PC liposomes of different acyl chain lengths as a 
function of urea concentration. .............................................................................. 102 
Figure 3.5: PagP folding kinetics in PC liposomes of different acyl chain lengths in 
0.24 M urea. ......................................................................................................... 103 
Figure 3.6: Three-dimensional structures of OMPs used in this study. .................. 105 
Figure 3.7: Subcloning of FadL. ............................................................................ 107 
Figure 3.8: Cloning of tBamA into pET11a. ........................................................... 108 
Figure 3.9: Purification of tOmpA, OmpT, OmpF, tBamA and FadL. ..................... 109 
Figure 3.10: OMP folding transients in the absence of lipids. ................................ 110 
Figure 3.11: Folding transients for OmpT and FadL in the absence of lipids. ........ 111 
Figure 3.12: The OMPs tOmpA, PagP, OmpF and tBamA fold with highly 
reproducible exponential kinetics. ......................................................................... 113 
Figure 4.1: Dimensions of the Skp chaperone. ..................................................... 119 
Figure 4.2: tOmpA, PagP, OmpF and tBamA interact with Skp and fold into DUPC 
liposomes under selected conditions. ................................................................... 121 
Figure 4.3: Different Skp:OMP ratios are required to sequester OMPs and inhibit 
folding. .................................................................................................................. 123 
Figure 4.4: 16-stranded OMPs require pre-incubation with a greater molar excess of 
Skp than 8-stranded OMPs to inhibit folding into synthetic liposomes. .................. 124 
Figure 4.5: Skp:OMP complexes have different stoichiometries. ........................... 127 
 
 
xiii 
Figure 4.6: BamA forms complexes with Skp with a 2:1 stoichiometry. ................. 127 
Figure 4.7: Collision cross-section distributions of Skp and Skp:OMP complexes. 131 
Figure 4.8: In vacuo molecular dynamics simulations of Skp. ............................... 133 
Figure 4.9: Possible architectures of Skp:OMP complexes. .................................. 135 
Figure 4.10: Molecular dynamics simulations of Skp, tOmpA and tBamA in solvent.
 ............................................................................................................................. 137 
Figure 4.11: In vacuo molecular dynamics simulations of 1:1 and 2:1 Skp-OMP 
complexes. ........................................................................................................... 138 
Figure 4.12: Molecular dynamics simulations of 1:1 and 2:1 Skp:OMP complexes in 
explicit solvent. ..................................................................................................... 140 
Figure 5.1:  The BamA -barrel has a reduced hydrophobic thickness on one side 
close to the 1 and 16 interface. ......................................................................... 147 
Figure 5.2: Purification of BamA POTRA domains, Skp and SurA. ....................... 150 
Figure 5.3: Fluorescence emission spectra of folded and unfolded OMPs. ........... 152 
Figure 5.4: Substantial fractions of BamA, tBamA and OmpA are folded in DUPC 
liposomes. ............................................................................................................ 152 
Figure 5.5: Effects of urea on BamA and OmpA folding efficiency in DUPC 
liposomes. ............................................................................................................ 154 
Figure 5.6: Effects of BamA and its constituent domains on the folding kinetics of 
tOmpA in DUPC liposomes. .................................................................................. 155 
Figure 5.7: The -barrel domain of BamA facilitates release and folding of tOmpA 
from its complex with Skp. .................................................................................... 157 
Figure 5.8: SurA is unable to release tOmpA from its complex with Skp. .............. 159 
Figure 5.9: Binding of SurA to tOmpA measured by microscale thermopheresis... 160 
Figure 5.10: Hydrophobic thickness of PC bilayers varies linearly with acyl chain 
length. ................................................................................................................... 161 
Figure 5.11: BamA folds with similar efficiencies into DLPC, DTPC and DMPC 
liposomes. ............................................................................................................ 162 
Figure 5.12: Example raw kinetic traces of tOmpA folding in the presence or 
absence of BamA in DLPC, DTPC and DMPC liposomes. .................................... 164 
Figure 5.13: BamA accelerates tOmpA folding more effectively in liposomes with 
longer acyl chain lengths. ..................................................................................... 165 
Figure 5.14: The BamA barrel and POTRA domains have electronegative regions 
which may be involved in release of substrates from Skp. .................................... 169 
Figure 6.1: Movements in the N-terminal TPR domains (1-3) of BamD propagate 
around the periplasmic ring to the BamA barrel in the ‘barrel elongation’ model. .. 175 
 
 
xiv 
Figure 6.2: The conserved VRGF motif maintains BamA barrel stability during 
catalysis in the ‘barrel elongation’ model. .............................................................. 179 
 
  
 
 
xv 
List of Tables 
Table 2.1 Typical cycling times for Vent DNA polymerase PCRs. ...........................68 
Table 2.2: Volumes of reagents for analytical digests of miniprepped DNA from 
colonies on transformation plates. ..........................................................................69 
Table 2.3: Typical volumes of reagents for digests of vector DNA, or PCR products 
for use in downstream ligation reactions. ................................................................69 
Table 2.4: Description of all vectors used in this thesis. ..........................................70 
Table 2.5: Volumes of reagents for Tris-tricine buffered SDS-PAGE gels. ..............78 
Table 2.6: Molar extinction coefficients at 280 nm of purified proteins. ....................80 
Table 2.7:  AKTA Programme parameters for gel filtration of OMPs. ......................73 
Table 3.1: Model OMPs investigated have a range of functions, sizes and number of 
-strands............................................................................................................... 104 
Table 3.2: Measured rate constants for OMP folding into DUPC liposomes. ......... 114 
Table 4.1: Measured rate constants for OMP folding into liposomes after pre-
incubation with varying molar ratios of Skp. .......................................................... 125 
Table 4.2: Observed and expected masses for the complexes studied. ................ 128 
Table 4.3: Experimentally determined modal collision cross-sections (CCSs) (nm2) 
for the observed charge states (z) of Skp and Skp:OMP complexes. .................... 132 
Table 4.4: Comparison of CCS values from MD simulations and IMS-MS 
measurements. ..................................................................................................... 140 
Table 5.1: Measured rate constants for tOmpA folding into DUPC liposomes in the 
presence of BamA constructs or OmpA. ............................................................... 156 
Table 5.2: Measured rate constants for tOmpA folding into DUPC liposomes from its 
complex with Skp in the presence of BamA constructs, OmpA or SurA. ............... 158 
Table 5.3: BamA folding efficiencies in DLPC, DTPC and DMPC liposomes. ....... 162 
Table 5.4: Measured t50 values for tOmpA folding into DLPC, DTPC or DMPC 
liposomes in the presence or absence of BamA. .................................................. 166 
 
  
 
 
xvi 
Abbreviations 
AAA ATPases associated with diverse cellular activities 
Apol Amphipol 
AFM Atomic force microscopy 
Au Absorbance units 
AUC Analytical ultracentrifugation 
BAM -barrel assembly machinery 
BCA Bicinchoninic acid 
BME -mercaptoethanol 
BN-PAGE Blue native polyacrylamide gel electrophoresis 
Bpa p-benzoyl-L-phenylalanine 
bR Bacteriorhodopsin  
BSA Bovine serum albumin 
CD Circular dichroism 
CL Cardiolipin 
cmc critical micelle concentration 
cOHB Oligo-(R)-3-hydroxybutyrates  
CCS Collisional cross-section 
cryoEM Cryo-electron microscopy 
dH2O Deionised water (greater than 15 MΩ resistance) 
DDPC Didecanoyl phosphatidylcholine 
DDPE Didecanoyl phosphatadylethanolamine 
DHFR Dihydrofolate reductase 
DLPE  Dilauroyl phosphatadylethanolamine  
DLPS Dilauroyl phosphatadylserine 
DMPC Dimyristoyl phosphatidylcholine 
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleotide triphosphate 
DOPC Dioleoyl phosphatidylcholine 
DPPC Dipalmitoyl phosphatidylcholine 
dsDNA Double stranded deoxyribonucleic acid 
DTPC Ditridecanoyl phosphatidylcholine 
DUPC Diundecanoyl phosphatidylcholine 
EDTA Ethylenediaminetetraacetic acid 
EM Electron microscopy 
 
 
xvii 
ER Endoplasmic reticulum 
ESI Electrospray ionisation 
EtOH Ethanol 
FA Facial amphipol 
FlAsh 4'5'-bis(1,3,2-dithioarsolan-2-yl)fluorescein 
FPOP Fast photochemical oxidation of proteins 
FRET Förster resonance energy transfer 
FTIR Fourier transform infrared spectroscopy 
GuHCl Guanidine hydrochloride 
HT His-tagged 
HDX Hydrogen-deuterium exchange 
HSQC Heteronuclear single quantum coherence 
IM Inner membrane 
IMS Ion mobility spectrometry 
ITC Isothermal calorimetry 
IPTG Isopropyl-β-d-thiogalactoside 
Kd Equilibrium dissociation constant 
KTSE Kinetics of tertiary structure formation determined by 
electropheresis 
LB Lysogeny broth  
LCFA Long chain fatty acid 
LDAO Lauryldimethylamine-N-oxide 
LMPG Lyso-myristoylphosphatidylglycerol 
Lol Localisation of lipoproteins 
LPR Lipid to protein ratio 
LPS Lipopolysaccharide 
Lpt Lipopolysaccharide transport 
LUV Large unilamellar vesicle 
MBP Maltose-binding protein 
MDR Multidrug resistance 
Mla Maintanence of OM lipid asymmetry 
MRE Mean residue ellipticity 
MRW Mean residue weight 
MS Mass spectrometry 
MST Microscale thermopheresis 
MWCO Molecular weight cut-off 
 
 
xviii 
NAO 10-nonyl acridine orange 
NCS Nonconvential surfactant  
NMR Nuclear magnetic resonance 
NOE Nuclear Overhauser effect 
OD Optical density 
OM Outer membrane 
OMP Outer membrane protein 
ORF Open reading frame 
PAGE Polyacrylamide gel electrophoresis 
PagP PhoP/Q activated gene P 
PC Phosphocholine 
PCR Polymerase chain reaction 
PDB Protein data bank 
PE Phosphatidylethanolamine 
PG Phosphatidylglycerol 
PMSF Phenylmethanesulfonylfluoride 
POTRA Polypeptide transport-associated  
PPIase Peptidyl-prolyl isomerise 
PPIs Protein-protein interactions 
PtdEtn Phosphatidylethanolamine 
RDG Rayleigh-Gans-Debye 
Rg Radius of gyration 
RMSD Root mean square deviation 
SANS Small angle neutron scattering 
SBDD Structure based drug design 
SDS Sodium dodecyl sulphate 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEC Size exclusion chromatography 
SEC-MALS Size exclusion chromatography multiangle light scattering 
SER Smooth endoplasmic reticulum 
Skp Seventeen kilodalton protein 
SMFS Single molecule force spectroscopy 
SurA Survival protein A 
SUV Small Unilamellar Vesicle 
TAE Tris-acetate-EDTA 
TCA Trichloroacetic acid 
 
 
xix 
TDQF Time-resolved distance determination by fluorescence quenching 
TEMED Tetramethylethylenediamine 
TEV Tobacco etch virus 
TF Trigger factor 
ThT Thioflavin T 
TLR Toll-Like Receptor 
Tris Tris (hydroxymethyl)-aminomethane 
TROSY Transverse-relaxation optimised spectroscopy 
UV Ultra violet 
VDAC Voltage-dependent anion channel 
WT Wild-type 
 
 
 
1 
1 Introduction 
“One should really consider the sequence of a protein molecule about to fold 
into a precise geometric form as a line of melody written in a canon form and 
so designed by Nature to fold back into itself, creating harmonic chords of 
interaction consistent with biological function.” 
Chris Anfinsen, 1964 
1.1 Life is defined by membranes 
Despite the incredible diversity of forms and lifestyles that characterise life on Earth, 
at the molecular level living things are comprised of surprisingly few building blocks. 
In the ~350 years since the extraordinary discovery that living things are composed 
of microscopic cells which are invisible to the naked eye1, we have learned that cells 
are mostly aqueous solutions of proteins, nucleic acids and carbohydrates, 
encapsulated by lipid membranes. In order to survive and replicate living things 
must exchange material, energy and information with their surroundings, and this 
exchange across lipid bilayers is mediated by membrane-embedded proteins. Thus, 
lipid membranes are fundamental to life, carrying out a vast array of functions. They 
separate organisms from the exterior world and allow the compartmentalisation of 
cellular processes in membrane-bound organelles within eukaryotic cells, such as 
lipid biosynthesis in the Smooth Endoplasmic Reticulum (SER), enzymatic digestion 
in lysosomes, and energy production in mitochondria. Membrane proteins (MPs) 
account for 20-30% of the Open Reading Frames (ORFs) within organisms2 and 
make up over 50% of potential human drug targets3. 
For proteins to fold stably into the hydrophobic environment of a biological 
membrane their structure must fulfil two energetic requirements: (1) the hydrogen 
bonding potential of their polar backbone carbonyl and NH groups at their amide 
bonds must be mostly satisfied4 to offset the energetic cost of peptide bond burial 
(~1.2 kcal/mol5); and (2) the amino acid side chain groups in contact with the acyl 
chains of the lipid bilayer must be predominantly hydrophobic. The secondary 
structures of α-helical and β-barrel membrane proteins allow them to solve these 
problems in different ways6,7. The residues within each helix in α-helical membrane 
proteins make backbone hydrogen bonds with each other, allowing the separate 
insertion of helices which can subsequently laterally associate with one another8. In 
contrast, β-barrel outer membrane proteins (OMPs) form cylindrical structures by 
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making hydrogen bonds between β-strand residues, potentially far from each other 
in sequence9. 
This project investigates the folding of β-barrel OMPs and, in particular, the role of 
the periplasmic chaperones Skp and SurA10, and BamA11, the main component of 
the β-barrel Assembly Machinery (BAM) complex which catalyses OMP folding and 
insertion into the outer membrane of Gram-negative bacteria9,12-14. There is 
considerable interest in the OMP assembly pathway as a potential target for novel 
antibiotics9. The BAM complex in particular is an attractive target given that it is 
surface located, highly conserved, and essential for viability9,13,15-18. This introduction 
will discuss the Gram-negative cell envelope and the OMP biogenesis pathway, as 
well as review recent genetic, structural and biochemical investigations which have 
dramatically increased our understanding of in vivo and in vitro OMP assembly over 
the last ~20 years. 
1.2 The Gram-negative cell envelope 
Gram-negative bacteria are surrounded by two membranes, the inner membrane 
(IM) which encloses the cytoplasm, and the outer membrane (OM) which is exposed 
to the extracellular space19. Between these is the periplasm, a viscous aqueous 
space (~0.14 m3)20 containing soluble proteins and the peptidoglycan cell wall21. 
The distance between the IM and the OM can be inferred from the structures of 
machineries which span the periplasm which gives estimates in the range 
~165-70 Å17,19 to ~210 Å22, the latter consistent with the dimensions observed by 
electron microscopy23,24. 
In contrast to the complexity of lipid species present in eukaryotic membranes25, 
there are only three lipid types with an abundance >1% in Escherichia coli (E. coli)26: 
phosphatidylethanolamine (PE), phosphatidylglycerol (PG), and cardiolipin (CL) 
(Figure 1.1). Deletion of genes in lipid biosynthesis pathways have shown that E. 
coli are still viable in the absence of CL27,28. The absence of CL leads to an 
enrichment of the other anionic lipid PG27,28, suggesting that CL may be functionally 
substituted by PG26. Strains lacking PE are also viable29,30, a surprising result given 
the high content of PE in wild-type strains (70-80%), and that loss of PE is 
associated with misfolding and incorrect orientation of some membrane proteins, 
such as LacY31. Cells which lack PE have an absolute requirement for divalent 
cations, possibly to aid neutralisation of the additional charges on the membrane 
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due to the increased levels of anionic PG and CL29,30. Taken together, these results 
imply that it is the general physical properties of the lipids, rather than the specific 
types, that is important for both membrane and membrane protein biogenesis26. 
Accordingly, E. coli cannot survive when lacking both PE and CL29. PE and CL are 
both cone-shaped lipids, with the cross-sections of their headgroups smaller than 
that of their acyl chains32 (Figure 1.1). As the shape of lipids within a bilayer is key to 
determining the physical properties of the membrane33, it is likely that the lethality 
due to the removal of both PE and CL is due to a lack of lipids with these biophysical 
properties26. 
 
Figure 1.1: The three major lipid species in E. coli. Structures of PE, PG 
and CL. Each lipid is shown with dioleoyl acyl chains. Different chain lengths 
(C14-C18)34 with different levels of saturation are found in vivo as discussed 
below. Image adapted from Oliver et al. (2014)35. 
The PE and PG components of bacterial membranes are thought to segregate into 
distinct domains36, and the overall spatial distribution of phospholipids within E. coli 
is asymmetric35. Anionic lipids (PG and CL) are enriched at the poles, as determined 
by fluorescence microscopy experiments using the fluorescent dye 10-nonyl acridine 
orange (NAO), which specifically binds PG and CL35, and quantitative liquid 
chromatography–mass spectrometry (LC-MS)35. This may have important 
consequences for the spatial control of OMP biogenesis, given that fluorescence 
microscopy experiments have recently demonstrated that nascent OMPs are 
inserted into the OM away from polar regions of the cell37. 
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The IM is a classical bilayer composed of phospholipids (70% 
phosphatidylethanolamine (PE), 25% phosphatidylglycerol (PG), >5% cardiolipin21,38 
(Figure 1.1)) with acyl chain lengths of mostly C16 and C18 in both leaflets34,39. 
Inner membrane proteins (IMPs) are α-helical membrane proteins which constitute 
~20% of the ~4000 ORFs in the E. coli genome40. IMPs are targeted to the SecYEG 
translocon by a hydrophobic N-terminal signal anchor sequence which is recognised 
by the Signal Recognition Particle (SRP) as the sequence emerges from the 
ribosome40. At the membrane, IMPs are assembled by the co-translational 
sequential insertion of α-helices into the IM by SecYEG using a lateral gating 
mechanism, with energy provided by the SecA ATPase41. A few lipoproteins are 
also associated with the IM, attached via an N-terminal lipid moiety42. 
The peptidoglycan layer (~6-7 nm in E. coli as measured by SANS43, AFM44, and 
cryoEM24) forms a mesh composed of saccharides cross-linked by short peptides45 
which is permeable to proteins under 100 kDa46. Consistent with its structural role in 
maintaining cell shape and integrity, the cell wall is resistant to extremes of pH and 
temperature, and is extremely strong (able to withstand ~3 atm of turgor pressure)47. 
Despite this, the peptidoglycan layer is highly elastic, able to reversibly expand or 
contract up to three-fold48. As well as being crucial for growth and division48, this 
ability to deform parallel to the long axis of the cell44 may also be important for 
allowing passage of components of the OM and their escorts across the periplasm. 
The OM forms a highly impervious selective permeability barrier which protects 
against detergents and toxic substances49. Crucially, the OM must be assembled in 
an environment without an external energy source, as the periplasm is devoid of 
ATP50. In contrast to the IM, the OM is an asymmetric bilayer with the inner and 
outer leaflets composed of phospholipids and lipopolysaccharide (LPS), 
respectively. The maintenance of OM asymmetry is aided by the Mla (maintanence 
of OM lipid asymmetry) complex, which couples ATP hydrolysis at the IM to the 
removal of mislocalised phospholipids from the outer leaflet of the OM51,52. The 
phospholipid content in the OM is similar to that of the IM, but is slightly enriched in 
PE (~80%) and lipids with saturated acyl chains34,39. LPS is a glycolipid typically 
composed of three regions: Lipid A, a dissacharide linked to six saturated fatty acyl 
chains (mostly of C14 acyl chain length in E. coli53,54), a core oligosaccharide region, 
and a long polysaccharide termed the O-antigen (Figure 1.2). The O-antigen is 
highly variable between Gram-negative species55, and also between organisms of 
the same species56. 
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Figure 1.2: LPS biogenesis pathway in E. coli. (a) LPS is synthesised on 
the inner leaflet of the IM, flipped across the membrane by MsbA, assisted 
across the periplasm by LptA, B, C, and F, before insertion into the outer 
leaflet of the OM by the LptDE complex. Image from Okuda et al. (2016)57 (b) 
Structure of LPS from E. coli K12. Kdo, 3-deoxy-D-manno-oct-2-ulosonic 
acid; Hep, L-glycero-D-manno-heptose; Glu, D-glucose; Gal, D-
galactose; EtN, ethanolamine; P, phosphate. Image reproduced from Ruiz 
et al. (2009)58. 
Phosphate groups attached to the sugar moieties in LPS (Figure 1.2) are involved in 
coordinating divalent metal cations, such as Mg2+ and Ca2+, allowing LPS molecules 
to pack closely together57. This packing of LPS saccharide units, which can number 
up to 60056, protects Gram-negative bacteria against hydrophobic molecules, such 
as antibiotics57. LPS is essential in most Gram-negative bacteria, as are the genes 
responsible for its transport to the OM (LptA-G in E. coli)57 (Figure 1.2), and stress 
responses are initiated when its integrity is compromised59,60. As well as performing 
a protective role, LPS also appears to be important in the assembly of at least some 
OMPs in vivo61. Consistent with this, in vitro work demonstrated that the 16-stranded 
porin PhoE folds with greater efficiency in phospholipid/LPS bilayers than in 
phospholipid/phospholipid bilayers62. The high density of negative charge on LPS 
molecules could explain why OMPs tend to have an excess of positive charge on 
their extracellular side (‘positive-outside’ rule)63, in contrast to membrane proteins 
inserted into the Endoplasmic Reticulum (ER) and the IM which obey a ’positive-
inside’ rule64,65. Further, a recent computational study predicted that LPS plays an 
important role in contributing to OMP thermodynamic stability66. 
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In addition to the OMPs embedded within it (Section 1.2.1), the E. coli OM has ~100 
associated lipoproteins, most of which are of unknown function19,67. Lipoproteins 
have their own dedicated transport system, the localisation of lipoproteins (Lol) 
system68 (Figure 1.3). As lipoproteins emerge from the Sec translocon their signal 
peptides are cleaved by signal peptidase II (SPase II) adjacent to an N-terminal 
cysteine residue, which is then modified by the covalent attachment of membrane 
anchoring acyl chains18. If the residue C-terminal to the cysteine is not aspartate 
(the signal for IM retention42), the lipoprotein is released from the IM by the LolCDE 
complex, bound by LolA as it crosses the periplasm, and assisted into the OM by 
LolB69. The majority of OM lipoproteins are located in the periplasm, such as the 
major lipoprotein Lpp (Braun’s lipoprotein) which covalently attaches to the 
peptidoglycan layer70. Lipoproteins can also be exposed on the surface of cells, as 
demonstrated in E. coli for RcsF71, which senses defects in the cell envelope60, the 
BAM complex member BamC37,72, and the free-form of Lpp73. Some lipoproteins 
have highly specialised roles, such as LptE, which is important in the assembly, and 
possibly function, of the 26-stranded OMP LptD, which inserts LPS into the outer 
leaflet of the OM57. 
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Figure 1.3: Pathways for the biogenesis of inner membrane proteins 
(IMPs), outer membrane proteins (OMPs) and lipoproteins. All three are 
synthesised in the cytoplasm and interact with the Sec translocon. IMPs are 
laterally released into the membrane. Lipoproteins are transported to the OM 
by the Lol machinery. OMPs are guided by periplasmic chaperones to the 
BAM complex which catalyses their folding and insertion into the OM. Image 
reproduced from Hagan et al. (2011)9. 
1.2.1 Outer membrane proteins (OMPs) 
The OM is densely packed with proteins (protein:phophospholipid:LPS ratio of 
5:1:1 (w/w))74 which are involved in a myriad of functions including the uptake of 
nutrients, release of waste materials, secretion of virulence factors, and resistance 
to host defence systems68. OM proteins are almost excusively β-barrel membrane 
proteins (Figure 1.4), with the notable exception of the Wza octamer, which forms an 
α-helical barrel in the membrane75. The only other biological membranes which 
contain OMPs are the outer membranes of mitochondria and chloroplasts, 
consistent with the hypothesis that these organelles have an endosymbiotic origin76. 
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Figure 1.4: Examples of β-barrel outer membrane proteins from different 
Gram-negative organisms. OMPs can be found as monomers (Pla from 
Yersinia pestis; PDB:2X5577), multimers (dimeric OmpLA from E. coli; PDB: 
1QD678, and trimeric LamB from Salmonella typhimurium; PDB: 2MPR79), or 
oligomers in which the β-barrel is made from several subunits (TolC from E. 
coli; PDB: 1EK980). Image created with PyMOL, based on an image from Kim 
et al. (2012)13 . 
Approximately 2-3% of genes in Gram-negative bacteria are β-barrel OMPs81 which 
are grouped into six families: (1) porins such as OmpC and PhoE; (2) passive 
transporters such as FadL; (3) active transporters such as the FhuA siderophore 
transporter and the BtuB vitamin B12 transporter; (4) enzymes such as the palmitoyl 
transferase PagP and the protease OmpT; (5) defensins such as OmpX; and (6) 
structural proteins such as OmpA68. Only two OMPs are known to be essential in E. 
coli, LptD (Figure 1.2) and BamA (Section 1.4.1). The trimeric porins are particularly 
abundant, covering ~70% of the membrane surface in Roseobacter denitrificans82. 
Non-specific 16-stranded porins such as OmpF and OmpC are present in ~105 
copies per cell83 and allow the passive diffusion of small hydrophilic molecules (up to 
~600 Da)68. A consequence of the OM being porous to small ions, including protons, 
is that the pH of the periplasm is dictated by that of the surrounding medium84. 
Some passive transporters have substrate specificity such as PhoE (16-stranded), 
an anion selective porin85, and LamB (18-stranded) which transports 
maltosaccharides across the OM86. Additionally, for essential molecules in low 
abundance in the external environment, active transport systems are used. For 
example, in the TonB system receptors, such as the 22-stranded OMPs BtuB, FepA 
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and FhuA, use energy from the IM via a complex energy-transducing system in 
order to import nutrients such as vitamin B12, the enterabactin and the ferrichrome 
siderophores, respectively87,88. 
OMPs of known structure contain between 8-26 membrane-embedded β-strands, 
with almost all containing an even number of anti-parallel β-strands in their native 
state89. One exception is the mitochondrial OMP VDAC (Voltage-dependent anion 
channel), whose structure indicates a 19-stranded -barrel90-92. The amphipathic β-
strands within OMPs expose hydrophilic side chains to the inside of the channel (for 
those OMPs with an internal lumen), while those in contact with the bilayer are 
largely hydrophobic89,93. Two striking structural features of natively folded OMPs are 
likely to be important in their biogenesis: (1) both the N- and C-termini are located in 
the periplasm94; and (2) they have characteristically long loops on their extracellular 
side, while on their periplasmic sides the turns are short, consisting of only a few 
amino acids89,94. This latter feature may be important for the formation of 
intermediate β-hairpins; AFM experiments have shown that OMPs are able to 
unfold95,96 and refold97 via β-hairpin units. 
While this project focuses on OMPs consisting of a single polypeptide chain, much 
larger β-barrel structures are formed in the outer membrane (OM) by the assembly 
of multiple monomeric subunits. These assemblies are usually involved in secretion, 
examples of which include CsgG, which is involved in curli biogenesis98 forming a 
36-stranded barrel in the OM from 9 subunits99, and the dodecameric GspD100-102, a 
member of the Type II secretion system (T2SS) family103. Available evidence 
suggests that these complexes assemble in pathways independent of the BAM 
complex104,105, and are therefore not considered further in this work. 
Another widely distributed class of proteins which form β-barrels in the OM are 
members of the autotransporter family106,107. Autotransporters consist of a large 
(often >100 kDa108) N-terminal ‘passenger’ domain, which is secreted into the 
extracellular space, and a 12-stranded β-barrel domain107. As crystal structures 
show that the diameter of this barrel (~10 Å) is too small to transport some of the 
folded passenger domains that autotransporters are able to secrete (10-20 kDa)108, 
the name ‘autotransporter’ is perhaps misleading109. Indeed, assembly of 
autotransporters has been shown to involve the BAM complex110-112, and/or the 
translocation and assembly module (TAM) complex113 (Section 1.4) via 
mechanism(s) which remain unresolved108. 
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1.2.2 The OMP biogenesis pathway 
In common with other proteins with a high β-sheet propensity, OMPs are 
aggregation-prone so must be chaperoned at every stage of their biogenesis14,81,114. 
Following synthesis on cytosolic ribosomes OMPs are initially bound by Trigger 
Factor (TF) which prevents their interaction with the SRP as occurs for IMPs115-117. 
Binding of IMPs to SRP leads to their subsequent cotranslational membrane 
insertion by the SecYEG translocon using a lateral gating mechanism. IMPs have a 
highly hydrophobic signal anchor sequence at their N-terminus, whereas the N-
terminal signal sequence (~20-30 residues) of proteins which are destined for 
secretion is less hydrophobic, and it is these differences in targeting signal 
characteristics which determine the pathway followed41. OMPs are escorted to the 
IM by the SecB chaperone118,119 which binds to and transfers substrates to the 
SecYEG translocon via the SecA ATPase120,121. OMPs are then translocated across 
the IM by the SecYEG translocon using energy provided by the SecA ATPase 
(Figure 1.3)122. Once through the IM their leader sequence is cleaved by signal 
peptidase I (SPase I) and the mature OMPs are bound by periplasmic chaperones13, 
such as SurA, Skp and DegP (Section 1.3). The time taken from synthesis to final 
folded state is in the order of minutes, with the lifetime of unfolded LamB in the 
periplasm reported to be ~2 min123,124. Recent kinetic modelling of the flux of 
unfolded OMPs across the periplasm suggests that, on average, OMPs make 100’s 
of interactions with chaperones, which are present in concentrations such that there 
is always a free reservoir available for OMP binding124. 
OMPs finally reach the BAM complex, which catalyses the folding and insertion of β-
barrel proteins into the OM15,125,126. Exactly how OMPs are targeted to the BAM 
complex is not known, but it has been proposed that, in addition to the recognition of 
non-specific β-sheet sequences, a C-terminal ~9 residue targeting motif is involved 
(Figure 1.5). Studies on the phosphate transporter PhoE demonstrated that a 
conserved phenylalanine residue at its C-terminus is essential for its efficient 
folding127,128. Robert and coworkers showed that the C-terminal motif is recognised 
by BamA in a species specific manner using in vitro binding experiments between 
BamA and unfolded OMPs or synthetic peptides derived from them129. The same 
study demonstrated that altering the C-terminal motif of neisserial PorA (a lysine to 
glutamine substitution at the -2 position) dramatically improved its assembly in vivo 
in the OM of E. coli129. However, a bioinformatics analysis of C-terminal targeting 
signals of all predicted OMPs from 437 organisms found little difference between 
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recognition motifs, such that OMPs from almost all Gram-negative bacteria should 
be able to be expressed in E. coli130. The targeting sequence is also important for 
the initiation of the E-dependent stress response, which is triggered by the 
presence of misfolded OMPs in the periplasm131, as peptides of the OMP signal 
sequence alone are able to trigger the E response132. 
 
Figure 1.5: Sequence alignment of the C-terminal residues of ten OMPs 
from E. coli. The conserved residues indicated have been proposed to form a 
targeting sequence for BAM-mediated assembly of OMPs. The conserved 
sequence is ΦxΦxΦxYxF/W, where Φ is a hydrophobic residue and x is any 
amino acid. Conserved hydrophobic residues are highlighted in yellow; the 
consensus residues Y at position -3 and F/W at position -1 are highlighted in 
purple and blue, respectively. Numbers in green indicate distance from the C-
terminus of the protein. 
A targeting signal known as the β-signal is important for assembly of mitochondrial 
OMPs which has the consensus sequence ζxGxxΦxΦ, where ζ is a polar residue, Φ 
is a hydrophobic residue, and x is any amino acid133. This sequence is also present 
in some bacterial OMPs, such as BamA and OmpF, and at least some Gram-
negative OMPs can be assembled into the mitochondrial OM134 and vice versa135. 
Interestingly, a peptide which contained the β-signal sequence found in E. coli 
BamA was recently shown to inhibit BAM function in vitro, and cause growth defects 
and sensitivity to antibiotics in vivo when expressed in the periplasm136. 
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1.3 Folding in the periplasm 
A complex array of folding factors are involved in the biogenesis, homeostasis and 
protection of proteins in the periplasm including chaperones, proteases, peptidyl-
proline isomerases (PPIases), and protein disulphide bond forming enzymes and 
isomerases10. Gram-negative bacteria are exposed to many environmental stresses, 
such as detergents, and extremes of pH and temperature. In such conditions many 
folding factors of the cell envelope are upregulated via one of five main stress 
responses (e, Cpx, Rcs, Bae, and Psp)18. This is a large and fascinating area of 
study, however, the discussion here will focus on the folding factors for which 
experimental results have been obtained in the current project: the major OMP 
chaperones in E. coli, Skp and SurA.  
1.3.1 Skp 
The cellular location and role of Skp (Seventeen kilodalton protein) was initially 
subject to much controversy. Skp was reported to be a cell surface LPS-binding 
protein137, a tetrameric DNA binding protein138, an outer membrane protein139 and a 
ribosome-binding protein140. Finally, Skp was demonstrated to be a soluble 
periplasmic protein141 (consistent with the presence of an N-terminal cleavage signal 
sequence in its nucleotide sequence142), which selectively binds to OMPs143 and is 
involved in maintaining OMP solubility in the periplasm144. Skp is a highly basic 
molecule (pI ~9.5) and its non-specific affinity for anionic molecules such as LPS, 
DNA and ribosomes most likely led to these initial artefactual results. 
Several groups have shown that the Skp gene is not essential in E. coli143-145. An 
early study found that chromosomal inactivation of Skp led to reduced OM levels of 
the major porins, which could be reversed by the addition of a plasmid expressing 
wild-type Skp143. However, later gene deletion studies found little effect on OM 
composition144,145, which was confirmed by a proteomics study which found that 
removal of Skp had no impact on the levels of 63 identified OMPs146. This indicates 
some redundancy in chaperone pathways, with other OMP chaperones, such as 
SurA and the chaperone/protease DegP able to functionally replace Skp147. 
Consistent with this, removal of additional chaperones in a ∆skp background have 
synergistic effects. One study found that ∆skp∆degP cells accumulate protein 
aggegrates in the periplasm, have increased sensitivity to the hydrophobic 
anitbiotics rifampicin, vancomycin and novobiocin, and are non-viable at 37 °C144. 
 
 
13 
Further, it was reported that a Skp/SurA double deletion is lethal145, consistent with 
proteomic analysis of OMP levels in ∆skp cells in which SurA was depleted, which 
showed a reduction of nearly all OMPs146. 
Cross-linking studies in spheroplasts indicated that Skp operates early in the 
pathway, while OMPs are emerging from the SecYEG translocon144,148. By contrast, 
attempts to cross-link Skp to BamA in vivo have been unsuccessful, even in the 
absence of SurA145. 
The crystal structure of Skp revealed a trimeric structure consisting of a 'body' 
domain, containing a 9-stranded β-barrel which mediates trimerisation, with long 
coiled-coil α-helical 'tentacles' which extend away from the 'body' domain149,150. Skp 
has a very large electrical dipole (estimated at ~3,700 Debye149), with the region 
around the subunit tips particularly enriched in conserved lysine and arginine 
residues (Figure 1.6).  
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Figure 1.6: Electrostatic surface potential of the Skp chaperone. (a) 
Surface electrostatics of Skp (PDB: 1U2M150) viewed from the side (upper) 
and bottom (lower). Electropositive and electronegative surfaces are 
highlighted in blue and red, respectively. Electrostatic surface representations 
(-2 kT/e to +2 kT/e) were generated using the APBS plugin for PyMOL151. (b) 
Secondary structure of Skp, also viewed from the side (upper) and bottom 
(lower) (PDB: 1U2M150). Individual subunits are shown in yellow, green, and 
cyan. Missing residues in chains B and C were modelled from chain A using 
PyMOL. 
The functional significance of this charge distribution may be that Skp acts as an 
electrostatic delivery vehicle152, with positive residues in the tips interacting with 
either BAM components (all of which have a pI <7.0), or with the inner leaflet of the 
outer membrane which has an overall net negative charge due to the presence of 
the negatively charged lipids PG (~10%39) and CL (~3%39). Supporting the latter 
hypothesis, in vitro experiments have shown that the presence of Skp can increase 
the kinetics of folding into negatively charged synthetic liposomes for both OmpA153 
and PagP152. Further, a recent study suggested that Skp can fold and insert OMPs 
directly into native membranes in vivo in the absence of the BAM complex154. No 
direct in vivo cross-links to BAM components have been reported for Skp145, 
however, site-specific photocrosslinking experiments showed that the -barrel 
domain of EspP (-domain) interacts sequentially with Skp and BAM components 
(BamA, BamB and BamD)112. 
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Using an in vivo pull-down assay, Jarchow et al. found that Skp interacts with >30 
OMPs, including a broad range of sizes from 8-stranded OMPs (OmpA, OmpX) to 
the 26-stranded LptD155. A Skp mutant which had a more hydrophobic interior was 
able to pull-down additional proteins to those pulled-down by wild-type Skp, 
providing evidence for client binding within the Skp cavity155. For one of the OMPs 
identified, OmpC, light-scattering assays have subsequently shown that Skp can 
prevent its aggregation in vitro156. The study by Jarchow et al. also demonstrated 
that, in addition to binding numerous OMPs, Skp also interacts with many soluble 
periplasmic proteins in vivo, including β-lactamase and maltose binding protein 
(MBP)155. The ability of Skp to effectively chaperone soluble proteins has been 
demonstrated by in vitro aggregation assays using lysozyme as the substrate150,157, 
and co-expression of Skp has been shown to improve the yield of recombinant 
soluble proteins158, including mammalian transcription factors159 and antibody 
fragments157. In vivo cross-linking studies showed that Skp interacts with the soluble 
passenger domain of the autotransporter EspP111. 
While no specific Skp-recognition sequence(s) within OMPs have been identified, 
hydrophobic and electrostatic interactions have both been implicated in Skp 
binding155,160,161. Skp has been shown to have high affinity for its substrates with 
affinities measured by changes in tryptophan fluorescence (Skp binding to tOmpA 
(the transmembrane -barrel domain of OmpA), NalP, OmpG, OmpA, and BamA)160 
and by Förster resonance energy transfer (FRET) experiments (Skp binding to 
OmpC)162 in the nanomolar range. Qu et al. found that addition of 1 M NaCl reduced 
the apparent affinity of Skp for substrates, suggesting that electrostatics maybe 
important for Skp-substrate interactions. This effect was not due to effects on Skp 
trimerisation as sedimentation equilibrium analytical ultracentrifuge (AUC) 
experiments revealed Skp trimerisation is unaffected by salt163. However, salt has 
been shown to promote the aggregation of unfolded OMPs164, so the apparent 
decrease in affinity of Skp for OMPs could be due to depletion of the unfolded OMPs 
due to aggregation163. 
A putative LPS-binding site was identified when the structure of Skp was first 
reported150, based on the similarity in position and type between four residues in the 
Skp structure to those bound to LPS in the FhuA crystal structure165. The presence 
of LPS increases the observed kinetic folding rates of OmpA in the presence of 
Skp153,166. However, an extensive bioinformatics search found that some residues in 
the proposed binding site are not well conserved167. Further, nuclear magnetic 
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resonance (NMR) studies revealed that LPS acts in a similar manner to the 
detergent lauryldimethylamine-N-oxide (LDAO), in that it destabilises and 
denaturates Skp into monomeric subunits167. Therefore, it is likely that this non-
specific denatuting effect of LPS on the Skp trimer, together with non-specific 
electrostatic effects between Skp and membrane-incorporated LPS152,153, provides 
the explanation for the previous kinetic data167. 
NMR studies are ideally suited to the study of dynamic protein interactions such as 
those between chaperones and their clients168,169. NMR has shown that Skp 
maintains substrates in an unfolded state170,171, with the high affinity between Skp 
and its substrates resulting from many weak and transient interactions171. Available 
evidence from NMR161,170,171, in vivo pull-down experiments155, in vitro cross-
linking170, and SANS172, suggests that substrates are bound by Skp within its 
hydrophobic cavity. A selective isotope labelling strategy allowed the detection of 
intermolecular nuclear Overhauser effects (NOEs) between Skp and tOmpA161. The 
resulting residue-specific map of the Skp-tOmpA interface showed that tOmpA is 
bound in the centre of the Skp cavity161. The mass spectrometry results presented 
here in Chapter 4 also support the hypothesis that Skp sequesters its clients173. Skp 
bears a striking structural similarity to the eukaryotic chaperone prefoldin174 (Figure 
4.9f), which has also been shown to sequester substrates within its cavity175. 
For OMP substrates which are attached to a soluble domain, 2D NMR experiments 
have demonstrated that Skp can be bound to the transmembrane domain while 
allowing the periplasmic domain to fold independently170. 1H15N transverse-
relaxation optimised spectroscopy (TROSY) heteronuclear single quantum 
coherence (HSQC) spectra were acquired for 15N labelled constructs of OmpA and 
tOmpA (the transmembrane domain of OmpA) in complex with Skp, and the OmpA 
periplasmic domain alone. The tOmpA-Skp spectrum exhibited a narrow dispersion 
of peaks of varying intensities characteristic of an unfolded protein, while the 
spectrum for OmpA in complex with Skp contained additional well-dispersed peaks 
indicative of a folded protein. Many of these additional peaks overlapped with those 
from a 1H15N TROSY-HSQC spectrum for the periplasmic domain alone, showing 
that the periplasmic domain is folded outside the Skp cavity170. This was also 
confirmed by NMR experiments in which T1 and T2 relaxation parameters were 
obtained for residues in the OmpA periplasmic domain. The results showed that the 
average rotational correlation time (c) was similar when the OmpA periplasmic 
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domain was free in solution to when it was covalently attached to the 
transmembrane domain in complex with Skp170.  
The potential of Skp as an antibiotic target may be limited as it is not an essential 
gene, at least in E. coli and N. gonorrhoea176. However, it does interact with the 
multidrug efflux pump TolC80, which spans the periplasm and is known to mediate 
drug resistance in many pathogens, including Vibrio cholerae177. Further, genetic 
evidence has also shown that Skp has a specific role in the assembly of the 
essential OMP LptD which mediates LPS insertion into the OM178. Investigations into 
the effects of Skp deletion from N. meningitides found that levels of the porin PorB 
were affected, which could not be complemented by the addition of Skp from E. 
coli179. However, deletion of N. meningitides SurA had no effect on OMP 
biogenesis179, in sharp contrast to the results obtained for E. coli SurA145,180 (Section 
1.3.2). This highlights the species-specificity of OMP chaperones, a factor which will 
need to be considered if drugs targeting OMP chaperones are to be developed. 
1.3.2 SurA 
SurA (Survival protein A) was first reported as a gene required for bacterial survival 
in the stationary phase181,182. Later SurA was identified as a member of the parvulin-
like family of PPIases183, which assists the correct folding of porins in the OM183,184. 
This was confirmed by genetic studies which found that depletion of SurA resulted in 
reduced OM density, in contrast to depletion of either Skp or DegP which had no 
effect145. Simultaneous removal of SurA and Skp is lethal147,185, with similar synthetic 
lethality observed for the double deletion of SurA and DegP147. These results led to 
the suggestion that Skp and SurA function in partially redundant parallel pathways, 
with SurA as the main chaperone pathway for OMPs and the Skp/DegP pathway 
becoming more important in times of stress145,147. However, differential proteomic 
analysis of 23 OMPs from wild-type and surA strains found that only a subset of 
eight OMPs were substantially reduced in the absence of SurA180. These include the 
porins OmpA, OmpF and LamB, which make up the bulk of the protein mass in the 
OM, as well as FadL, OmpX, FecA, FhuA and LptD. RT-PCR analysis of mRNA 
levels in surA cells showed that FhuA and LptD are the only OMPs for which a 
reduction in protein expression levels could not be explained by reduced 
transcription of their genes due to E induction, suggesting these are true SurA 
substrates180. Interestingly, a later proteomics study showed that BamA assembly, 
was not dependent on SurA or Skp146. 
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SurA was found to be associated with the OM186 and, by contrast to other 
periplasmic chaperones, has been directly cross-linked to the BAM complex in 
vivo145,187. An arginine residue (R64) in polypeptide transport-associated (POTRA) 
domain 1 of BamA is important for this interaction187, and the P2 domain of SurA has 
been implicated in this interaction by in vivo photocross-linking188. 
SurA (45 kDa) consists of an N-terminal domain and a small C-terminal domain, 
interspersed with two PPIase domains (P1 and P2) (Figure 1.7). The SurA crystal 
structure showed an elongated structure189 reminiscent of Trigger Factor, which also 
has a PPIase domain at one end190. 
 
Figure 1.7: Crystal structure of SurA. (a) SurA consists of N- and C-terminal 
domains which form the core chaperone unit, interspaced by two PPIase 
domains. Image created in PyMOL (PDB: 1M5Y189), with missing residues 
added using MODELLER191. (b) Domain structure of SurA coloured as in (a). 
Only the second PPIase domain (P2) of SurA exhibits significant PPIase activity, 
and general chaperone activity was still present in a mutant which lacked both the 
P1 and P2 domains (SurA-NCt)185. Interestingly, protection against aggregation of 
thermally-denatured citric synthase was enhanced for SurA-NCt compared with wild-
type SurA185. Expression of the PPIase domains in vivo could not complement 
surA cells, by contrast to SurA-NCt which almost completely complements wild-
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type SurA, suggesting that the main role of SurA is as a chaperone185. Consistent 
with this, SurA homologues in other species lack the P2 domain (e.g. 
Haemophilus)185 or both P1 and P2 domains (e.g. Rickettsia)192. 
Xu et al. (2007) solved the structures of peptides in complex with the P1 domain of 
SurA and full-length SurA lacking P2 (SurA-P2)193. Surprisingly, the structures 
showed peptides bound to P1, and in the case of SurA-P2, a dimeric structure was 
solved involving a large-scale structural rearrangement. This suggests that SurA can 
adopt very different tertiary structures when binding substrates, and the authors 
propose that P1 may be involved in determining substrate specificity193. Recent 
genetic evidence highlighted the involvement of P1 in SurA function in E. coli; SurA 
mutations which suppress OMP assembly defects caused by BamA and BamB 
mutations, were found to map to the P1 domain194. 
The SurA C-terminal ~10 amino acids contain a single β-strand, which forms a 
three-stranded β-sheet with a β-hairpin from the N-terminal domain (Figure 1.8)189. 
Deletions of these C-terminal residues have shown that formation of this β-sheet is 
essential for SurA chaperone activity in vivo195. However whether this indicates a 
functionally relevant location, for example providing an interaction site for OMP 
substrates via β-augmentation196, or merely disrupts the overall fold of the protein is 
unclear195. 
 
Figure 1.8: Structure of SurA highlighting the C-terminal β-strand 
essential for chaperone activity in vivo. Image created in PyMOL (PDB: 
1M5Y189), with missing residues added using MODELLER191. 
 
SurA has been shown to bind unfolded OMPs162,197 and have a specificity for 
substrates rich in the Ar-X-Ar motifs common in OMPs (where Ar is an aromatic 
residue and X is any amino acid)198. Measured affinities are in the low M range (Kd) 
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for SurA binding to peptides from phage display libraries186,197,198, and to the full-
length OMPs OmpF and OmpG using a peptide competition assay197. Tighter 
binding (Kd of ~0.1 M) was observed for SurA binding to the 16-stranded OmpC in 
fluorescence-based experiments162. 
It may transpire that rather than having one specific binding site, hydrophobic 
surfaces at multiple locations across SurA may interact with OMP substrates, as 
NMR studies have demonstrated for the chaperones Trigger Factor199 and SecB169 
in complex with unfolded soluble proteins. A recent in vivo photocross-linking study 
showed that SurA interacts with OMPs in many regions across the surface of the N-
terminal domain188 (Figure 1.9). Specific regions within OMP substrates may also 
preferentially bind to SurA; recent in vivo photocross-linking of SurA to OMPs with 
genetically incorporated p-benzoyl-L-phenylalanine (Bpa)200 (OmpF or LamB with 
Bpa at 17 or 19 different positions, respectively) showed that these OMPs interact 
with SurA preferentially at their N- and C-terminal regions188. Consistent with this, 
the Ar-X-Ar motif shown to be recognised by SurA198 is very common in OMP 
sequences at their C-terminus (Figure 1.5)130. 
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Figure 1.9: SurA has hydrophobic patches across the whole of its 
structure and in vivo cross-links map to the N-terminal domain. Views of 
SurA from (a) the side, and (b) the front – P2 facing out of the page). 
Hydrophobic residues (Gly, Ala, Val, Leu, Ile, Met, Phe and Trp) are shown in 
orange. Residues which, when replaced with Bpa cross-link to OMPs in vivo, 
map to different regions within the N-terminal domain188 are highlighted in 
green (upper). Domain organisation is shown in cartoon representation 
(lower). Image created in PyMOL (PDB: 1M5Y189), with missing residues 
added using MODELLER191. 
It is also highly likely, given the size of SurA (45 kDa) relative to some of its known 
substrates (e.g. FhuA (79 kDa) and LptD (87 kDa)), that its chaperone activity 
involves multivalent binding. Indeed, recent analytical size exclusion 
chromatography (SEC) experiments for SurA in complex with FhuA were consistent 
with a 2:1 SurA:FhuA stoichiometry97, and in vivo cross-linked products between 
SurA and OmpF suggested that 2-3 copies SurA may bind OmpF188. 
In vitro single molecule force spectroscopy (SMFS) experiments recently 
demonstrated that the presence of SurA allowed the refolding of FhuA in β-haipin 
units in a stepwise manner following mechanically induced unfolding97. FhuA was 
mostly misfolded in the absence of SurA, while FhuA remained unfolded in the 
presence of Skp, leading to the suggestion that SurA specifically biased the 
conformations of dynamic, unfolded states towards those which favour productive 
folding97. There is much left to discover about SurA, but its importance is highlighted 
by the link between SurA and virulence of a number of pathogens201,202. 
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1.3.3 DegP 
DegP (also known as HtrA203) is a dual function serine protease/chaperone which is 
upregulated in response to the accumulation of unfolded OMPs in the periplasm, 
and by envelope stresses such as heat shock, via both the E and Cpx stress 
response systems10. The switch between DegP protease and chaperone function is 
governed by temperature, with protease activity dominating at high temperatures (42 
ºC) and DegP functioning mostly as a chaperone below 28 ºC204. 
Structurally DegP (47 kDa) consists of three domains, a chymotrypsin-like protease 
domain and two PDZ domains involved in substrate binding10. The resting state is a 
hexamer which can undergo oligimerisation to form large 12-mer and 24-mer cages 
in the presence of substrate205 (Figure 1.10). However, DegP protease activity is not 
dependent on the formation of these higher order structures206. A cryo-EM structure 
of the DegP 12-mer contained density which, surprisingly, was consistent with a 
folded monomer of the porin OmpC. This led the authors to speculate that, as well 
as forming a proteolytic chamber, DegP cages could provide a folding compartment 
for nascent OMPs205. 
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Figure 1.10: Model of a DegP 12-mer based on a cryo-EM reconstruction. 
Structure of a DegP 12-mer with folded 16-stranded porin (yellow) modelled in 
to account for the density in the centre of the cage. Image created with 
PyMOL (PDB: 2ZLE205). 
Studies using fluorescently-labelled chaperones and OMPs showed that DegP can 
form ternary complexes with substrates and either Skp or SurA162. While DegP-OMP 
complexes are thermodynamically more stable than those between OMPs and 
either Skp or SurA, the association rate (kon) between OMPs and DegP is ~1000-
fold slower, suggesting a kinetic partitioning model for OMP transport across the 
periplasm162. This work has led to a proposal that DegP may operate late in the 
OMP biogenesis pathway207, however, attempts to cross-link DegP to the BAM 
complex have been unsuccessful145. 
1.3.4 FkpA 
FkpA (26 kDa), like SurA, is a dual function PPIase and chaperone implicated in 
OMP biogenesis. As for SurA, in vivo and vitro studies have indicated that these 
activities are independent from one another10. Deletion of FkpA is not lethal, but in 
one study led to an upregulation of periplasmic proteases and an increase in OM 
permeability208. FkpA appears to become important in OMP assembly at heat shock 
temperatures (44 ºC)209. The synthetic lethal phenotype of a skpsurA strain could 
be suppressed at high temperatures by over-expression of FkpA. Further, in vitro 
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work showed FkpA is more effective at preventing the aggregation of OmpF at 44 ºC 
than at 37 ºC, and fluorescence-based experiments showed that both the 
association rate and affinity between FkpA and OmpF is increased at elevated 
temperatures209. 
Structurally FkpA consists of an N-terminal helical domain involved in chaperone 
activity and a C-terminal PPIase domain (Figure 1.11). The crystal structure showed 
a v-shaped dimer which suggested substrates may be cradled in the crevice 
between monomers210, with this ‘mother’s arms’ chaperone model later supported 
NMR studies211. 
 
Figure 1.11: Crystal structure of the FkpA dimer. The N-terminal 
chaperone domain and C-terminal PPIase domain are shown in yellow and 
green, respectively. Image created with PyMOL (PDB: 1Q6U210). 
 
Schwalm et al. (2013) showed that the assembly of LptD is compromised in 
fkpAskp strains, providing further evidence that FkpA is involved in OMP 
biogenesis178. Interestingly, the defect in LptD assembly caused by loss of FkpA and 
Skp, could be suppressed by a mutation which leads to a 1000-fold increase in the 
expression level of the general chaperone Spy178,212. However, while this indicates 
Spy is able to chaperone OMPs, its upregulation was unable to complement for loss 
of SurA178. 
1.3.5 PPIases and disulphide isomerases 
In addition to SurA and FkpA two other proteins in the periplasm are known to have 
PPIase activity: PpiA and PpiD68. PpiA is a highly active PPIase in vitro213, but its 
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deletion had no effect on total OMP levels or their rate of assembly in vivo214. There 
is conflicting evidence on the role of PpiD in OMP folding. PpiD was first reported as 
a multicopy suppressor of SurA215. Deletion of the gene was reported to impair OMP 
folding and surA and ppiD double null mutants were found to be synthetically 
lethal215. However, these results have not been replicated and the Silhavy group 
later reported that PpiD deletion has no effect on OMP biogenesis216. Interestingly 
even quadruple ppiDppiAfkpAsurA null mutants were found to be 
phenotypically indistinguishable from a surA strain216. However, in vivo PpiD has 
been shown to have partially overlapping substrate specificity with SurA217. 
A recent in vivo cross-linking study found simultaneous cross-links between PpiD, 
SecYEG, SurA, and BAM complex members, leading the authors to speculate that 
PpiD is involved in a supercomplex that spans the periplasm188. However, if this 
were a major pathway for OMPs across the periplasm, OMP production in ppiD 
mutants should be severely comprised216. Further, kinetic modelling of OMP flux 
through the periplasm suggests that such a supercomplex is not needed to explain 
all known experimental data124. 
The correct formation of disulphide bonds in proteins can be crucial to their stability, 
and, together with the cis-trans isomerisation of peptidyl-prolyl bonds, is often the 
rate limiting step in protein folding. The disulphide isomerases DsbA and DsbB are 
involved in the catalysis of disulphide bond formation, with DsbC and DsbD 
operating later as ‘proof-readers’. Their involvement in OMP biogenesis is limited as 
only a small subset of OMPs contain disulphide bonds218. LptD is a notable 
example, for which both DsbA and DsbC have been reported to assist in the correct 
ordering of disulphide bonds in the native state219,220. 
1.4 The BAM complex 
The structure and function of the BAM complex has been the focus of intense 
research interest in the 13 years since the discovery of the role of BamA in OMP 
assesmbly15. BAM is a hetero-oligomeric complex which, in E. coli, consists of five 
subunits: BamA-E, formerly known as YaeT, YfgL, NlpB, YfiO and SmpA, 
respectively (Figure 1.12)9,125,126. This section will consider what is known about the 
roles of each subunit, and discuss the complete221,222 and near-complete221,223 BAM 
structures recently available, and their implications for BAM mechanism. 
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Figure 1.12: Schematic of the E. coli BAM complex. The major subunit, 
BamA, consists of a C-terminal membrane-embedded β-barrel domain and 
five N-terminal POTRA domains. The four lipoproteins BamB-E are scaffolded 
by the BamA POTRA domains. BamB binds BamA separately to BamCDE. 
Most information on the BAM complex has come from studies in E. coli9, but the 
subunits are widely conserved across Gram-negative species224. The largest 
subunit, BamA, is an integral membrane protein, and the only component present in 
all Gram-negative bacteria224. Its role in OMP assembly was first identified in 
Neisseria meningitides; depletion of the neisserial BamA homologue Omp85 led to 
growth and OMP assembly defects, and its deletion was lethal15. BamA homologues 
exist in mitochondria and chloroplasts225-227, reflecting the endosymbiotic origin of 
these organelles227. In mitochondria, OMPs are assembled by the Sorting and 
Assembly Machinery (SAM) complex, whose BamA homologue is Sam50. Sam50 
associates with two essential cytosolic proteins Sam35 and Sam37 which are 
unrelated to BamB-E228. Much less is known about OMP assembly in plants; the 
BamA homologue in chloroplasts (Toc75-V) is involved229,230, but its accessory 
proteins remain to be identified13,231. 
BamB-E are lipoproteins, anchored to the OM via their N-terminal acyl chains, with 
molecular weights of 42, 37, 28 and 12 kDa, respectively in E. coli. The ratio 
between the BAM subunits in structures from BAM isolated from the E. coli OM is 
1:1:1:1:1221,222,232, making a core complex of ~203 kDa. This ratio was also 
suggested for the BAM complex made by reconstitution of purified BamAB and 
BamCDE subcomplexes, although it was difficult to resolve whether one or two 
copies of BamE were associated with the complex due to its low molecular 
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weight233. Native mass spectrometry (MS) of OM-purified BAM complex indicated 
the presence of a small population of complexes with an additional BamE subunit232, 
and BamE dimerization has also been observed in vitro234-236. 
Co-immunoprecipitation experiments in E. coli showed that any BAM complex 
member expressed with a His-tag can pull-down the entire complex125,126. BamB 
binds BamA separately from BamD, and BamC and BamE both depend on BamD 
for their stable interaction with BamA237. Consistent with the idea of a modular BAM 
complex, sub-complexes of BamAB and BamCD, in addition to the BamABCDE 
complex, have been observed in the OM of wild-type cells, suggesting BAM sub-
complexes may dynamically associate in vivo72. 
The oligomeric state of the BAM complex in vivo is not known, however in one study 
purified E. coli BamA was seen to form possible tetramers as evidenced by a 
473 kDa peak in a size exclusion chromatograph (SEC)129. Monomers, dimers and 
trimers of BamA, as well as tetramers were detected by Blue Native Polyacrylamide 
Gel Electrophoresis (BN-PAGE). The authors accounted for the differences in the 
SEC and BN-PAGE data by suggesting that Coomassie dye binding to BamA shifts 
the equilibrium towards the formation of smaller oligomers and monomers129. The 
Omp85 family member HMW1B from Haemophilus influenzae also forms 
tetramers238, however no tetramerisation of the whole BAM complex has yet been 
observed. Recent evidence indicates that a single copy of the whole BAM complex, 
in nanodiscs containing E. coli polar lipid extract, is sufficient for the assembly of the 
autotransporter EspP239. However, spatial clustering of BAM complexes may be 
functionally relevant, as BAM has been observed in 0.5 m ‘OMP islands’ in vivo37. 
Further, recent genetic experiements suggested multiple copies of BAM may be 
involved in the assembly of trimeric porins240. 
Genetic deletion of BamA15,125 or BamD241 is lethal, while deletion of BamB, BamC 
or BamE leads to varying degrees of OMP assembly and growth defects13. The 
molecular details of how the BAM complex aids OMP insertion and folding have yet 
to be elucidated. However, a wealth of structural and biochemical information has 
become available in recent years for each of the BAM components which is 
summarised below. 
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1.4.1 BamA 
BamA is a member of the TpsB/Omp85 superfamily which contains members with 
functions associated with protein translocation across, and assembly into, Gram-
negative bacterial outer membranes242. BamA is the most conserved BAM 
component, and the only one with homologues in all known Gram-negative 
species224; the thermophilic bacterial species Thermus thermophilus and 
Thermosynechococcus elongates contain no homologues of the lipoproteins BamB-
E243,244. Proteins in the Omp85 family consist of a C-terminal membrane-inserted 16-
stranded β-barrel domain with up to seven tandemly-linked POTRA domains. The 
number of POTRA domains varies between one and seven according to the function 
of the Omp85 family member226,244,245, and also between species. The Omp85 
protein Mxan5763 of Myxococcus xanthus has seven POTRA domains246. 
Mitochondrial Sam50 has only one POTRA domain, and one study surprisingly 
reported that the Sam50 POTRA domain is non-essential for β-barrel assembly and 
cell growth in yeast133. BamA from cyanobacteria, such as T. elongates, have three 
POTRA domains244 while BamA from proteobacteria, such as N. meningitides and 
E. coli, have five (Figure 1.13)68,247. 
 
Figure 1.13: E. coli BamA domain organisation. BamA consists of five N-
terminal tandemly-linked POTRA domains (P1-P5) of approximately 75 
residues each, and a 385 residue C-terminal 16-stranded β-barrel domain.  
The first and last POTRA domains in cyanobacteria (1 and 3) correspond, in terms 
of sequence and structure, to the first and last POTRA domains in proteobacteria (1 
and 5)244. TamA, a BamA homologue involved in autotransporter assembly113, has 
three POTRA domains248. The TAM complex has no other OM components, and 
instead is associated with an inner membrane protein, TamB113,249. The number of 
BamA POTRA domains that are essential appears to vary between bacterial 
species. In E. coli, it was initially observed by domain deletion experiments that only 
POTRAs 3-5 are essential247. However, a later study, using a different expression 
system, found that all five POTRA domains were required for normal growth and 
viability250. By contrast, in N. meningitidis it was found that only POTRA 5 (nearest 
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the C-terminal β-barrel) was required; only minor OMP defects resulted from 
deletion of POTRAs 1-4251. Replacement of BamA in N. meningitides and E. coli 
with BamA from other Gram-negative species was lethal, except in the case where 
species were closely related (N. gonorrhoea BamA could complement BamA from 
N. meningitides)252. The β-barrel domain of BamA was reported to be essential in N. 
meningitides as its substitution with an unrelated β-barrel was lethal251. However, in 
this study the OmpLA β-barrel was chosen. As OmpLA forms dimeric structures253, 
the lack of viability of these mutants may due to the formation of dimers of POTRA 
domains-OmpLA barrel fusion proteins. Interestingly, it was found that chimeric E. 
coli BamA fusion proteins, carrying either the β-barrel or POTRA domains from 
various BamA orthologues, were viable254. While the BamA β-barrel domains were 
found to be functionally interchangeable between most species, compensatory 
mutations in the POTRA domains could improve OMP assembly, suggesting that 
the BamA membrane and soluble domains need to be precisely tuned for efficient 
OMP assembly254. 
 
BamA POTRA domains are proposed to have at least three roles: (1) to serve as 
docking sites for BamB-E, as evidenced by domain deletion experiments247, and 
confirmed by recent structures221-223; (2) to interact with periplasmic OMP 
chaperones – POTRA 1 has been shown to interact with SurA187; and (3) to form a 
binding site for OMP substrates. Early evidence for BamA directly binding OMPs 
came from conductance experiments in planar lipid membranes which showed that 
BamA forms a pore whose conductance, and therefore presumably size, increases 
when bound to unfolded OMPs255. Robert et al. used this observation to 
demonstrate that the binding between OMPs and BamA is species specific129. NMR 
data have also demonstrated binding between β-strand sequences of PhoE and 
BamA POTRA domains256. However, this binding was very weak, as chemical shift 
changes in 50 M POTRA domains 1-2 were not saturated on addition of up to 1.5 
mM PhoE peptide256. There are no reports of POTRA domains binding directly to 
full-length OMP substrates in vitro. 
In common with other Omp85 family members BamA POTRA domains have low 
sequence identity between each other245. However, the publication by the Kahne 
group in 2007 of a crystal structure of E. coli POTRA domains 1-4 (and a small 
section of POTRA 5) revealed domains which are highly superimposable, with a fold 
consisting of two α-helices and a 3-stranded β-sheet (β1-α1-α2-β2-β3) (Figure 
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1.14)247. A further crystal structure of POTRAs 1-4 by the Sousa group showed a 
structural difference to that of the Kahne group in the orientation of POTRAs 2 and 
3257. In the Kahne structure the angle between the two domains is 30° (‘bent’ 
conformation), whereas in the Sousa structure the angle is 130° (‘extended’ 
conformation) (Figure 1.14). 
 
Figure 1.14: E. coli BamA POTRA domains in ‘bent’ and ‘extended’ 
conformations showing flexibility in the hinge between POTRAs 2 and 3. 
The two independent structures of POTRAs 1-4 are shown superimposed at 
POTRA 3 (Kahne structure in green (PDB: 2QCZ247), Sousa structure in blue 
(PDB: 3EFC257). The POTRA 5 domain has been modelled from a structure of 
POTRAs 4-5 (PDB: 3OG5257). The proposed functional movement of the 
POTRA domains, hinged at the loop between POTRAs 2 and 3257, is indicated 
by a pink arrow. Structures aligned and images created with PyMOL. 
NMR and SAXS data for POTRAs 1-5 confirmed that there is flexibility between 
these domains256. A subsequent crystal structure of POTRAs 4-5, published in 2010, 
revealed that the complete periplasmic domain of BamA forms a corkscrew-like 
structure258. The authors additionally performed Ensemble Optimisation Method 
(EOM) analysis on SAXS data for POTRAs 1-5, which suggested that the two 
crystal structures represent two preferred conformations of the complete periplasmic 
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domain, with some rigidity at all POTRA interfaces except POTRAs 2 and 3258. Solid 
state NMR studies of complete BamA also indicated flexibility within the POTRA 
domains259. Crystal structures of BamA POTRAs-BamB fusions demonstrated that 
the POTRA 2-3 hinge is the location bound by BamB260,261, suggesting that BamB 
may be involved in the regulation of POTRA domain conformations260. Newly 
available X-ray and cryo-EM structures for full-length BamA11, and BAM 
complexes221-223,232 (Section 1.4.6) indicate flexibility between all POTRA domains, 
and between the POTRA domains and the BamA barrel. This is consistent with 
results from molecular dynamics (MD) simulations of full-length BamA embedded in 
a native OM262. However, the largest variation in the angles between domains in all 
structures containing BamA occurs at the POTRA 2-3 hinge221-223,232,247,257. 
A breakthrough came in 2013 when the first structures of BamA became available, 
from the organisms Neisseria gonorrhoeae and Haemophilus ducreyi (Figure 
1.15)11. 
 
 
32 
 
Figure 1.15: Crystal structures of BamA. BamA structure from (a) N. 
gonorrhoea (PDB: 4K3B11), and (b) H. ducreyi (PDB: 4K3C11). 
The structures revealed three key features: (1) in the N. gonorrhoeae structure the 
lumen of the BamA -barrel was occluded by POTRA 5, whereas in the H. ducreyi 
structure the cavity is accessible, suggesting a possible gating mechanism; (2) the 
side of the of the BamA β-barrel at the interface between β1 and β16 has a 
narrowing of the hydrophobic surface. This feature was proposed to be involved in 
local membrane thinning and increase in lipid disorder to aid OMP insertion, and 
was backed by evidence from MD simulations of the BamA barrel in DMPE 
bilayers11; and (3) in the N. gonorrhoeae structure only two hydrogen bonds are 
present between β1 and β16, with the C-terminus of β16 twisted into the barrel 
lumen, suggestive of a lateral gating mechanism. Lateral opening events at the 
β1/β16 seam were observed in MD simulations of the BamA barrel in DMPE 
bilayers at 340 K, which were not seen in control simulations of the BtuB and FhaC 
barrel domains11. Experiments in which cysteine mutations designed to cross-link 
the β1 and β16 strands were introduced into BamA in vivo were found to be lethal 
(Figure 1.16)221,263. 
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Figure 1.16: Lateral opening of the BamA barrel is essential in vivo. (a) 
BamA model in the ‘closed’ state, based on HdBamA crystal structure (PDB: 
4K3C11). (b) BamA model in the ‘open’ state, from MD simulations of E. coli 
BamA. (c) Residues for which disulphide cross-links were introduced in 
vivo263. Yellow and green circles represent residues which face into the lumen 
of the barrel or into the membrane, respectively. All cross-link mutants were 
lethal in the absence of reductant, with the exception of the Y423C/I806C 
mutant which exhibited reduced colony formation. Image adapted from Noinaj 
et al. (2014)263. 
Recently, complementary experiments were performed in vitro which investigated 
the effect of cross-linking the BamA barrel of purified BAM complexes reconstituted 
in proteoliposomes of E. coli polar lipid extract232. Cross-linking of the BamA barrel 
substantially affected the folding of OmpT, which could be rescued to near wild-type 
levels in the presence of reductant232. Interestingly, BAM activity was not completely 
ablated in the oxidised state, suggesting that the lethal phenotype observed for 
BamA barrel cross-links in vivo may be due to kinetic effects on OMP insertion. 
One key mechanistic problem in OMP assembly is how OMP extracellular loops 
and/or extracellular domains are translocated across the OM. MD simulations of the 
E. coli BamA barrel revealed an opening just above the lateral gate, between the 
loop connecting β1 and β2 (L1), and the L6 loop. This opening was proposed to 
function as a substrate exit pore263. Consistent with this, Cys mutants designed to 
prevent opening of the exit pore by disulphide cross-linking are lethal, but can be 
rescued by the presence of reductant (Figure 1.17)221,263. 
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Figure 1.17: Putative substrate exit pore in the BamA β-barrel domain. (a) 
Opening of the proposed exit pore in MD simulations of the E. coli BamA 
barrel. (b) Model of the BamA barrel with the exit pore in the closed state. (c) 
Residues designed to form a cross-link between L1 and L6 which when 
mutated to Cys (E435 and S665) are shown as yellow spheres. The 
E435C/S665C mutant is lethal, and can be rescued by the presence of 
reductant263. Image adapted from Noinaj et al. (2014)263. 
1.4.2 BamB 
Although deletion of BamB is non-lethal, strains lacking BamB have severe OMP 
assembly defects125,264. BamB deletions show the same phenotype as SurA 
mutants123, and double deletion of these two proteins is lethal264, suggesting that 
SurA and BamB operate in the same pathway13. The OMPs most affected in bamB 
strains are large β-barrels (16-24 stranded264-266), leading to the suggestion that 
BamB may function by providing additional locations for OMP binding via β-
augmentation for larger substrates13,267. However, not all larger barrels are equally 
affected in bamB null mutants; the levels of the 16-stranded OmpC are only slightly 
reduced in the absence of BamB265. Further, ITC experiments showed no evidence 
for binding of peptides derived from OMPs to BamB from Pseudomonas 
aeruginosa268, and indeed no studies have reported an interaction between BamB 
and OMP substrates269.  
The crystal structures of BamB from E. coli267,270-272, and Pseudomonas 
aeruginosa268, reveal that it forms an eight-bladed β-propeller (Figure 1.18). BamB 
has a short, funnel-like shape with a height of 28 Å and a width of 48 Å, and an 
opening in the centre of ~10 Å at its narrowest point. This pore is a conserved 
structural feature in BamB not present in other β-propeller proteins. However, this 
 
 
35 
appears not to be functionally important as a BamB mutant designed to obstruct this 
pore (N62W/S329W) could fully complement a bamB strain268. 
 
Figure 1.18: Crystal structure of BamB from E. coli. BamB forms an eight 
bladed β-propeller structure with a four-stranded β-sheet in each blade. Image 
created with PyMOL (PDB: 3PIL273).  
In vitro experiments using a reconstituted BAM complex found that the absence of 
BamB reduced the efficiency of OMP assembly, consistent with in vivo results233. 
Thus, BamB is important in the BAM mechanism, but if it is not directly involved in 
binding OMPs, its main role may be to modulate the activity of BamA268 (Section 
1.4.1). Another possibility is that BamB interacts with SurA to facilitate the handover 
of nascent OMPs from SurA to BamA272, but experimental evidence for such an 
interaction is lacking. 
BamB, while not essential, is a good potential antibiotic target; useful drugs which 
act on proteins involved in OMP assembly need not be lethal. They may cause 
defects in the OM that allow the entry of other antibacterials, or may attenuate 
virulence mediated by OM factors. Recent evidence demonstrated that deletion of 
BamB from Klebsiella pneumonia attenuated virulence in vivo274, highlighting the 
potential of BamB as a target, which may be less prone to selection pressure than 
essential bacterial proteins275. 
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1.4.3 BamC 
The role of BamC has also remained enigmatic. Genetic deletion of BamC results in 
reduced OMP levels and increased membrane permeability, but these defects are 
milder compared with deletion of BamB125,276. Structurally, BamC consists of an N-
terminal unstructured region followed by two helix-grip domains connected by an α-
helical linker (Figure 1.19). 
 
Figure 1.19 – Domain organisation of BamC. An N-terminal unstructured 
region (blue) is followed by two helix-grip fold domains separated by a short α-
helical linker. The N-terminal domain (yellow) and the C-terminal domain 
(green) are both helix-grip domains. 
The crystal structure of the C-terminal helix-grip domain revealed an antiparallel six-
stranded β-sheet with one 310 helix and two α-helices (Figure 1.20). The N-terminal 
BamC unstructured region is the most conserved part of the protein; the crystal 
structure of a BamCD complex demonstrated that it forms a ‘lasso’ which binds 
BamD over much of the BamD surface (Figure 1.21)270. 
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Figure 1.20 – Crystal structure of the E. coli BamC C-terminal domain. 
The domain forms a helix-grip fold consisting of a six-stranded β-sheet, two α-
helices and a short 310 helix. Image created with PyMOL (PDB: 3SNS
277). 
 
Figure 1.21: Crystal structure of the BamCD complex. The crystallised 
complex consists of full-length BamD and BamC (residues 26-217) lacking its 
C-terminal helix-grip domain. The unstructured N-terminal domain of BamC 
forms a lasso-like structure across the surface of BamD (yellow). Motifs 1, 2 
and 3 in the lasso-like N-terminal region of BamC are highlighted in light blue, 
green and pink, respectively. The remaining residues in BamC, including the 
N-terminal helix-grip domain, are shown in orange. The N’ denotes N-terminus 
of BamC. (PDB: 3TGO270). 
Work by Webb and colleagues using immunofluorescence microscopy, protease 
shaving, and whole-cell ELISA experiments unexpectedly found that part of BamC is 
surface exposed on the extracellular face of the OM72. Further, a recent study was 
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able to use an anti-BamC antibody to track the spatial location of the BAM complex 
in vivo37. Bioinformatic analysis of the unstructured N-terminal domain of BamC 
revealed that it contains three conserved motifs (Motif 1, 2 and 3)72. Motifs 1, 2 and 
3 correspond to the conserved regions BamC28-42, BamC54-68 and BamC74-102, 
respectively (Figure 1.21). The crystal structure of the BamCD complex (Figure 1.21) 
reveals that a large majority of contacts with BamD are made by Motif 1 and Motif 2 
of BamC72,270. Webb et al. further showed that only the first 25 residues of BamC are 
necessary for interaction with BamD, hence the residues in Motif 3 are not required 
for BamD interaction. The authors therefore suggest that both BamC helix-grip 
domains are extracellular with Motif 3 of the BamC N-terminal region spanning the 
OM and Motifs 1 and 2 interacting with BamD in the periplasm. The possible 
functional implications are not clear; the extracellular helix-grip domains of BamC 
may help to stabilise the interstrand loops of BamA72. 
1.4.4 BamD 
BamD is the only essential BAM lipoprotein241, and similarly to the other BAM 
lipoproteins, its exact functions are unclear. However, it has been suggested that 
BamD may play a role in initial substrate recognition235,270. Its structure consists of 
five tandem tetratricopeptide (TPR) motifs (Figure 1.22)278,279. TPR motifs are found 
in proteins which are involved in protein-protein interactions (PPIs), such as the Hop 
adaptor protein which mediates the interaction between the chaperones Hsp70 and 
Hsp90280. TPRs are also found in proteins which bind targeting sequences; PEX5, a 
cytosolic receptor for peroxisomal proteins, utilises TPR motifs to recognise and 
bind substrates via their C-terminal targeting sequences (Figure 1.23a)281. 
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Figure 1.22: Crystal structure of BamD from E. coli. Five helix-turn-helix 
TPR motifs are separated by interconnecting loops. Image created with 
PyMOL (PDB: 3Q5M278). 
 
Figure 1.23: Proposed BamD binding pocket for OMP C-terminal 
targeting sequence. (a) The PEX5 receptor for peroxisomal proteins (blue) is 
shown aligned with BamD (grey). The pentapeptide containing the 
peroxisomal targeting sequence SKL (PTS1) which was crystallised with 
PEX5281 is highlighted in red. (b) The N-terminal ‘lasso’ region of BamC (red) 
occludes the proposed OMP binding pocket in BamD (grey). The pentapeptide 
containing the PTS1 sequence, modelled in from the PEX5 crystal structure281, 
is shown in black. Image reproduced from Kim et al. (2011)270. 
The structure of BamD is very similar to that of the TPR motifs of PEX5 (r.m.s.d. of 
1.7 Å270), and peptides containing C-terminal OMP targeting sequences could be 
cross-linked to a truncated BamD construct of TPRs 1-3, as well as full length 
BamD235. Thus, it was proposed that the N-terminal binding pocket between TPRs 1 
and 2 of BamD could possibly be the recognition site for OMP C-terminal targeting 
sequences (Figure 1.5). However, the structure of the BamCD complex shows that 
the N-terminal unstructured region of BamC also binds BamD in this region (Figure 
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1.21). This occludes the potential binding pocket, suggesting a possible mechanism 
for BamC to regulate the function of BamD (Figure 1.23b)270. However, the recent 
BAM complex structures show that the BAM lipoproteins and the BamA POTRA 
domains form a ring structure in the periplasm221-223,232, and it seems likely that 
substrates enter this ring en route to the membrane. The N-terminal BamC ‘lasso’ 
which binds BamD faces out from, rather than into the periplasmic ring, suggesting 
that if BamD does bind OMP targeting sequences, it does so on the opposite face of 
the molecule to that proposed by Kim et al. (2011) (Figure 1.23)270. Recent in vitro 
evidence suggested that peptides based on OMP targeting sequences (β-signals) 
can bind BamD, and inhibit BAM function136. Further, in vivo expression of peptides 
containing β-signals caused growth defects and increased susceptibility to 
antibiotics. In vivo cross-linking studies showed that these peptides bound BamD, 
suggesting a promising starting point for the design of novel antibiotics which target 
the BAM complex136. 
Further evidence that BamD binds substrates separately to BamA comes from work 
by the Silhavy group which identified a temperature-sensitive lethal mutation 
(E373K) in POTRA domain 5 of BamA which prevents the association of the BamAB 
and BamCDE subcomplexes. Suppressor mutations in BamD (residue R197) could 
restore BAM function without re-establishing a stable interaction between the 
BamAB and BamCDE subcomplexes. The authors suggest this demonstrates that 
both BamD and BamA interact directly with OMPs, and that BamD is activated by 
the R197 mutations, a role normally performed by BamA282. 
One specialised role for BamD may be in the assembly of BamA. It was shown that 
BamD alone can assemble BamA into proteoliposomes composed of E. coli lipid 
extract, by contrast to OmpA, which requires additional BAM complex members283. 
1.4.5 BamE 
BamE is the smallest protein in the complex and, similar to BamC, its deletion 
produces mild OMP assembly defects126,276. Structurally, BamE consists of two α-
helices packed against a three-stranded antiparallel β-sheet (Figure 1.24)234,236. 
BamE can exist as a monomer or a domain-swapped dimer in solution236, and there 
is conflicting evidence as to whether the dimer is relevant in vivo. One group found 
no BamE dimers in the periplasm234, while another reported BamE dimers purified 
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from the OM235. Recently, native-MS of the intact BAM complex suggested a small 
population of complexes contain two BamE subunits232. 
 
Figure 1.24: NMR structure of BamE from E. coli. The BamE fold has two 
α-helices at its N-terminal region and a three-stranded antiparallel β-sheet at 
its C-terminal region. Image created with PyMOL. (PDB: 2KXX234).  
It was proposed that BamE may play a structural role as the BAM complex is 
destabilised in its absence, as judged by the difference in protein levels of BAM 
complex components that co-purify with His-tagged BamA between wild-type and 
bamE strains126. NMR studies showed that BamE can bind simultaneously to 
BamD and PG, leading to the suggestion that BamE may be involved in anchoring 
the BAM complex to negatively charged PG-rich regions in the OM284. Native-MS 
experiments are needed to resolve if BAM selectively binds lipids in the OM285. 
BamE has been shown recently to play an essential role in the assembly of 
RcsF/OMP complexes, which are important in the Rcs stress response60. RcsF is an 
OM lipoprotein with a surface exposed region which senses envelope stress286, and 
contains a hydrophilic transmembrane domain which is threaded through the lumen 
of OMPs71. In a bamE strain RcsF/OmpA complexes were not detectable, 
demonstrating a key role for BamE in envelope stress signalling mechanisms60. 
1.4.6 Structural insights into the whole BAM complex 
Despite the availability of structures for all individual components of the BAM 
complex, it was not until 2016 that the first insights into the overall architecture of 
BAM were obtained. First, a crystal structure of the BamACDE complex (lacking 
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BamB) was published223, quickly followed by two crystal structures of the intact 
BamABCDE complex221,222. 
 
Figure 1.25: Crystal structures of BamACDE and BamABCDE complexes 
from E. coli. (a-c) Structure of BamACDE viewed from the (a) membrane 
plane, (b) extracelluar side, and (c) periplasm. BamD forms a ring structure by 
binding to POTRAs 1, 2 and 5. BamC binds to both BamD and POTRA 1 and 
2 of BamA in this structure. BamE to both BamA and BamD. (d-f) Structure of 
BamABCDE viewed from the (d) membrane plane, (e) extracelluar side, and 
(f) periplasm. BamA-E are shown in red, green, blue, magenta, and cyan, 
respectively. Image reproduced from Gu et al. (2016)221. 
The BAM complex forms a ‘hat-like’ shape, with the BamA barrel forming the crown 
of the hat in the OM, and the BamA POTRA domains and BAM lipoproteins forming 
a ring structure (the brim of the hat) in the periplasm (Figure 1.25)221,222. Substrates 
presumably pass through this ring en route to the membrane. In the BamACDE 
structures the extracellular loops L1-3 which help form a dome over the barrel in 
previously published BamA structures are displaced upwards, and the first six β-
strands (β1-β6) of the BamA barrel are rotated away ~65º from β16 to form an 
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opening in the lateral gate with a maximum distance of ~15 Å (Figure 1.25a)221. The 
lumen of the BamA barrel in the BamACDE structures is occluded by POTRA 5 and 
periplasmic turns T1-T4 of BamA (Figure 1.25b,c)221,223. This BAM conformation was 
termed ‘lateral open’. By contrast, in the BamABCDE structures (Figure 1.25d)221,223 
the BamA barrel is in a closed conformation and sealed by extracellular loops, 
similar to that observed in previously published BamA structures263,287. In the 
BamABCDE structures the whole periplasmic ring structure in the periplasm is 
rotated by 30º compared with ‘lateral open’ structures, with the BamA barrel lumen 
open to the periplasm as it is no longer occluded by POTRA 5 (Figure 1.25e,f)221,222. 
Conformational changes also occur throughout the POTRA domains, with the 
largest changes occurring at the hinge region between POTRAs 2-3232,257. This BAM 
conformation has been termed ‘inward open’221, but is also referred to as ‘lateral 
closed’232. 
The presence of two possible BAM conformations is consistent with bacterial 
genetic studies by the Silhavy group which identified two conformations of BamA in 
vivo, a protease sensitive conformation which could be labelled in the L6 loop by 
PEG-maleimide, and a protease resistant conformation which could not be labelled. 
These may correspond to the ‘lateral open’ and ‘inward open’ conformations, 
respectively, observed in crystal structures221-223. 
In the BAM complex crystal structures the ‘lateral open’ state was only observed in 
the absence of BamB, allowing the possibility that lateral opening in BamA may be 
driven by BamB dissociation. However, the recent publication of a cryo-EM structure 
of the intact BamABCDE complex in a ‘lateral open’ conformation excludes this 
possibility (Figure 1.26)232.  
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Figure 1.26: Cryo-EM structure of the E. coli BAM complex. BamA binds 
BamB via POTRAs 2 and 3. BamC binds BamD via its unstructured N-terminal 
region; no density for the BamC C-terminal domain is visible in the structure. 
BamD interacts with BamA separately mainly via POTRA 5, but also makes 
contacts with POTRAs 1 and 2. BamE binds BamD and also interacts with 
BamA via POTRA 5. The BAM complex structure viewed from (a) membrane 
plane, and (b) periplasm. Image created with PyMOL (PDB: 5LJO232). 
The solution structure of the BAM complex, in contrast to the BAM complex crystal 
structures, also contained density for the detergent micelle. N-terminal residues of 
BamB, and loops containing hydrophobic residues in BamA POTRA 3 and BamD 
are observed making contact with the detergent micelle. This suggests that regions 
of the BAM complex other than the BamA barrel may be involved in contacting the 
membrane, and possibly modulating the lipid environment of the OM to facilitate 
OMP folding232 (Figure 1.27). Consistent with this, the two tryptophan residues in 
POTRA 3 were observed inserting into the OM in MD simulations of BamA in a 
native membrane262. 
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Figure 1.27: Interactions between BamA POTRA 3 and BamD and the 
detergent micelle in the cryo-EM structure of the BAM complex. (a) A 
hydrophobic loop within the body of BamA POTRA 3 (blue, white arrow) is 
buried within the micelle (grey) (inset). The N-terminus of BamB (green, black 
arrow), also makes contact with the micelle. (b) A hydrophobic 310 helix in 
BamD (orange) is inserted into the micelle. Hydrophobic residues are buried in 
the acyl chains of the detergent (inset). Image reproduced from Iadanza et al. 
(2016)232. 
The two different conformations of the BAM complex in crystal structures has led to 
speculation that these represent ‘resting’ and ‘active’ states of the BAM reaction 
cycle, with these corresponding to the ‘inward open’ (‘lateral closed’) and ‘lateral 
open’, respectively. However, in the cryo-EM solution structure in DDM micelles, 
BAM is in the ‘lateral-open’ state, and there was no evidence of alternative 
conformations in the data set232. Therefore, the ‘lateral open’ conformation could be 
the true BAM resting state, and intriguingly, this leaves the β1 strand available for 
potential interactions with nascent OMPs via β-augmentation (Section 1.4.7). 
However, this conformation could possibly be due to the detergent used, and further 
structures in more native-like membranes will be needed to resolve this. 
1.4.7 Models of β-barrel folding and insertion by the BAM complex 
The least well understood part of BAM function in OMP biogenesis is the final 
folding and insertion step. In 2012, Kim et al. summarised the four models that have 
been proposed (Figure 1.28)13: 
1) ‘Export model’: OMPs are translocated through the BamA pore before entry into 
the OM (Figure 1.28a). The BamA barrel lumen is ~25 Å in diameter11,129, 
therefore sufficiently large to accommodate unfolded OMPs during translocation. 
However, it is not clear how OMPs could fold into the membrane from the 
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extracellular environment. If the C-termimal domains of BamC are indeed 
extracellular72 and are involved, deletion of BamC would be expected to produce 
more severe OMP assembly defects than observed experimentally125,276. 
2) ‘BamA-assisted model’: OMPs are folded and inserted at the lipid-BamA 
interface with the BamA β-barrel domain acting as a scaffold (Figure 1.28b). 
3) ‘Oligomeric BamA-assisted model’: Tetramerisation of the BAM complex allows 
the folding and insertion of OMPs in the space between the four complexes, 
again using the BamA β-barrel domain as a scaffold (Figure 1.28c). 
4) ‘Budding model’: BamA β-barrel opens up between its N- and C-terminal β-
strands which serve as templates for the newly folding OMP  (Figure 1.28d). As 
the substrate completes folding and forms a β-barrel the terminal β-strands of 
BamA are released to return the BamA barrel to the closed state. This model 
has the merit that the energetic cost of opening up the BamA barrel is offset by 
the formation of new hydrogen bonds with the incoming substrate13. 
 
Figure 1.28: Four models of β-barrel assembly by the BAM complex. (a) 
OMPs are first translocated through the BamA channel. (b) The BamA β-barrel 
acts as a scaffold for folding. (c) OMPs fold between a BAM complex tetramer. 
(d) The BamA β-barrel domain opens up to template OMP folding, forming a 
hybrid barrel with the nascent OMP. Image from Kim et al. (2012)13. 
Reconstituted whole BAM complex in nanodiscs ~10 Å in diameter288,289, a size 
unable to accommodate more than one BAM complex copy, allowed the assembly 
of the autotransporter EspP239, arguing strongly against the need for BAM to 
oligomerise in order to be functional (Figure 1.28c). However, the finding that BAM 
is located in clusters with other OMPs in the OM (‘OMP islands’)37,290 suggests that 
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the spatial closeness of individual BAM complexes may play a role in the assembly 
of some OMPs. These may include the trimeric porins which have been shown 
recently to be specifically affected by reduction in the expression levels of BamA 
and BamD240. 
In all four models the BamA POTRA domains could bind OMPs by β-augmentation 
prior to OMP insertion. These models are not necessarily mutually exclusive; the 
Buchannan group favour a hybrid model in which the BamA barrel destabilises the 
membrane (‘BamA-assisted’), but is also involved in templating folding of nascent 
OMPs and the formation of a hybrid BamA:OMP barrel263 (Figure 1.29).  The 
molecular mechanisms underlying BAM activity may also vary depending on the 
substrate240; a single mechanism may be insufficient to explain all aspects of BAM 
activity. Much more work is needed to elucidate the molecular mechanisms of how 
the BAM complex catalyses folding as there is little evidence to support any of these 
models. 
 
Figure 1.29: Model for BamA-mediated OMP biogenesis proposed by the 
Buchannan group. Image reproduced from Noinaj et al. (2014)263. 
1.5 In vitro studies of OMP folding  
The field of membrane protein folding has lagged far behind that of soluble protein 
folding partly due to the lack of available membrane protein structures, although the 
number of new membrane protein structures has increased rapidly in recent years89. 
In addition, membrane proteins are much less experimentally tractable due to their 
high hydrophobicity14,291. Membrane protein folding is also complicated by the need 
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to consider the effects of the folding environment. The folding, stability and 
dynamics of membrane proteins are all influenced by general properties of the 
bilayer, such as curvature, hydrophobic thickness, and fluidity292. The folding 
environment can also influence the final native state of OMPs; the mitochondrial 
voltage-dependent anion-selective channel (hVDAC1) forms structures with different 
amounts of -helical and -sheet secondary structure depending upon whether the 
protein is folded in detergent or lipid293.  
There is some evidence that similar principles are involved in the folding of α-helical 
and -sheet membrane proteins291. Both classes can fold spontaneously into 
bilayers to structures which are at free energy minima, can undergo reversible two-
state folding under defined conditions, and can be assembled from polypeptide 
fragments291,294,295. However, α-helical and β-barrel proteins may not fold by the 
same mechanism(s) given the large differences in their structures. The folding of β-
barrel membrane proteins may be more cooperative than the folding of α-helical 
proteins, given that the insertion of single β-strands into a membrane is 
thermodynamically more unfavourable than the sequential insertion of hydrophobic 
α-helices296. 
In vitro methods involving purified OMPs, model membranes and chemical 
chaotropes have been used to study the thermodynamics and kinetics of OMP 
folding and unfolding for over 20 years297,298. Conditions for in vitro folding into a 
large variety of lipid bilayers and detergent micelles have been established for many 
OMPs, using a variety of buffers, pH values, temperatures and denaturants291,298. In 
vitro studies have also begun to explore the influence of chaperones152,153,299 and 
BAM components233,239,283,300-302 on in vitro OMP folding. This brief review of the 
major insights into the kinetics and thermodynamics of OMP folding from in vitro 
studies will focus on results obtained for OmpA and PagP, as these are two of the 
best characterised OMPs, and experimental results have been obtained for both 
these OMPs in the current project. 
Most OMP folding studies have been performed using the OmpA porin from E. 
coli298, the most abundant OMP in the OM (~200,000 copies/cell)83. OmpA is a 325-
residue protein consisting of an N-terminal 171-residue 8-stranded β-barrel domain 
(Figure 1.30a)303, and a 154-residue globular C-terminal periplasmic domain (Figure 
1.30b)304 which interacts with the cell wall305. OmpA is a multifunctional protein and 
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has proposed roles as a membrane pore, an immune evasin, an adhesion, and as a 
receptor for certain bacteriophages, in addition to its structural role306. 
 
Figure 1.30: Structures of the OmpA N-terminal β-barrel domain and the 
C-terminal soluble domain. (a) Crystal structure of the N-terminal residues of 
OmpA (1-171) which form an 8-stranded β-barrel in the OM (PDB: 1QJP303). 
Approximate location of the membrane is indicated by black lines. (b) NMR 
structure of the C-terminal OmpA soluble domain, residues 172-325 (PDB: 
2MQE39). Images created with PyMOL.  
In landmark studies the Jähnig group first demonstrated that urea-denatured OmpA 
could be refolded spontaneously in vitro into micelles of the detergent β-
octylglucoside307 and lipid vesicles297. They took advantage of the fact that folded 
and unfolded OMPs migrate at different apparent molecular weights if not boiled 
prior to SDS-PAGE analysis (‘heat-modifiability’)308-310, a technique which has 
proved invaluable in the field. Successful OmpA folding in vitro307,311 allowed the 
exploration of the factors affecting OmpA folding by systematic variation of the 
folding conditions and environment305. OmpA can fold to its native state in a large 
variety of detergents, provided the detergent concentration is above its critical 
micelle concentration (CMC)312, as well as into lipid containing Small Unilamellar 
Vesicles (SUVs) (~50 nm) and Large Unilamellar Vesicles (LUVs) (~100 nm)53,313. 
Detailed kinetic studies on the folding of OmpA over a wide range of temperatures 
(2 ºC – 40 ºC) revealed that OmpA can fold via a sequential pathway containing a 
number of folding intermediates314. Urea-denatured OmpA was proposed to refold 
into dioleoyl phosphatidylcholine (DOPC) bilayers with at least three distinct kinetic 
intermediates: (1) a rapidly formed (<1 s) IW state, formed via hydrophobic collapse 
as the folding reaction is initiated, as detected by Trp fluorescence, (2) a membrane-
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adsorbed state, IM1, and (3) a second-membrane-adsorbed state, IM2, in which β-
hairpins may be partially inserted into the membrane314,315. The proposed folding 
reaction pathway (Figure 1.31) was supported by later kinetic experiments using a 
technique termed time-resolved distance determination by fluorescence quenching 
(TDFQ)316. The locations of tryptophan residues in single tryptophan OmpA mutants 
within the bilayer could be measured during folding by the quenching of their 
fluorescence by brominated lipids. By adjusting the position of bromine atoms in the 
bilayer, Kleinschmidt and colleagues were able to show that all four β-hairpins of the 
OmpA barrel cross the bilayer simultaneously, providing evidence for a concerted 
folding and insertion mechanism317. Subsequently, the kinetics of OmpA secondary 
and tertiary structure formation on folding into diC12:0PC (DLPC) LUVs were 
investigated by CD and gel electrophoresis, respectively53. The rate constants for 
these processes were the same, again suggesting a concerted folding mechanism53. 
Consistent with this model, recent hydrogen-deuterium exchange (HDX) 
experiments, which monitored OmpX folding into detergent micelles, found that the 
rate of hydrogen bond formation between β-strands was the same between all β-
strands, and synchronised to tertiary structure formation318. 
 
Figure 1.31: Proposed OmpA folding reaction pathway. Following rapid 
hydrophobic collapse to IW a fraction of OmpA molecules may form 
aggregrates (A) while the remainder proceed to a membrane bound 
intermediate (IM1). A second partially intermediate (IM2) is followed by folding to 
the native state (N). Image reproduced from Kleinschmidt & Tamm (1996)314. 
OmpA, has also been suggested to be able to fold via parallel pathways in diC18:1PC 
(DOPC) vesicles314,319, similar to results obtained for the 14-stranded OMP 
FomA319,320. Parallel pathways were observed for the folding of OmpA into micelles 
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of the detergent octyl maltoside321. In both cases, the origin of the ‘fast’ phase has 
been attributed to direct binding to lipids or surfactant on dilution from denaturant, 
with the ‘slow’ phase due to hydrophobic collapse to an unfolded aqueous state prior 
to adsorbtion322. Consistent with this notion, for the parallel pathways observed for 
PagP folding, the amplitude of the ‘slow’ phase (i.e. the proportion of molecules 
following this pathway) increases as the lipid:protein ratio (LPR) is decreased323.  
The rate of association of neighbouring OmpA β-strands during folding was 
measured by fluorescence quenching in mutants containing a single tryptophan 
residue and a single nitroxyl-labelled cysteine residue324. The results indicated that, 
in the membrane-adsorbed state, OmpA β-strands are not in close proximity, and 
that the neighbouring β-strands on the extracellular side appear to associate before 
those on the periplasmic side324. 
Truncation of the four surface-exposed extracellular loops of OmpA showed that 
none appear to be important for OmpA folding in vivo325. OmpA was also found to be 
tolerant of mutations within individual β-strands provided that: (1) residues are not 
mutated to proline; (2) most of the lipid facing residues remain hydrophobic, and no 
charged residue is placed in the central region of the β-strand; and (3) side-chains 
facing the lumen of the barrel are not too enlarged, presumably due to packaging 
constraints326. Recently, computational methods were used to completely redesign 
the hydrophobic surface of the OmpA β-barrel327. The results generated a mutant 
with ~60% of the lipid-facing residues of OmpA replaced which was still able to 
insert and fold into membranes327. 
The in vivo folding environment of OMPs is the asymmetric OM bilayer containing 
phospholipids in the inner leaflet, and LPS in the outer leaflet21 (Section 1.2). LPS 
does play a role in assisting the assembly of at least some OMPs in vivo61, however 
recapitulating asymmetric bilayers in vitro is technically challenging322. LPS was 
shown not to be required for OmpA folding in vitro307. However, the efficiency of 
refolding of PhoE in vitro is improved by LPS62,328, with this effect likely due to the 
presence of negative charges in the inner core region (Figure 1.2b)329. Steeghs et al. 
were able to isolate a mutant strain of N. meningitidis which was unable to 
synthesise Lipid A, demonstrating that LPS is not essential for OMP folding in vivo in 
at least one organism330. 
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Spontaneous refolding into membrane mimetics has now been observed for many 
different OMPs291. In one study the folding behaviour of nine OMPs (OmpX, OmpW, 
OmpA, PagP, OmpT, OmpLA, FadL, BamA and OmpF) with differing functions and 
ranging in size from 8-16 β-strands was investigated313. Folding conditions were 
systematically varied and the following interesting observations were made: 
(1) Higher pH values promote folding. In DLPC LUVs higher folding efficiency 
was observed for all OMPs as the folding environment becomes more basic. 
The OMPs in the study have a pI of between 5-6, so this effect may be due 
to the increase in their net negative charge as the pH is raised. 
(2) Thinner bilayers increase the kinetics of folding. OMPs were folded into three 
different LUVs containing either diC10:0PC (DDPC), diC11:0PC (DUPC), or 
diC12:0PC (DLPC) lipids. All OMPs folded fastest in DDPC bilayers, 
consistent with previous results obtained for OmpA53. 
(3) Increased elastic curvature promotes folding. A comparison of OMP folding 
into SUVs and LUVs showed that folding efficiency was generally enhanced 
in SUVs which have a higher elastic curvature, and exhibit more defects than 
LUVs305. 
(4) No trends emerged when the effect of temperature on folding efficiency was 
examined. In folding experiments ranging between 30 °C and 50 °C in DDPC 
LUVs, the folding efficiency of the OMPs either increased, decreased or 
remained the same as temperature was increased. This varied behaviour 
was not correlated to β-barrel size.  
Much work has been carried out trying to establish conditions for the reversible two-
state folding of OMPs in order to calculate their thermodynamic stabilities. Protein 
stability, or the Gibbs free energy of folding (G°UN), is obtainable when the 
population of folded and unfolded forms of a protein population can be measured at 
equilibrium interchanging reversibly within the time frame of an experiment291. A 
protocol resulting in reversible denaturation was first established for the folding of 
urea-denatured OmpA into SUVs331. Equilibrium unfolding experiments were carried 
out in a range of different bilayers containing different phospholipid head groups and 
different types of acyl chains at 37.5 °C. A value for G°UN of -3.4 kcal/mol was first 
obtained in a reference bilayer of C16:0C18:1PC containing a 7.5% mole fraction of 
negatively charged C16:0C18:1PG. Substitution of the C16:0C18:1PC lipids for guest 
lipids allowed the investigation of how the physical properties of the membrane, 
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such as curvature stress and the hydrophobic mismatch between OMP hydrophobic 
length and bilayer thickness, modulate OMP stability. Increasing the intrinsic 
curvature stress by inclusion of C16:0C18:1PE lipids increased OmpA stability; 
substitution with 30% C16:0C18:1PE increased G°UN by ~60%. Substitution of the 
reference bilayer lipid with lipids that decreased the membrane hydrophobic 
thickness reduced OmpA stability; addition of 30% diC10:0PC (DDPC) reduced G°UN 
by ~50%. A PagP construct containing a C-terminal His-tag (HT-PagP) was later 
shown to fold reversibly in DLPC bilayers between urea concentrations of 7 M and 
10 M (Section 1.5.1)332. HT-PagP stability was calculated as -14.4 kcal/mol, 
somewhat higher than that reported for OmpA in SUVs (<7 kcal/mol)331.   
Conditions for reversible folding of OmpLA into DLPC liposomes were also obtained 
by a thorough screen of parameters affecting folding (lipid composition, temperature, 
salt concentration, incubation time, pH and liposome morphology)333. Under 
reversible folding conditions a G°UN value of -32.5 kcal/mol was obtained for the 
free energy of unfolding of OmpLA. The authors found that three factors produced 
reversible folding: acidic conditions (pH 3.8), the gradual dilution of OmpLA into 
folding conditions, and the presence of small amounts of the detergent 3-N,N-
dimethylmyristylammonio)propanesulfonate (SB3-14) to act as a solubilising 
‘holdase’. SB3-14 was selected as it does not disrupt the integrity of DLPC LUVs, 
and has a low CMC (~0.1-0.4 mM, 25 °C)334 and low aggregation number (83 - the 
number of molecules per micelle), enabling a low concentration to be used333. This 
reversible OmpLA folding system at pH 3.8 was then used to develop a 
hydrophobicity scale for the water-to-bilayer transfer free energies of the 20 natural 
amino acids into a lipid bilayer (the Moon-Fleming scale)335. The Fleming group 
subsequently used the conditions optimised for OmpLA to achieve path-independent 
folding for two further OMPs, OmpW and PagP336. However, the stability of not all 
OMPs can be obtained with this method as reversible folding was not achieved for 
OmpX, OmpT and FadL. Despite this, the study allowed the comparison of OMP 
stabilities obtained under the same experimental conditions for the first time. Values 
for G°UN of -18.3 ± 0.5 kcal/mol and -24.4 ± 0.4 kcal/mol were obtained for OmpW 
and PagP, respectively. The G°UN value for PagP is approximately 10 kcal/mol 
more favourable than that obtained previously by Huysmans et al.332. Fleming and 
coworkers account for this difference by differences in experimental conditions. In 
the Huysmans study urea was used; PagP may retain some residual structure in the 
unfolded state, and was believed to remain adsorbed to the membrane in the 
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unfolded state in this denaturant332. In the Fleming study, the more potent 
denaturant GuHCl was used, leading to complete PagP dissociation from the 
membrane in the unfolded state. The authors calculate a value of -10.74 kcal/mol for 
the free energy of transfer of the PagP sequence from water to the DLPC bilayer 
using the Wimley-White interfacial scale, thus accounting for the apparent 
discrepancy in PagP stabilities336. 
An interesting correlation was found between the stabilities of OmpW, PagP and 
OmpLA and the water-to-bilayer transition free energy of the residues which are in 
contact with the bilayer, calculated using the Moon-Fleming hydrophobicity scale335. 
The authors suggest that the large thermodynamic stabilities observed for OMPs 
may serve as a sorting mechanism for OMPs in the periplasm336. While the low 
stability value obtained for OmpA in lipid vesicles (<7 kcal/mol) may argue against 
this, the Otzen group reported a much higher value of -12-15 kcal/mol for the 
reversible folding of OmpA in octyl maltoside micelles using GuHCl as the 
denaturant321, and a similar value (-14.3 kcal/mol) was obtained for urea-denatured 
OmpA stability in LDAO micelles337. Interestingly, in a study on the folding of OmpA 
into the ampiphatic polymer (APol) A8-35 the thermodynamic stability was 
measured as only -1.9 kcal/mol, and a 52 day incubation time was required before 
the folding and unfolding titration curves overlaid337. These results suggest that the 
increased stability observed for membrane proteins in APols compared to 
detergents and lipids338 is due to kinetic trapping of the native state by a very large 
activation barrier to unfolding, rather than an increase in thermodynamic stability337. 
1.5.1 PagP 
PagP (PhoP/Q activated gene P) is a 163-residue OM acyltransferase enzyme 
which catalyses the transfer of a palmitate residue from the sn-1 position of a 
phospholipid to a Lipid A moiety of LPS339,340 (Figure 1.32). This reinforces the OM, 
providing protection against cationic peptides341, and aids immune evasion by 
antagonising Toll-Like Receptor 4 (TLR4) signalling342.  
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Figure 1.32: Reaction catalysed by PagP. A palmitate residue (red) from the 
sn-1 position of phosphatidylethanolamine (PtdEtn) is transferred to the Lipid 
A moiety of LPS. Image reproduced from Bishop (2005)342. 
The structure of PagP, solved by NMR343 and X-ray crystallography344,345, reveals an 
8-stranded β-barrel with a 19-residue N-terminal α-helix which associates with the β-
barrel on the periplasmic side of the OM in vivo (Figure 1.33). PagP can be 
produced easily in large quantities in the laboratory, in common with most OMPs346. 
Highlighting this, the yields of intrinsically disordered proteins have been increased 
by targeting them to inclusion bodies by fusion to PagP, with protein expression 
yields of >100 mg fusion protein per litre of minimal media obtained347. 
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Figure 1.33: Native PagP forms an 8-stranded barrel with a 19-residue N-
terminal helix. (a) Crystal structure of PagP (green). Residues which destabilise 
the barrel on mutation, W17 and R59, are highlighted in yellow and orange, 
respectively. Residues involved in exiton formation leading to a positive peak in 
the native far-UV CD spectra at 232 nm, Y26 and W66, are shown as magenta 
and cyan spheres, respectively. The native structure is tilted approximately 25° to 
the normal of the membrane. Approximate location of the membrane indicated by 
black lines. Image created with PyMOL (PDB: 3GP6345). (b) Example far-UV CD 
spectra of folded and unfolded PagP (Section 2.10.4).  
A high concentration of urea is required to solubilise an aggregation-prone C-
terminal His-tagged construct of PagP152,348. High folding efficiency was achieved in 
cyclofos-7 detergent micelles and DLPC LUVs in the presence of 7 M urea348. 
Huysmans et al. investigated the role of the unusual N-terminal α-helix (Figure 1.33) 
in the folding and stability of PagP using variants in which either the helix was 
removed (PagP1-19), or mutations were made which interfered with the 
interactions between the β-barrel and the helix (W17A and R59L)348. The formation 
of secondary and tertiary structure in detergent micelles (cyclofos-7) and DLPC 
liposomes were monitored by far-UV CD; the spectrum of folded PagP has a 
negative maximum at 218 nm typical of β-sheet secondary structure, and an 
additional positive peak at 232 nm which has been attributed to a ‘Cotton effect’ 
between residues W66 and Y26 (Figure 1.33)349. PagP folding was also monitored 
by tryptophan fluorescence, Fourier transform infrared spectroscopy (FTIR), 
changes in electrophoretic mobility on cold SDS-PAGE gels, and gain of enzyme 
activity348. It was found that secondary and tertiary structure of PagP forms 
simultaneously, as previously reported for OmpA53. The results also showed that 
none of the mutants prevented folding of the β-barrel domain into detergent or 
liposomes. All mutants, however, were thermodynamically destabilised relative to 
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wild-type. Interestingly, the decrease in stability of the W17A mutant was dependent 
on the folding environment and was much more destabilising in the liposome 
experiments compared with those in cyclofos-7 detergent micelles. Kinetic 
experiments in DLPC liposomes established that the destabilisation of all mutants 
was due to an increase in the dissociation rate from the lipid-inserted state. This led 
to the conclusion that at least one of the functions of the PagP helix is as a ‘post-
assembly clamp’ which docks with the folded PagP β-barrel, increasing its 
stability348. 
Subsequent work established that PagP undergoes fully reversible two-state folding 
and unfolding between urea concentrations of 7 M and 10 M in 100 nm DLPC 
liposomes at a molar LPR of 3200:1332. Folding was monitored by tryptophan 
fluorescence and was found to be independent of protein and lipid concentration (for 
PagP concentrations of 0.1-0.4 M and LPRs between 800:1 and 4000:1). 
Equilibrium denaturation experiments enabled the calculation of the thermodynamic 
stability of PagP in DLPC LUVs, yielding a free energy of unfolding value, G°UN, of 
-14.4 ± 0.4 kcal/mol, and a calculated value for MUN (a measure of the surface area 
buried on folding to the native state) of 1.64. ± 0.05 kcal/mol/M. The urea 
dependence of PagP folding and unfolding kinetics was measured by initiating 
folding and unfolding reactions from PagP in 10 M and 7 M urea, respectively. 
Unfolding reactions fitted well to a single exponential function at all urea 
concentrations, while the folding kinetics below 7.8 M urea were complicated by the 
presence of a large burst phase. A chevron plot (which plots the linear dependence 
of the logarithm of the observed rate constant on denaturant concentration) of the 
PagP kinetic data was constructed (Figure 1.34). Analysis of the kinetic data 
provided confirmation of reversible two-state folding as: (1) the denaturation 
midpoint (Cm), where the folding and unfolding arms meet, was in good agreement 
with the equilibrium stability data; (2) the sum of the kinetic m-values (mf and mu) 
obtained from the slopes of the folding and unfolding arms of the chevron plot were 
in agreement with the MUN value obtained from equilibrium experiments; and (3) the 
value for the free energy of unfolding, G°UN, obtained from equilibrium denaturation 
agreed well with that obtained from the kinetic data (using G°UN = -RT(kf /ku)), 
where R is the gas constant, T is the temperature in Kelvin, and kf and ku are the 
rate constants of folding and unfolding, respectively. 
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Figure 1.34: Chevron plot of PagP kinetic data. The logarithm of the 
observed rate constants for folding and unfolding depend linearly on the 
concentration of denaturant. The kinetic m-values mf and mu are obtained from 
the slopes of the folding and unfolding limbs are indicated. Image adapted 
from Huysmans et al. (2010)332. 
Verification of the reversibility of PagP (un)folding under these conditions allowed 
the construction of the first model of the transition state structure of an OMP using 
Φ-value analysis. 19 single amino acid mutants across the entire PagP structure 
were constructed and the proteins purified. The change in stability of the transition 
state was calculated from kinetic experiments in the unfolding direction (as folding 
did not fit a single exponential below 7.8 M urea) and the change in stability of the 
native state was measured by equilibrium urea titration experiments332. A Φ-value 
was calculated for each mutant by taking the ratio of these two values, giving a 
number between 0 and 1. Φ-values of 0 suggest that the mutated residue does not 
make native-like contacts in the transition state, while Φ-values of 1 suggest that the 
residue is as structured in the transition state as it is in the native state350,351. The 
results indicated a highly polarised transition state in which the β-barrel structure is 
largely formed (Figure 1.35C). Five residues which had a Φ-value of >0.5 were 
present in the C-terminal half of the structure (strands E-H), while five variants with a 
Φ-value of <0.3 were located near the N-terminal helix, consistent with the docking 
of the helix as the final folding step348 (Figure 1.35A and Figure 1.35B). Two of the 
mutants gave rise to negative Φ-values, which the authors interpret as an indication 
that non-native contacts are formed in the transition state in the region of these 
mutations. Taken together, the results suggest a tilted insertion mechanism in which 
the C-terminal half of PagP enters the bilayer and partially folds first while the N-
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terminal helix remains unstructured332. Interestingly, in coarse-grained simulations of 
OmpA folding into lipid bilayers the β-barrel domain entered the membrane at an 
angle of approximately 45° to the bilayer normal, hinting that tilted insertion may be 
a more general OMP folding mechanism352.  
 
Figure 1.35: Φ-value analysis of PagP folding in DLPC LUVs. (a) Location 
and Φ-values of PagP mutated residues in cartoon representation. (b) 
Topology map and Φ-values of PagP mutated residues indicating the mutated 
residues cover all 8 β-strands. (c) Model of the polarised transition state and 
proposed tilted-insertion mechanism. Φ-values are coloured as indicated in 
the scale bar. Image reproduced from Huysmans et al. (2010)332. 
The β-Tanford value (βT), which is defined as mf /MUN, gives a measure of how far 
the transition state is along the reaction coordinate. The βT for PagP was calculated 
as 0.6, suggesting that the transition state is approximately midway along the folding 
reaction coordinate. This contrasts sharply with the much lower value of ~0.1 
reported for the α-helical protein bacteriorhodopsin (bR) in SDS, which suggests the 
bR transition state is close to the unfolded state353,354. This difference could be due 
to differences in residual secondary structure in the denatured states of α-helical 
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and β-barrel membrane proteins, or may reflect differences in their folding 
mechanisms. 
A subsequent study investigating the folding kinetics of PagP into DLPC liposomes 
in the presence of 7 M urea from an unfolded state (10 M urea) revealed parallel 
folding pathways323. On dilution from denaturant, a burst phase is observed by 
tryptophan fluorescence as PagP adsorbs to the lipid bilayer, followed by a time-
course as folding and insertion occurs. At high LPRs this time-course fits to a single 
exponential, while at low LPRs a second exponential with a slower rate constant is 
present. The effect on PagP folding of altering the properties of the lipid bilayer by 
the addition of guest lipids was also investigated. Addition of di-
lauryolphosphatadylethanolamine (DLPE), which increases the lateral pressure and 
acyl chain packing of the bilayer, led to an increase in the population of PagP 
molecules following the slower folding pathway, while addition of di-
lauroylphosphatadylserine (DLPS), which increases the overall net negative charge 
of the membrane, reduced the folding rate of the fast folding pathway. These results 
not only demonstrate that PagP can fold by different pathways, but also highlight the 
importance of lipid-protein interactions in modulating these pathways323. 
1.5.2 Studies of BAM complex function in vitro 
A major breakthrough in the field came in 2010 with the in vitro reconstitution of the 
complete BAM complex by the Kahne group using purified components233. It was 
known that BamB binds BamA separately from BamD, and BamC and BamE 
depend on BamD for their interaction with BamA241,247. Therefore, the BamAB and 
BamCDE subcomplexes were co-expressed and purified separately, before 
holocomplex reconstitution in proteoliposomes containing E. coli polar lipid extract. 
The protease OmpT was chosen as the substrate as its rate of folding into 
proteoliposomes could be monitored by the cleavage of a fluorogenic peptide355. 
The folding rate of OmpT was orders of magnitude higher in the presence of the 
BAM complex compared with lipid alone. Folding rate enhancement was achieved 
without the input of an energy source, and the folding rate observed (seconds to 
minutes) was on a similar time-scale to that observed by in vivo pulse-chase 
experiments for PhoE356 and LamB123. Verification that the increase in fluorescence 
corresponded to an increase in the level of folded OmpT was carried out by cold 
SDS-PAGE. After 30 minutes, reactions containing 35S-labelled OmpT were 
centrifuged and samples from the pellets analysed by cold SDS-PAGE. The results 
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showed that while the folding yield of OmpT was low (7%) in the presence of the 
complete BAM complex, in its absence the yield was negligible. Loss of BamB from 
the complex greatly reduced the folding rate and yield as did loss of BamCDE. The 
presence of SurA increased the OmpT folding rate in a concentration-dependent 
manner233. However, how much of this effect is due to solubilisation of the substrate, 
rather than specific targeting to BAM by SurA is unclear. In a later study, it was 
shown that SurA could be functionally replaced by urea in experiments in which 
FLAG-tagged BamA was folded by the reconstituted BAM complex283. Subsequent 
work established that each reconstituted BAM complex could catalyse the assembly 
of multiple substrates301. One key question in the evolution of the BAM complex is 
the ‘chicken and egg’ problem of how was the first BamA molecule folded, if it is 
needed to catalyse OMP folding, yet is itself an OMP? This question was resolved 
by the Kahne group, who reported that BamA, but not OmpA, can be assembled by 
BAM lipoproteins in vitro283. 
Recently it was shown that all five BAM complex members can be co-expressed and 
co-purified, either from multiple plasmids357, or a single plasmid239. The reconstituted 
BamABCDE complex expressed from a single plasmid appeared to be more active 
than that reconstituted from BamAB and BamCDE subunits, and was able to 
assemble the autotransporter EspP239. Iadanza et al. (2016) modified the BAM 
reconstitution method, forming proteoliposomes by dialysis, rather than the dilution 
method used previously232. Using a modified version of the Kahne group OmpT 
assay this protocol led to substantially greater OmpT folding activity, likely due to 
greater efficiency of BAM reconstitution. This assay was then used to provide the 
first in vitro demonstration of the importance of BamA lateral gating in BAM 
function232. 
The presence of prefolded BamA alone, in the absence of BamB-E, was reported to 
increase the kinetics of OmpA folding into DLPC LUVs at 40 °C299. This was 
confirmed by experiments in which the presence of BamA in DDPC LUVs, 
containing a mole percentage of 20% DDPE (diC10:0PE), dramatically increased 
(>10-fold) the kinetics of OmpX, tOmpA, OmpA and OmpLA folding300. This 
suggests that one function of BamA is to decrease the kinetic energy barrier 
imposed by native lipid headgroups300. It was later found that the mechanism by 
which BamA alone enhances folding rates is catalytic, rather than stoichiometric302. 
BamA is an unusual catalyst in that it has two substrates, protein and lipid, and in 
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these studies it is not clear if BamA-assisted OMP folding rate increases are due to 
its interactions with nascent OMPs, destabilisation/thinning of the bilayer, or both. 
1.6 Current questions 
This introduction has highlighted the progress made in the OMP folding field, both in 
vivo and in vitro, and the remaining challenges ahead. Many key questions remain 
unresolved including: 
1. What are the molecular mechanism(s) by which periplasmic chaperones 
bind and transport OMPs, and how are their substrates delivered to the 
BAM complex? 
2. What are the functions of the individual components of the BAM complex? 
3. How do BAM components interact with each other, chaperones and OMP 
substrates? 
4. What is the molecular mechanism by which the BAM complex catalyses β-
barrel folding, insertion and release into the outer membrane? 
5. How is OMP assembly coordinated with the biogenesis of other OM 
components (lipids, LPS, lipoproteins)? 
It is also not known whether the BAM complex aids in the oligomerisation of OMP 
multimers, or how OMP assembly is coordinated with the biogenesis of other OM 
components (lipids, LPS, lipoproteins), or the molecular details of how the BAM 
complex is involved in extracellular secretion9,111. How similar the folding behaviour 
and pathways of OMPs observed in vitro are to the situation in a living cell is also 
unclear. 
The experiments presented in the following chapters take a classical biochemical 
approach of purifying the components involved in a biological process and trying to 
recreate aspects of an in vivo process in vitro to aid its understanding. The results 
represent a fascinating journey into the world of OMP folding, which while providing 
some answers, in keeping with scientific tradition, provoke many more unanswered 
questions. 
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2 Materials and Methods 
2.1 Materials and Reagents 
2.1.1 General chemicals 
Purite 18 MΩ water was used in all protocols. 30% (w/v) acrylamide:0.8% (w/v) bis-
acrylamide and 10% (w/v) sodium dodecyl sulphate (SDS) was purchased from 
Severn Biotech Ltd., UK. Agar was purchased from Melford Laboratories, UK. 
Ready mixed LB-Broth (Miller) was purchased from Merck, Germany. Agarose, 
imidazole and ethylenediaminetetraacetic acid (EDTA) were purchased from Acros 
Organics, Belgium. Sodium chloride (NaCl), tris(hydroxymethyl)aminomethane 
(Tris), glycerol, glucose, sucrose, glacial acetic acid and hydrochloric acid (32% 
(w/v) HCl) were purchased from Fisher Scientific, UK. Carbenicillin disodium salt, 
dithiothreitol (DTT) and isopropyl β-D-1-thiogalactopyranoside (IPTG) were 
purchased from Formedium, UK. Triton X-100 (protein grade) was purchased from 
Merck Millipore, USA. Urea (>99% purity) was purchased from MP Biomedicals, UK 
or Sigma-Aldrich, USA. Ethidium bromide, magnesium sulphate (MgSO4), 
magnesium chloride (MgCl2), chloramphenicol, bromophenol blue, guanidine 
hydrochloride (GuHCl), ammonium persulphate (APS), ammonium acetate, 
ammonium hydroxide, tetramethylethylenediamine (TEMED), dimethyl sulfoxide 
(DMSO), tris(2-carboxyethyl)phosphine (TCEP), and ethanol were purchased from 
Sigma-Aldrich, USA. 
2.1.2 Lipids 
1,2-didecanoyl-sn-glycero-3-phosphocholine (diC10:0PC) (DDPC), 1,2-diundecanoyl-
sn-glycero-3-phosphocholine (diC11:0PC) (DUPC), 1,2-dilauroyl-sn-glycero-3-
phosphocholine (diC12:0PC) (DLPC), 1,2-ditridecanoyl-sn-glycero-3-phosphocholine 
(diC13:0PC) (DTPC), and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (diC14:0PC) 
(DMPC) lipids were obtained from Avanti Polar lipids (Alabaster, Alabama, USA). 
HLPC grade chloroform and methanol for lipid storage were purchased from Sigma-
Aldrich, USA. 
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2.1.3 Molecular Biology Materials  
E. coli strains BL21(DE3), BL21(DE3)pLysS, XL1-Blue and DH5 were purchased 
from Stratagene, UK. Competent E. coli DH5 cells were also purchased from New 
England Biolabs (NEB). OrangeG loading dye was purchased from Invitrogen. Vent 
DNA polymerase, Antarctic Phosphatase and all restriction enzymes were 
purchased from NEB. T4 DNA ligase (with 10x ligase buffer), 1 kbp and 100 bp DNA 
ladders, deoxyribonucleotide triphosphates (dNTPs) and 5-bromo-4-chloro-indoyl-β-
D-galactopyranoside (X-Gal) were purchased from Promega UK. QIAprep Spin 
Miniprep and QIAquick gel extraction kits were purchased from Qiagen, UK. Site-
directed mutagenesis was performed with the Q5 Site-directed mutagenesis kit 
(NEB), using primers designed using the online NEBasechanger utility358. The 
plasmids for tOmpA, PagP, OmpA and BamA encoding the mature OMP sequences 
were kindly provided by Dr Karen Fleming (John Hopkins University, USA). In these 
plasmids the OMP genes were ligated into pET11a between the NdeI (5’) and 
BamHI (3’) restriction sites313. Plasmid pET21b (Novagen) containing the Skp 
gene was a gift from Prof James Bardwell (University of Michigan, USA). Prof 
Sebastian Hiller (University of Basel, Switzerland), Prof Daniel Kahne (Harvard 
University, USA), and Dr Susan Buchanan (NIH, USA) kindly provided the HT-
Skp-pET28b171, HT-SurA-pet28b233 and BamAB-pETDUET-1 plasmids, 
respectively. 
2.1.4 Protein Chemistry Materials 
The analytical Superdex S-75 HiLoadTM 26/60 column, Sephacryl S-200 HiLoadTM 
16/60 column, Superdex Peptide 10/300 column, 5 ml HisTrap columns, 5 ml HiTrap 
Q columns and 5 ml HiTrap SP columns were purchased from GE Healthcare, UK. 
All buffers used during protein purification were filtered before use by vacuum 
filtration through 0.45 M filters purchased from Millipore, UK. Small volumes were 
filtered through 0.2 M or 0.45 M Minisart syringe filters purchased from Sartorius, 
UK. Vivaspin 20 concentrators (MWCO 5 kDa or 10 kDa) were purchased from 
Sartorius, UK. SnakeSkin dialysis tubing (3.5 kDa MWCO), bicinchoninic acid (BCA) 
assay kits, and Alexa Fluor 488 C5 maleimide were purchased from Thermo Fisher 
Scientic, UK. 
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2.2 Molecular Biology  
2.2.1 E. coli Bacterial Strains 
DH5: 
fhuA2 lac(del)U169 phoA glnV44 Φ80' lacZ(del)M15 gyrA96 recA1 relA1 endA1 thi-
1 hsdR17  
 
XL1-Blue: 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’ proAB laclq ZM15 Tn10 
(Tetr)] 
 
BL21(DE3): 
F– ompT hsdSB (rB–, mB–) gal [dcm] [Ion] (DE3) 
 
BL21(DE3) pLysS: 
F– ompT hsdSB (rB–, mB–) gal [dcm] [Ion] (DE3) 
2.2.2 Growth media 
E. coli cells were grown in lysogengy broth (LB) (Miller) medium (Merck, Germany) 
at a concentration of 25 g/L. The medium was autoclaved for 20 min at 120 °C and 
supplemented with carbenicillin (100 mg/ml in sterile H2O) to a final concentration of 
100 g/ml when cooled to room temperature. For solid agar plates 25 g/L of LB and 
15 g/L of agar were autoclaved for 20 minutes at 120 °C. On cooling to 
approximately 50 °C, carbenicillin (100 g/ml) was added and 20-25 ml poured into 
sterile Petri dishes. For growth of BL21(DE3)pLysS cells, chloramphenicol (34 
g/ml, from a 34 mg/ml stock dissolved in ethanol) was added to the medium for the 
maintenance of the pLysS plasmid in addition to carbenicillin (100 g/ml). All 
antibiotics were filter sterilised prior to use. For cells transformed with pET28b 
vectors, 100 g/ml carbenicillin was replaced with 30 g/ml kanamycin in the above 
protocols. 
For transformation of Supercompetent XL1-Blue cells NZY+ medium was used. 
NZY+ broth was prepared as follows:  
- 10 g NZ amine 
- 5 g yeast extract 
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- 5 g NaCl 
A solution contained the above was made up to a final volume of 1 litre with dH2O 
and adjusted to pH 7.5 using NaOH. The solution was autoclaved and the following 
filter sterilised supplements were added: 
- 12.5 ml 1 M MgCl2 
- 12.5 ml 1 M MgSO4 
- 20 ml 20 % (w/v) glucose 
2.2.3 Agarose gel electrophoresis 
Agarose gels were prepared by heating 150 ml of 1.5% (w/v) agarose in 1x TAE 
buffer in a microwave until all agarose was dissolved. TAE buffer was prepared as a 
50x stock, containing 121 g Tris, 28.55 ml glacial acetic acid, 50 ml 0.5 M EDTA in 
500 ml (pH 8.0). The solution was left to cool to ~50 ºC before addition of 10 l per 
100 ml of a 10 mg/ml solution of ethidium bromide. Gels were then poured into a 12 
x 15 cm gel tray containing a lane comb and allowed to set. Agarose gels were 
electrophoresed in 1x TAE buffer. DNA samples were mixed 9:1 with a 10x 
OrangeG loading buffer (50 mM Tris, 60% (v/v) glycerol, OrangeG dye powder). 
Samples containing 1 kb and 100 bp DNA ladders were included to enable size 
comparison. Gels were run at 100 volts for approximately 1 hour or until sufficient 
size resolution had been achieved. Gels were imaged using a UV transilluminator 
(Syngene). 
2.2.4 Preparation of competent cells 
Cells of the desired strain were streaked onto an LB agar plate containing no 
antibiotics using a sterile loop and incubated overnight at 37 °C. A single colony was 
selected and used to inoculate 5 ml of autoclaved LB and incubated overnight at 37 
°C with shaking at 200 rpm. This culture was used to inoculate 100 ml of sterile LB 
which was grown (37 °C, 200 rpm) until the optical density (OD) at 600 nm was 0.4-
0.45. Cells were harvested by centrifugation (4000 rpm (4000 g), 10 min, 4 °C) in a 
pre-chilled Beckman JS-5.3 rotor. The pellet was resuspended gently in 10 ml of 
filter-sterilised, pre-chilled 100 mM CaCl2. After incubation on ice for 10 minutes the 
cells were centrifuged as described previously and the supernatant removed. The 
pellet was resuspended gently in 2 ml of pre-chilled 100 mM CaCl2 30% (v/v) 
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glycerol. Cells were aliquoted (50 l) into pre-cooled 1.5 ml  Eppendorf tubes on dry 
ice and stored at -80 °C. 
2.2.5 Transformation of E. coli strains 
For transformation from plasmid stocks, 50 l of laboratory-prepared competent 
cells were thawed on ice for 10 min then transferred to a pre-chilled round bottomed 
14 ml transformation tube. 1-2 l vector DNA (100-200 ng/l) was added and the 
solution gently mixed. After incubation on ice for 30 min, the tubes were heat 
shocked at 42 °C for 45 sec and returned to ice for 5 min. All 50 l was plated 
directly onto LB agar containing 100 g/ml carbenicillin (or 30 g/ml kanamycin for 
cells transformed with pET28b vectors), and incubated at 37 °C overnight. For 
transformation of ligation reactions, XL-1 Blue Supercompetent cells (Stratagene, 
UK) or competent DH5 cells (NEB) were used as per manufacturer’s instructions. 5 
l of ligation reaction mixture was added per 100 l or 50 l of XL-1 Blue 
Supercompetent, or competent DH5 cells, respectively.  
2.2.6 Polymerase Chain Reaction (PCR) 
Vent DNA polymerase was used as per manufacturer’s instructions.  A typical 100 l 
PCR contained the following: 
 
- 100 ng dsDNA template 
- 0.5 M of each primer 
- 750 M of each dNTP 
- 1 x Thermopolymerase buffer (NEB) 
- 2 mM MgSO4 
- 1 U Vent DNA polymerase (NEB) 
- 1 L DMSO 
 
The following PCR primers used for the cloning of the barrel domain of BamA 
(tBamA): 
Forward primer: 5’-CACACACAC CATATG agc ttc aac ttt ggt att ggt tac gg – 3’ 
Reverse primer: 5’ – GTGTGTGT GGATCC tta tta cca ggt ttt acc gat gtt aaa ctg g - 
3’ 
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NdeI and BamHI restriction sites are highlighted in green and blue text, respectively. 
Stop codons are highlighted in red text. Nucleotides at the 3’ which bind to the 
template DNA are indicated with uncapitalised text. The PCR cycling conditions 
used for amplification of tBamA are given in Table 2.1. 
 
Step Time Temperature 
1 5 minutes 95 ºC 
2 30 seconds 
95 ºC 
(melting) 
3 30 seconds 
54 ºC 
(annealing) 
4 90 seconds 
72 ºC 
(extension) 
5 Repeat steps 2-4, 39 times 
6 5 minutes 72 ºC 
 
Table 2.1 Typical cycling times for Vent DNA polymerase PCRs.  
2.2.7  Agarose gel DNA extraction 
To extract DNA bands after agarose gel electrophoresis the QIAquick gel extraction 
kit (QIAGEN, UK) was used as per manufacturer’s instructions. 
2.2.8 Plasmid preparation 
For small-scale DNA preparation, 10 ml of LB/carbenicillin was inoculated with a 
single colony and incubated overnight at 37 °C with shaking at 200 rpm. After 
obtaining a cell pellet by centrifugation, the plasmid DNA was purified using the 
QIAprep Spin Miniprep Kit (QIAGEN,UK) or the Wizard Plus SV Miniprep Kit 
(Promega, UK), both as per manufacturer’s instructions. To obtain larger amounts of 
DNA, 100 ml of LB/carbenicillin was inoculated with a single colony, grown 
overnight, and after obtaining a cell pellet by centrifugation, the plasmid DNA was 
purified using the HiSpeed Plasmid Midi Kit (QIAGEN,UK) as per manufacturer’s 
instructions. The 1 ml DNA eluate was concentrated to a volume of 100 l using a 
QIAquick spin column (QIAGEN,UK). DNA concentrations were obtained using a 
Nanodrop 2000 (Thermo Fisher Scientific, UK) as per manufacturers’ instructions. 
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2.2.9 Restriction Digests 
The restriction endonucleases NdeI and BamHI were purchased from New England 
Biolabs (NEB) and used as per manufacturer’s instructions. Analytical digests of 
plasmed minipreps derived from colonies on transformation plates were incubated at 
37 °C for 30 min (Table 2.2). Restriction digests of larger volumes of DNA (e.g. 
pET11a vector DNA (5 g), or gel extracted PCR products) for use in downstream 
ligation reactions were incubated at 37 °C for 4-5 h (Table 2.3). 
Plasmid 
DNA (l) 
NEB 
Buffer 4 
(l) 
10x BSA 
(l) 
Sterile 
water (l)  
NdeI 
(l) 
BamHI 
(l) 
5 2 2 10 0.5 0.5 
 
Table 2.2: Volumes of reagents for analytical digests of miniprepped 
DNA from colonies on transformation plates. 
Plasmid 
DNA (l) 
NEB 
Buffer 4 
(l) 
10x BSA 
(l) 
Sterile 
water (l)  
NdeI 
(l) 
BamHI 
(l) 
20 3 3 1 1.5 1.5 
  
Table 2.3: Typical volumes of reagents for digests of vector DNA, or PCR 
products for use in downstream ligation reactions. 
 
2.2.10 Plasmid vector descriptions 
Details of all plasmids used in this project are given in Table 2.4. DNA sequences of 
all vectors are available on request from the Radford Lab, University of Leeds. 
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Plasmid name and vector Description of insert sequence 
BamAB-pETDUET-1 
Full-length BamA and BamB genes including signal sequences. 
Used as DNA template for tBamA and BamA POTRAs cloning 
P1-5-pET11a BamA POTRA domains 1-5 of mature BamA (residues 21-425)* 
HT-P1-5-pET11a 
BamA POTRA domains 1-5 of mature BamA (residues 21-425) 
with hexahistidine tag at the N-terminus* 
HT-MBP-TEV-POTRAs-
pMAL 
Maltose-bindng protein (MBP) with an N-terminal 6x His-tag 
fused to BamA POTRA domains 1-5 of mature BamA (residues 
21-425), separated by a TEV cleavage site for removal of HT-
MBP* 
PagP-pET11a Mature PagP (residues 26-186)
313
 
HT-OmpT-pET11a 
Mature OmpT (residues 21-317) preceded by an N-terminal 6x 
His-tag and TEV protease cleavage site (MH6ENLYFQG-
OmpT)
359
 
OmpF-pET11a Mature OmpF (residues 23-362)* 
FadL-PEX-K4 
Mature FadL (residues 26-446) gene synthesised by Eurofins 
Genomics, and delivered in PEX-K4 plasmid
360
 
FadL-pET11a Mature FadL (residues 26-446)* 
BamA-pET11a Mature full-length BamA (residues 21-810)
313
 
tBamA-pET11a 
C-terminal beta-barrel domain of mature BamA (residues 425-
810)* 
OmpA-pET11a Mature full-length OmpA (residues 22-346)
313
 
tOmpA-pET11a 
N-terminal 171 residues mature OmpA (residues 22-193). I.e. 
OmpA with the C-terminal soluble domain deleted
313
. 
Cys-tOmpA-pET11a 
N-terminal 171 residues mature OmpA (residues 22-193) with an 
additional N-terminal cysteine residue* 
Skp-pET21b 
Full length Skp gene (residues 1-161) including signal sequence 
for periplasmic expression 
HT-Skp-pET28b 
Mature Skp (residues 21-161) preceded by an N-terminal 6x His-
tag and thrombin protease cleavage site 
(MGSSH6SSGLVPRGSH-Skp)
171
 
HT-SurA-pET28b 
Mature SurA (residues 21-428) preceded by an N-terminal 6x 
His-tag and thrombin protease cleavage site 
(MGSSH6SSGLVPRGSH-SurA)
233
  
 
Table 2.4: Description of all vectors used in this thesis. All gene 
sequences are from E. coli. *Vector was produced in the current project using 
NdeI and BamHI restriction enzymes. 
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2.2.11 DNA sequencing 
All DNA sequencing was carried out by Beckman Coulter Genomics.  The T7 
promoter forward primer (TAA-TAC-GAC-TCA-CTA-TAG-GG) and the T7 terminator 
reverse primer (CTA-GTT-ATT-GCT-CAG-CGG-TG) were used for sequencing of all 
pET vectors. 
2.2.12 DNA ligations 
Ligations of DNA inserts into pET11a were carried out using T4 DNA ligase in 1x 
ligation buffer with overnight incubation at 4 °C. A typical ligation reaction contained 
the following: 
 
- Digested pET11a  1 l 
- Digested insert DNA  7 l  
- 10x T4 DNA ligase buffer 1 l 
- T4 DNA ligase (3 U/μl) 1 l 
 
Prior to ligation, digested pET vectors were dephosphorylated at the 5’ ends using 
Antarctic phosphatase as per manufacturer’s guidelines, to prevent vector-only re-
ligation. Digested insert DNA and digested vector DNA were purified by agarose gel 
electrophoresis followed by gel extraction prior to the ligation reaction, to remove 
restriction endonuclease and Antarctic phosphatase reagents. 5 µl of ligation 
reaction mixture was used for transformation into XL1-Blue Supercompetent cells 
(Section 2.2.5). 
2.2.13 Cloning of OmpF, tBamA and OmpT 
Codon optimised synthetic genes (Eurofins, Germany) of the mature sequences of 
OmpF (residues 23-362) and FadL (residues 26-446) were cloned into pET11a  
(Novagen, UK) between the NdeI (5′) and BamHI (3′) restriction sites. To create the 
tBamA construct, residues 425-810 of BamA were amplified by PCR, using plasmid 
BamAB-pETDUET-1 as the template DNA, and the resultant product then ligated 
into pET11a after restriction digestion, as described above. The OmpT mature 
sequence (residues 21-317) was amplified by PCR from E. coli XL1-blue cells to 
include an N-terminal 6x His-tag and a Tobacco Etch Virus (TEV) protease cleavage 
site (MH6ENLYFQG-OmpT), and subsequently cloned into the pET11a vector as 
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described above. The cloning of OmpT and OmpF were performed by Dr L. M. 
McMorran (University of Leeds) and Dr A. N. Calabrese (University of Leeds), 
respectively. 
2.3 Outer membrane protein expression and purification 
2.3.1 Expression and purification of untagged outer membrane 
proteins 
The relevant plasmid was transformed into BL21(DE3) cells and 5 ml LB medium 
containing 100 g/ml carbenicillin was inoculated with a single colony from the 
transformation plate and incubated at 37 °C with shaking (200 rpm) overnight. This 
starter culture was added to 500 ml LB medium containing 100 µg/ml carbenicillin 
and grown at 37 °C with shaking (200 rpm).  Expression was induced with 1 mM 
IPTG when the culture reached an OD600 of 0.5-0.6, and then harvested after 4h by 
centrifugation (5000 g, 15 min, 4 °C). Cells were resuspended in 20 ml 50 mM Tris-
HCl, pH 8.0, 5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride (PMSF), 2 mM 
benzamidine, and lysed by sonication (6 x 1 min bursts with 1 min cooling on ice 
between each sonication). The insoluble fraction was collected by centrifugation 
(25000 g, 30 min, 4 °C), resuspended in 20 ml 50 mM Tris-HCl, pH 8.0, 2% (v/v) 
Triton-X-100 and incubated for 1 h at room temperature, with gentle agitation. The 
insoluble fraction was again pelleted (25000 g, 30 min, 4 °C) and the inclusion 
bodies were washed twice by resuspending in 50 mM Tris-HCl, pH 8.0, incubating 
for 1 h at room temperature with gentle agitation, followed by centrifugation (25000 
g, 30 min, 4 °C). The inclusion bodies were solubilised in 25 mM Tris-HCl, 6 M 
GuHCl, pH 8.0 and centrifuged (20000 g, 20 min, 4 ºC). The supernatant was 
filtered (0.2 μM syringe filter, Sartorius, UK) and purified further by gel filtration in 6 
M GuHCl, 25 mM Tris-HCl, pH 8.0 using a Superdex 75 HiLoadTM 26/60 column (or 
Sephacryl S-200 HiLoadTM 16/60 column for preparations of BamA) connected to 
the ÄKTA Prime chromatography system. The column was washed with two column 
volumes of dH2O and equilibrated with two column volumes of 6 M GuHCl, 25 mM 
Tris-HCl, pH 8.0. For each gel filtration run, ~4 ml of ~5 mg/ml of OMP was loaded 
into a 5 ml loop. An example programme used is shown in Table 2.5. 
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Breakpoint 
(ml) 
Flow rate 
(ml/min) 
Fraction 
size (ml) 
Injection valve 
position 
Autozero 
0 2 0 Load No 
10 2 0 Inject Yes 
20 2 0 Load No 
105 2 3 Load No 
355 2 0 Load No 
 
Table 2.5:  AKTA Programme parameters for gel filtration of OMPs. Gel 
filtration was carried out using a Superdex 75 HiLoad 26/60 column in 6 M 
GuHCl, 25 mM Tris-HCl, pH 8.0. 
Samples from peak fractions were buffer exchanged into 8 M urea using Zeba spin 
desalting columns (Thermo Scientific, UK), or subjected to TCA precipitation prior to 
analysis by SDS-PAGE to assess purity. Peak fractions were pooled, concentrated 
to ~500 μM using Vivaspin 20 (5 kDa MWCO) concentrators (Sartorius, UK), snap-
frozen in liquid nitrogen, and stored at -80 °C. 
2.3.2 Expression and purification of His-tagged OmpT 
Expression and inclusion body purification for His-tagged OmpT was carried out as 
for untagged OMPs. OmpT inclusion bodies were then solubilised in 50 mM sodium 
phosphate, 6 M GuHCl, 250 mM NaCl, pH 8.0, and then centrifuged (25000 g, 20 
min, 4 ºC).  The supernatant was filtered (0.2 μM syringe filter, Sartorius, UK) and 
loaded on to a 5 ml HisTrap column (GE Healthcare, UK) equilibrated with 50 mM 
sodium phosphate, 6 M GuHCl, 250 mM NaCl, pH 8.0. The column was washed 
with 10 column volumes of 50 mM sodium phosphate, 6 M GuHCl, 250 mM NaCl, 5 
mM imidazole, pH 8.0.  OmpT was eluted with 50 mM sodium phosphate, 6 M 
GuHCl, 250 mM NaCl, 250 mM imidazole, pH 8.0, and peak fractions were pooled 
and dialysed overnight against H2O at 4 ºC. The resultant precipitated protein was 
collected by centrifugation  (25000 g, 20 min, 4°C), solubilised in 25 mM Tris-HCl, 6 
M GuHCl, pH 8.0 (~500 µM), snap-frozen in liquid nitrogen, and stored at -80 °C. 
Expression and purification of His-tagged OmpT was performed by T.G. Watkinson. 
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2.4 Expression and purification of BamA POTRA domains 
A pMAL-c5X (NEB) plasmid was modified previously by addition of an N-terminal 6x 
His-tag and replacement of the thrombin cleavage site with a TEV cleavage site. 
This vector was used to make a construct that contained maltose-binding protein 
(MBP) fused to BamA POTRA domains 1-5 of mature BamA (residues 21-425) with 
an additional C-terminal cysteine residue, separated by a TEV cleavage site. This 
vector was produced previously by T. Crosskey (University of Leeds)361. The C-
terminal cysteine residue was removed by site-directed mutagenesis to produce the 
HT-MBP-TEV-POTRAs construct (Figure 2.1). 
 
Figure 2.1: Schematic of HT-MBP-TEV-POTRAs construct. HT: His-tag, 
TEV: TEV cleavage site. 
HT-MBP-TEV-POTRAs-pMAL was transformed into BL21(DE3) cells, and a single 
colony used to inoculate an LB starter culture containing 100 g/ml carbenicillin 
which was grown overnight (37 ºC, 200 rpm). 10 ml starter culture was used to 
inoculate 2x 1 L of LB, supplemented with 100 g/ml carbenicillin. Cells were grown 
at 37 °C with shaking (200 rpm) until the culture reached an OD600 of ~0.6, at which 
point expression was induced with 1 mM IPTG. After 4 h expression cells were 
harvested by centrifugation (5000 g, 15 min, 4 °C). Cells were resuspended in 20 
mM Tris-HCl, pH 8.0, 300 mM NaCl, 20 mM imidazole, EDTA-free protease inhibitor 
tablets (Pierce Biotechnology, USA), and lysed using a cell disrupter (Constant Cell 
Disruption Systems, UK).  Following centrifugation to remove cell debris (20 min, 4 
°C, 39000 g), the lysate was applied to 5 ml HisTrap columns and washed with 20 
mM Tris-HCl, pH 8.0, 300 mM NaCl, 20 mM imidazole. HT-MBP-TEV-POTRAs was 
eluted with a 0-500 mM imidazole gradient with 20 mM Tris-HCl, pH 8.0, 300 mM 
NaCl, 20 mM imidazole. Fractions containing HT-MBP-TEV-POTRAs were pooled, 
then dialysed to into 20 mM Tris-HCl, pH 8.0, 300 mM NaCl. To prevent aggregation 
following TEV cleavage the protein was diluted to a volume of ~100 ml with 20 mM 
Tris-HCl, pH 8.0, 300 mM NaCl. Following the addition of 14.4 mM -
mercaptoethanol (BME), His-tagged TEV protease (provided by Dr D. Walsh 
(University of Leeds)) was added at a 1:10 TEV: HT-MBP-TEV-POTRAs molar ratio 
and incubated overnight at 4 ºC. The cleavage reaction was passed over 5 ml 
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HisTrap columns and the flow through, containing cleaved BamA POTRAs was 
collected. BamA POTRAs were concentrated to ~100 M using Vivaspin 20 (5 kDa 
MWCO) concentrators (Sartorius, UK), aliquoted, snap-frozen in liquid nitrogen and 
stored at -80 °C. The expression and purification of BamA POTRAs was performed 
by Dr A. N. Calabrese (University of Leeds). 
2.5 Expression and purification of Skp 
The pET21b plasmid, containing the full-length Skp gene, including the N-terminal 
signal sequence, was transformed into BL21[DE3] cells (Stratagene, UK). After 
inoculation with a 10 ml starter culture (LB, supplemented with100 g/ml 
carbenicillin), cells were grown in 12 x 1 L LB medium containing 100 g/ml 
carbenicillin at 27 °C with shaking (200 rpm) until the culture reached an OD600 of 
~0.6 (after ~6 h). Cultures were induced with 25 M IPTG, expressed overnight, and 
harvested by continuous centrifugation at 15000 rpm (Heraeus Contifuge, Rotor 
8575, Thermo Fisher Scientific, UK).  The cell pellet was gently resuspended in 50 
mM Tris-HCl, 5 mM EDTA, 50 mM NaCl, pH 7.5 at 4 °C with gentle agitation for ~48 
h. 1 mg/ml polymyxin B sulphate was added to the resuspended cells, and then 
incubated for 1 h at 4 °C with gentle agitation. Spheroplasts were sedimented by 
centrifugation (12 000 g, 20 min 4 °C) and the supernatant dialysed against 20 mM 
Tris-HCl, 100 mM NaCl, pH 8.0 (Buffer A) overnight at 4 °C. The periplasmic extract 
was filtered (0.4 m syringe filter, Sartorius, UK) and loaded onto a HiTrapQ (5 ml) 
anion exchange column (GE Healthcare, UK).  The flow through from this column 
was loaded onto a HiTrap SP (5 ml) cation exchange column (GE Healthcare, UK) 
equilibrated with Buffer A. The column was washed with 5 column volumes of Buffer 
A and eluted with a gradient (0-100 %) of 20 mM Tris-HCl, 750 mM NaCl, pH 8.0 
(Buffer B). Peak fractions were dialysed against 20 mM Tris-HCl, pH 8.0 and 
concentrated to ~50 M (trimer) using Vivaspin 20 (5 kDa MWCO) concentrators 
(Sartorius, UK). Aliquots were snap-frozen in liquid nitrogen and stored at -80 °C. 
2.6 Expression and purification of His-tagged Skp 
His-tagged Skp was expressed and purified using a protocol adapted from Burmann 
et al.171. The pET28b plasmid, containing the Skp gene with an N-terminal 6xHis-tag 
and thrombin cleavage site, was transformed into BL21[DE3]pLysS cells 
(Stratagene, UK). Following inoculation with a 10 ml starter culture (LB, 
supplemented with 30 µg/ml kanamycin), cells were grown in 2x 1L LB medium 
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containing 30 µg/ml kanamycin at 37 °C with shaking (200 rpm) until the culture 
reached an OD600 of ~0.6. The temperature was then lowered to 20 °C and 
expression induced with 0.4 mM IPTG. Following overnight expression (~18 h) cells 
were harvested by centrifugation, resuspended in 25 mM Tris-HCl, pH 7.2, 150 mM 
NaCl, 20 mM imidazole, containing a cocktail of EDTA-free protease inhibitors 
(Roche), and lysed using a cell disrupter (Constant Cell Disruption Systems, UK).  
Following centrifugation to remove cell debris (20 min, 4 °C, 39000 g), the lysate 
was applied to 5 ml HisTrap columns (GE Healthcare) and washed with 25 mM Tris-
HCl, pH 7.2, 150 mM NaCl, 20 mM imidazole.  His-tagged Skp was denatured on-
column with 25 mM Tris-HCl, 6 M GuHCl, pH 7.2, and eluted with a 0-500 mM 
imidazole gradient over 50 ml in 25 mM Tris-HCl, 6 M GuHCl, pH 7.2. Fractions 
containing Skp were pooled and the protein refolded by dialysis against 25 mM Tris-
HCl, pH 7.2, 150 mM NaCl. Refolded His-tagged Skp was concentrated to ~50 M 
(trimer) using Vivaspin 20 (5 kDa MWCO) concentrators (Sartorius, UK), aliquoted, 
snap-frozen in liquid nitrogen and stored at -80 °C. 
2.7 Expression and purification of His-tagged SurA 
His-tagged SurA was expressed and purified with the same protocol as for His-
tagged Skp (Section 2.6), and stored at a concentration of ~200 µM. 
2.8 Protein expression yields 
Expression yields for outer membrane proteins were >50 mg/L of bacterial culture. 
Yields for purified His-tagged Skp, His-tagged SurA and BamA POTRA domains 
were also >50 mg/L. Yields for Skp expressed and purified from the periplasm were 
~5 mg/L. 
2.9 General protein methods 
2.9.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
Tris-tricine buffered SDS-PAGE gels (Table 2.6). were used to monitor protein 
purification and to visualise the ratio of folded to unfolded OMPs in band shift assays. 
Protein samples were diluted two-fold in 2x loading buffer (50 mM Tris-HCl pH 6.8, 
2% (w/v) SDS, 0.1% (w/v) bromophenol blue, 10% (v/v) glycerol).  All samples 
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except those used in cold SDS-PAGE band shift assays were boiled for 5 min prior 
to loading.  Precision Plus Protein™ Dual Xtra Standards (Bio-Rad, UK) were 
loaded into one lane to aid size determination and identification of protein bands. 
Gels were electrophoresed with the inner reservoir of the gel tank containing 
cathode buffer (100 mM Tris, 100 mM tricine, 0.1% (w/v) SDS, pH 8.25) and the 
outer reservoir containing anode buffer (200 mM Tris-HCl, pH 8.9). A current of ~30 
mA was applied until the samples entered the resolving gel, at which point the 
current was adjusted to 60 mA. Semi-native SDS-PAGE gels were made as detailed 
in Table 2.6, except without the addition of SDS. Semi-native SDS-PAGE 6x loading 
buffer contained 50 mM Tris-HCl pH 6.8, 0.1% (w/v) SDS, 0.1% (w/v) bromophenol 
blue, 30% (v/v) glycerol). Semi-native SDS-PAGE gels were run in a cold cabinet at 
4 ºC for ~12 h at 14 mA to avoid denaturation of the BamA barrel129. All gels were 
stained using Instant Blue stain (Expedeon, UK) and imaged using the Syngene 
InGenius gel documentation system (Syngene, UK). Densitometry quantification of 
folded and unfolded OMP bands in cold SDS-PAGE assays was performed using 
ImageJ362. 
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Reagent 
Resolving gel      
volumes (ml) 
Stacking gel       
volumes (ml) 
30% (w/v) acrylamide:0.8% 
(w/v) bis-acrylamide 
7.5 0.83 
3 M Tris, 0.3% (w/v) SDS  
(pH 8.45) 
5.0 1.55 
H2O 0.44 3.72 
Glycerol 2.0 - 
10% (w/v) ammonium 
persulphate 
0.1 0.2 
N,N,N’,N’-tetramethyl-
ethylenediamine (TEMED) 
0.01 0.01 
 
Table 2.6: Volumes of reagents for Tris-tricine buffered SDS-PAGE gels. 
The volumes indicated are sufficient for casting two 8 cm by 10 cm mini-gels 
using a 1.5 mm spacer. 
2.9.2 Trichloroacetic acid (TCA) precipitation of proteins 
TCA precipitation of purified outer membrane proteins was used to remove GuHCl 
and concentrate the sample prior to SDS-PAGE analysis. The procedure was 
carried out in a cold room at 4 °C. Equal volumes of 12.5 % (w/v) TCA and sample 
solution were vortexed and incubated on ice for 20 min. Solutions were then 
centrifuged (13000 rpm, 10 min, 4 °C) in a microcentrifuge and the supernatant 
removed.  1 ml of ice cold ethanol was added to wash the precipitated protein and 
the centrifugation step repeated. The supernatant was again discarded and the 
remaining ethanol removed by placing tubes in a 100 °C heat block for 
approximately 5 min. The pellets were then resuspended in SDS loading buffer and 
boiled for 10 min prior to SDS-PAGE analysis. 
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2.9.3 Determination of protein concentration 
The protein concentrations of all OMPs, BamA POTRA domains, and SurA were 
determined spectrophotometrically using their absorbance at 280 nm. Theoretical 
molar extinction coefficients at 280 nm, calculated using the ExPASy Protparam 
server363, are shown in Table 2.7.   
Skp has a very low molar extinction coefficient at 280 nm (1490 M-1 cm-1) as its 
sequence contains no tryptophan residues, and only one tyrosine residue. 
Therefore, for increased accuracy364, Skp concentrations were determined using a 
bicinchoninic acid (BCA) assay (Thermo Fisher Scientific, UK), according to the 
manufacturer’s instructions. 
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Protein 
Molar extinction 
coefficients at 280 nm 
(M-1 cm-1)  
PagP 82,390 
tOmpA 46,870 
Cys-tOmpA 46,870 
OmpA 52,955 
OmpT 79,760 
OmpF 54,210 
FadL 94,770 
tBamA 101,315 
BamA 140,165 
BamA POTRAs 38,850 
SurA 29,450 
 
Table 2.7: Molar extinction coefficients at 280 nm of purified proteins. 
2.10 Characterisation of PagP in DLPC liposomes (Chapter 3) 
2.10.1 Liposome preparation 
DLPC was dissolved in a 90:10 (v/v) chloroform:methanol solution in glass test 
tubes. Solvent was then removed by drying under a gentle stream of N2, followed by 
further drying in a desiccator under high vacuum for >3 h. The resulting thin lipid film 
was resuspended at a concentration of 40 mM in 50 mM sodium phosphate, pH 8.0 
and left to stand at room temperature for 30 min. 100 nm LUVs were prepared by 
extruding the lipid suspension 11 times through 0.1 m polycarbonate membranes 
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(Nucleopore, Whatman, Clifton, NJ) using a mini-extruder (Avanti, Alabaster, AL, 
USA), and used within 72 h. 
2.10.2 SDS-PAGE band shift assays 
100 µl samples were made containing 16 mM (total lipid) DLPC liposomes, 5 M 
PagP, between 1 M and 8 M urea in 1 M increments in 50 mM sodium phosphate 
pH 8.0.  The final LPR was 3200:1.  Samples were allowed to equilibrate overnight 
at 25 ºC.  2x SDS loading buffer was added immediately prior to gel loading, with 
the exception of a boiled sample (in 1 M urea) which was boiled in 2x SDS loading 
buffer for 10 min prior to loading.  
2.10.3 Fluorescence emission spectra 
Fluorescence emission spectra were measured using a Photon Technology 
International Fluorimeter (Ford, West Sussex, UK).  Samples contained 0.4 M 
PagP, 12.8 mM DLPC (LPR 3200:1), 7 M or 10 M urea for folded and unfolded 
samples, respectively, in 50 mM sodium phosphate, pH 8.0.  Samples were 
incubated at 25 °C overnight prior to measurement. Both excitation and emission slit 
widths were set to 3 nm. Each spectrum was recorded from 295 nm to 400 nm in 1 
nm increments, using an excitation wavelength of 280 nm. 
2.10.4 CD spectra 
Far-UV CD spectra of PagP were acquired on a Chirascan plus circular dichroism 
spectrometer (Applied PhotoPhysics) with a bandwidth of 1 nm, a scan speed of 20 
nm min-1, a step size of 1 nm and a pathlength of 0.1 mm. The average of eight 
scans was taken to enhance signal to noise. PagP samples contained 10 M PagP 
in 50 mM sodium phosphate, pH 8.0. An LPR of 800:1 was used to reduce light 
scattering.  Samples were refolded for 16 h before measurement. Corresponding 
blank spectra, containing all reagents except for PagP, were subtracted for each 
sample. The Mean Residue Ellipticity (MRE) at each wavelength was obtained by 
first calculating the Mean Residue Weight (MRW):  
𝑀𝑅𝑊 =
𝑀
𝑁 − 1
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where 𝑀 is the molecular mass of the protein in Daltons, and 𝑁 is the number of 
amino acids it contains.  The MRE is then given by: 
[θ]𝑀𝑅𝐸 =
𝑀𝑅𝑊 × θ𝜆 
10 ×  𝑑 ×  𝑐
 
where [θ]𝑀𝑅𝐸  is the MRE, θ𝜆  is the measured ellipticity at a particular wavelength, 𝑑 
is the pathlength in cm, and 𝑐 is the concentration in g/ml. 
2.11 Preparation of liposomes 
DUPC, DLPC, DTPC and DMPC lipids were obtained as a powder, dissolved in a 
80:20 (v:v) chloroform:methanol mixture at 25 mg/ml, and stored at -20 ºC until use. 
Appropriate volumes were transferred to glass test tubes and an even lipid film was 
created by drying with a gentle stream of nitrogen while being shaken moderately in 
a 42 ºC water bath. Lipid films were further dried in a vacuum desiccator for >3 h, 
followed by resuspension in 50 mM glycine-NaOH, pH 9.5 to a concentration of 40 
mM. Resuspended lipids were vortexed briefly and allowed to stand for 30 min. After 
vortexing again, lipids were subjected to 5 freeze-thaw cycles using liquid nitrogen. 
Large Unilamellar Vesicles (LUVs) (100 nm) were prepared by extruding the lipid 
suspension a minimum of 11 times through a 0.1 m polycarbonate membrane 
(Nuclepore, New Jersey, USA) using a mini extruder (Avanti Polar Lipids, Alabama, 
USA). In the case of DMPC, the mini extruder was pre-warmed and the extrusion 
performed at 37 ºC to be well above the transition temperate for DMPC (24 ºC)365. 
Liposomes were stored at 4 ºC. DUPC liposomes were used within 48 h of 
preparation. DLPC, DTPC and DMPC liposomes were used within 72 h. 
2.12 CD spectroscopy of folding factors 
Far-UV CD spectra were acquired on a Chirascan plus circular dichroism 
spectrometer (Applied PhotoPhysics) with a bandwidth of 2.5 nm, a scan speed of 
0.5 nm s-1, a step size of 1 nm and a pathlength of 1.0 mm. CD of soluble proteins 
(Skp, SurA and BamA POTRA domains) were acquired in 0.24 M urea, 50 mM 
glycine-NaOH, pH 9.5, at 25 ºC, using a protein concentrations of ~0.2 mg/ml. 
Samples for CD of BamA in LUVs composed of DLPC, DTPC or DMPC, contained 
1.5 M BamA, 1.2 mM lipids (LPR 800:1), 0.24 M urea, 50 mM glycine-NaOH, pH 
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9.5, and were measured at 25 ºC. BamA-containing samples were folded overnight 
at 25 ºC. An LPR of 800:1 was used to reduce light scattering. 
To enhance signal to noise the average of three or eight scans was taken for soluble 
folding factors or BamA, respectively. Corresponding blank spectra, containing all 
reagents except the protein components, were taken and subtracted. Mean residue 
ellipticities (MREs) were calculated as in Section 2.10.4. 
2.13 BamA band shift assays in DLPC, DTPC and DMPC 
BamA folding efficiency in DLPC, DTPC and DMPC liposomes was assessed by 
semi-native SDS-PAGE band shift assays129 (Section 2.9.1). Samples contained 0.8 
M BamA 1.28 mM lipids (LPR 1600:1), 0.24 M urea, 50 mM glycine-NaOH, pH 9.5, 
and were folded overnight at 25 ºC prior to analysis. 
2.14 Kinetic folding assays 
Kinetic measurements were carried out using a Quantum Master Fluorimeter 
(Photon Technology International, UK) controlled by FelixGX software v4.3. For 
each experiment, four separate samples were run in a four cell changer maintained 
at 25 ºC by a peltier-controlled temperature unit. Tryptophan fluorescence of 
samples was excited at a wavelength of 295 nm, and fluorescence emission was 
monitored at 335 nm. 295 nm rather than 280 nm was chosen as the excitation 
wavelength as this minimises the fluorescence intensity contribution from Skp, which 
contains a single tyrosine residue, but no tryptophan residues. The excitation slit 
widths were set to 0.3-0.6 nm and the emission slit widths were set to 5 nm. The 
high emission:excitation slit width ratio was important to minimise photobleaching on 
the experimental timescale. Folding was initiated by dilution of denaturant and 
manual mixing in quartz cuvettes  (10 x 4 mm, Hellma Analytics, UK). Cuvettes were 
shaken ~three times following OMP dilution before insertion into the fluorimeter. 
2.14.1 Kinetic assays in DUPC liposomes (Chapters 4 and 5) 
OMPs were buffer exchanged from 25 mM Tris-HCl, 6 M GuHCl, pH 8.0 into 50 mM 
glycine-NaOH, 8 M urea, pH 9.5 using Zeba spin desalting columns (Thermo 
Scientific, UK) and diluted to 80 M. OMP folding reactions in the absence of 
additional folding factors were initiated by diluting OMPs manually from this 80 µM 
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unfolded protein stock in 8 M urea to a final concentration of 0.4 M protein and 
0.24 M urea in the presence of 1.28 mM DUPC liposomes (a lipid:protein molar ratio 
(LPR) of 3200:1), in 50 mM glycine-NaOH, pH 9.5. The final volume for each sample 
was 500 l. For experiments in which tOmpA was folded into DUPC liposomes in 
which BamA, tBamA, or OmpA were prefolded, 0.8 M of BamA, tBamA, or OmpA 
were folded by dilution into liposomes from a 100 M stock for >1.5 h prior to 
addition of tOmpA to initiate the folding reaction. 
For experiments involving preincubation with either Skp, SurA or BamA POTRAs, 
OMPs were pre-incubated with these factors for approximately 1 min prior to 
addition of liposomes. OMPs were diluted and mixed from an 80 M stock in 8 M 
urea to a final concentration of 2.4 M, in the presence of either a two-fold molar 
excess or SurA or POTRA domains, or a 1:1, 2:1, or 4:1 molar ratio of Skp:OMP, in 
0.24 M urea, 50 mM glycine-NaOH, pH 9.5 (no lipids). This stock was then further 
diluted 6x in presence of 1.28 mM DUPC in 0.24 M urea, 50 mM glycine-NaOH, pH 
9.5 to begin the assay. Experiments in which these mixtures were added to DUPC 
liposomes which contained prefolded BamA, tBamA, or OmpA were performed as 
for tOmpA alone in the presence of these prefolded OMPs (above). In experiments 
in which Skp-tOmpA mixtures were added to a solution containing free SurA or 
BamA POTRAs, as well as DUPC liposomes, SurA and BamA POTRAs were pre-
added to liposomes at a concentration of 0.8 M (a two-fold molar excess over 
tOmpA). The final volume for each sample was 540 l. Note that at the 
concentrations of Skp utilised here, Skp has been shown to be in a dynamic 
equilibrium between folded monomer subunits and trimers163. All Skp concentrations 
referred to here are trimer equivalents.   
 
For each experiment with a particular liposome batch, four samples were measured 
concurrently. A minimum of three replicates were globally fitted using IgorPro 6.0 
(Wavemetrics, Oregon, USA) to extract rate constant(s), forcing the fits to share the 
same rate constant(s). Transients were fitted either to a single exponential function: 
 
  𝑦 = 𝐴1 ∙ 𝑒
−𝑘1𝑡 +  𝑐 (2.1) 
or to a double exponential function: 
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  𝑦 = 𝐴1 ∙ 𝑒
−𝑘1𝑡 +  𝐴2 ∙ 𝑒
−𝑘2𝑡 +  𝑐 (2.2) 
Where k1 and k2 are rate constants, A1 and A2 are their associated amplitudes, and c 
is a constant. Transients were fitted to a double exponential function if a satisfactory 
fit was not obtained to a single exponential function as judged by inspection of 
residuals. Experiments were performed for each condition using three separate 
liposome batches, and reported errors are the standard deviation of rate constants 
between liposome batches. The standard deviation, , for each rate constant was 
defined as: 
  
𝜎 = √
𝛴𝑖 (𝑥𝑖 − ?̅?)
2
𝑛 − 1
 
(2.3) 
where xi is a rate constant for a particular condition, ?̅? is the mean rate constant for 
that condition, and n is the number of replicates. 
2.14.2 Kinetic assays for tOmpA in DLPC, DTPC and DMPC in the 
presence or absence of BamA (Chapter 5) 
Stocks of BamA and tOmpA at 100 M and 80 M, respectively, were prepared in 8 
M urea, 50 mM glycine-NaOH, pH 9.5 (Section 2.14.1). Folding experiments were 
initiated by dilution of tOmpA to a concentration of 0.4 M protein and 0.24 M urea 
in the presence of 1.28 mM DLPC, DTPC and DMPC liposomes (LPR 3200:1), in 50 
mM glycine-NaOH, pH 9.5, and monitored by fluorescence spectroscopy as 
described in Section 2.14. The final volume for each sample was 500 l. In BamA-
containing experiments, 0.8 M BamA (two-fold molar excess) was prefolded 
overnight at 30 ºC. As the tOmpA alone experiments exhibited a lag in kinetics a 
sigmoidal fit to the data was used to guide the eye: 
  𝑦 = 𝑏𝑎𝑠𝑒 +
𝑚𝑎𝑥
1 +  e
(
xhalf−𝑥
𝑟𝑎𝑡𝑒 )
 (2.4) 
This equation is implemented in the IgorPro 6.0 set of standard fitting functions; 
𝑏𝑎𝑠𝑒 corresponds to the value of 𝑦 when 𝑥 is small, 𝑏𝑎𝑠𝑒 + 𝑚𝑎𝑥 corresponds to the 
value of 𝑦  when 𝑥  is large, 𝑥ℎ𝑎𝑙𝑓  corresponds to the value of 𝑥  when 𝑦  is at 
(𝑏𝑎𝑠𝑒 + 𝑚𝑎𝑥 )/2, and 𝑟𝑎𝑡𝑒 corresponds to the gradient of the rise in the sigmoid, 
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with a smaller value for rate leading to a faster rise. Data for tOmpA folding into 
DLPC or DTPC in the presence of BamA were fitted to a single exponential function, 
equation (2.1), while data for tOmpA folding into DMPC in the presence of BamA 
was fitted to a double exponential function, equation (2.2). To compare the tOmpA 
folding data in the presence and absence of BamA quantatively, the t50 value, the 
time taken to reach 50 % of the total fluorescence change on folding was used. 
Software was written in the Python programming language366 to extract t50 values. 
For each transient the minimum fluorescence value was located, and the maximum 
value was defined by fitting a horizontal baseline to the final section of the data. 
Three separate liposome batches were used for each lipid type, and for each 
condition (lipid ± BamA) four transients were used for the t50 calcuation i.e. a total of 
12 transients per condition. Errors were calculated as the standard error of the mean 
(S.E.M) defined as: 
  𝑆. 𝐸. 𝑀 =  
𝜎
√𝑛
 (2.5) 
where  is the standard deviation, equation (2.3), and n, is the number of samples. 
To calculate the error in the fold change in t50 value with or without the presence of 
BamA, the standard error of the mean was propagated using the following: 
  
𝛿𝑅 = |𝑅| ∙ √(
δX
𝑋
)
2
+ (
δY
𝑌
)
2
 
(2.6) 
where R is the error in the fold change, |R| is the fold change value, X and Y are 
the mean t50 values with or without BamA, respectively, and X and Y are the 
S.E.M. values with or without BamA, respectively. 
2.15 Fluorescence emission spectra (Chapter 4) 
Fluorescence emission spectra were acquired on the same instrument as the kinetic 
assays in Section 2.14. Each spectrum was recorded from 305 nm to 400 nm in 1 
nm increments, using an excitation wavelength of 295 nm. All spectra were acquired 
at 25 ºC and all samples contained 50 mM glycine-NaOH, pH 9.5, in a sample 
volume of 500 l. OMPs from an 80 M stock in 8 M urea were diluted to a final 
concentration of 0.4 M in the presence of a 2-fold molar excess of Skp in 0.24 M 
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urea, 8 M urea, or buffer alone in 0.24 M urea. Folded samples were prepared by 
dilution of an 80 M OMP stock to 0.4 M in the presence of 1.28 mM DUPC 
liposomes (molar LPR 3200:1) in 0.24 M urea and incubated at 25 ºC for ~1.5 h 
prior to acquisition of the fluorescence emission spectra. 
2.16 Temperature denaturation of BamA and OmpA 
BamA or OmpA was folded by dilution from a 100 M stock in 8 M urea, 50 mM 
glycine-NaOH, pH 9.5, to a final concentration of 0.8 M OMP, in the presence of 
0.24 M urea, 1.28 mM DUPC LUVs in 50 mM glycine-NaOH, pH 9.5, at 25 ºC. The 
final volume for each sample was 500 l. A temperature ramp experiment was 
performed in in which a fluorescence emission spectrum was recorded from 320 nm 
to 370 nm in 1 nm increments, using an excitation wavelength of 280 nm, every 1 ºC 
between 20 ºC and 90 ºC. The average wavelength (av) of the spectrum was 
calculated for each measured temperature using: 
 
𝜆𝑎𝑣 =
 ∑ 𝜆𝑖𝐼
𝑖=370
𝑖=320 𝑖
∑ 𝐼𝑖=370𝑖=320 𝑖
 
(2.7) 
where i and Ii  are the wavelength, and the fluorescence intensity at I, respectively. 
To extract the temperature at which 50% of molecules are unfolded (apparent Tm) 
the data were fitted to the following modified Gibbs-Helmholtz equation367,368: 
 
𝜆𝑎𝑣 =  
(𝑎𝑇 + 𝑏) (
1
𝑄𝑅
) e
(
Δ𝐻
𝑅 )(
1
𝑇𝑚
−
1
𝑇) + 𝑐𝑇 + 𝑑
1 +  (
1
𝑄𝑅
) e
(
Δ𝐻
𝑅 )(
1
𝑇𝑚
−
1
𝑇)
 
(2.8) 
where a and b are the slope and intercept of the pre-transition baseline, 
respectively, c and d are the slope and intercept of the post-transition baseline, 
respectively, H is the change in enthalpy, R is the gas constant (8.314 J.K-1.mol-1), 
Tm is the transition temperature in Kelvin, T is the temperature in Kelvin, and QR is 
the quantum yield ratio between the folded and unfolded states. The QR term is 
required to account for the observation that the average wavelength (av) does not 
vary linearly with the proportion of folded and unfolded molecules152,331, and is 
defined as: 
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𝑄𝑅 =
 ∑ 𝐼𝑖=370𝑖=320 𝑖 (𝐹)
∑ 𝐼𝑖=370𝑖=320 𝑖 (𝑈)
 
 
(2.9) 
Where ∑ 𝐼𝑖(𝐹)and ∑ 𝐼𝑖(𝑈)  are the sum of the fluorescence intensities measured 
between 320 and 370 nm in the folded and unfolded state, respectively. 
Temperature ramp experiments were performed on a Chirascan plus circular 
dichroism spectrometer (Applied PhotoPhysics) in fluorescence mode. Data fitting 
was performed using IgorPro 6.0 (Wavemetrics, Oregon, USA).  
2.17 Mass Spectrometry 
Skp:OMP complexes were prepared by rapid dilution of the denatured OMP (400 
M in 8 M urea, 50 mM glycine-NaOH, pH 9.5) to a final concentration of 5 M into a 
solution of Skp (5 M in 50 mM glycine-NaOH, pH 9.5). The samples were then 
buffer exchanged into 200 mM ammonium acetate, pH 10 using Zeba spin desalting 
columns (Thermo Scientific, UK) immediately prior to MS analysis. nanoESI-IMS-MS 
spectra were acquired using a Synapt HDMS hybrid quadrupole-travelling wave-
time of fight mass spectrometer (Waters Corporation, UK) using platinum/gold-
plated borosilicate capillaries prepared in-house. Typical instrument parameters 
were: capillary voltage 1.2-1.6 kV, cone voltage 40 V, trap collision voltage 6 V, 
transfer collision voltage 10 V, trap DC bias 20 V, backing pressure 4.5 mBar, IMS 
gas pressure 0.5 mBar, travelling wave height 7 V, travelling wave velocity 250 ms-1. 
Data were processed using MassLynx v4.1, Driftscope 2.5 (Waters Corporation, UK) 
and Massign369. CCSs were estimated by a calibration approach370-372 using arrival 
time data for ions with known CCSs (β-lactoglobulin A, avidin, concanavilin A and 
yeast alcohol dehydrogenase, all Sigma Aldrich, UK). Estimated modal CCSs are 
shown as mean ± standard deviation of three independent experiments. Theoretical 
CCSs for globular proteins with a given effective gas phase density were calculated 
according to published methods using the following equation373:  
  Ω = 𝜋(√3𝑚 4𝜋⁄ 𝜌
3
 + 𝑅𝑔𝑎𝑠 )
2 (2.10) 
where  Ω  is the CCS, 𝑚  is the mass of the protein or protein complex, 𝜌  is the 
effective gas-phase density, and 𝑅𝑔𝑎𝑠 is the radius of the buffer gas molecule (set to 
1.55 Å as nitrogen (N2) was the buffer gas used). All mass spectrometry 
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experiments and analyses, including production the mass spectrometry figures in 
Chapter 4, were performed by Dr A. N. Calabrese. 
2.18 Modelling of Skp-OMP complexes 
All modelling was performed with the PyMOL Molecular Graphics System 
(v1.7rc1)374 using scripts written in Python 2.7.5. To generate models of the 
Skp:OMP complexes, the missing residues in chains B and C of the Skp crystal 
structure (PDB: 1U2M150) were modelled from chain A. For the Skp:tOmpA/PagP 
model the OMP was modelled as a sphere of radius 20 Å with its origin positioned at 
the geometric centre between the α-carbon atoms of residue 50 of each Skp chain.  
For the Skp:OMP model with expanded Skp subunits, each chain was positioned 
around a sphere of radius 25 Å representing the larger OMP. The flexible tips of 
each subunit (residues 51-101) were modelled hinged slightly inwards to wrap 
around the substrate. The side-by-side parallel and antiparallel 2:1 Skp:OMP 
models were created by duplication of the Skp:tOmpA/PagP model and appropriate 
rotation and translation. The interlocking trimer 2:1 Skp:OMP model was generated 
by duplication of the Skp model with expanded subunits and appropriate rotation 
and translation of the duplicated Skp. Theoretical CCS values were generated using 
the calibrated trajectory method implemented in the software IMPACT (Ion Mobility 
Projection Approximation Calculation Tool)375. 
2.19 Molecular Dynamics Simulations 
Molecular dynamics (MD) simulations were prepared using the AmberTools 14 suite 
of programs, and performed using AMBER and the ff14SB forcefield376,377. To 
simulate apo-Skp in water, a Skp model was first generated from the Skp crystal 
structure (PDB: 1U2M150) with the residues absent in chains B and C modelled from 
chain A. Following addition of hydrogen atoms using xleap, Skp was placed in a 
TIP3P water box with a 10.0 Å cutoff and the system neutralised with a total of 15 
Cl- ions. The system was equilibrated by performing an initial energy minimisation, 
followed by 80 ps of restrained MD during which the system was heated to 300 K 
with gradual release of restraints. This was followed by an unrestrained MD 
simulation of 100 ns. 
Simulations of the collapse of the extended chains of tOmpA and tBamA were 
carried out using a Generalised Born/Solvent Accessible surface area (GB/SA) 
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implicit solvent model378,379. Use of an implicit solvent model speeds up exploration 
of conformational space by at least an order of magnitude due to the neglect of 
frictional forces from collisions with water molecules380, leading to rapid adoption of 
a collapsed configuration from the initially linear structure. The polypeptide starting 
structures were generated in xleap and, after initial energy minimisation, were 
simulated for 3 ns. The starting models for the simulation of Skp-tOmpA and Skp2-
tBamA in vacuo were created in PyMOL by positioning OMPs, after simulated 
collapse, within the cavity of Skp trimer structures in an ‘open’ conformation taken 
from the explicit solvent apo-Skp simulation. All simulations except apo-Skp in 
explicit water were performed in triplicate. Each in vacuo simulation of Skp-tOmpA 
and 2:1 Skp:tBamA was performed using a starting OMP structure from a different 
simulation. In vacuo simulations of apo-Skp were performed using three different 
starting structures selected from the simulation of apo-Skp in explicit water. For all in 
vacuo simulations the system was equilibrated by performing an initial energy 
minimisation, followed by eight steps of restrained MD during which the system was 
heated to 300 K with gradual release of restraints. This was followed by an 
unrestrained MD simulation of 100 ns. 
To simulate the 1:1 Skp:tOmpA and 2:1 Skp:tBamA complexes in solution, starting 
models were generated as detailed above for the in vacuo simulations. The 
Skp:OMP complexes were placed in a TIP3P water box with a 10.0 Å cutoff and the 
system neutralised with a total of 10 Cl- ions (1:1 Skp:tOmpA) or 12 Cl- ions (2:1 
Skp:tBamA). The systems were equilibrated by performing an initial energy 
minimisation, followed by 80 ps of restrained MD during which the system was 
heated to 300 K with gradual release of restraints. This was followed by an 
unrestrained MD simulation of 100 ns. Simulations were repeated in triplicate for 
each complex. 
Theoretical collision cross-sections (CCSs) of final structures at the end of 
simulations were calculated, for comparison with IMS-MS data, using the trajectory 
method and the software IMPACT375. CCS values for all structures following in 
vacuo simulations were obtained after 100 ns of unrestrained simulation. CCS 
values for tOmpA and tBamA in implicit solvent were obtained after 3 ns of 
unrestrained simulation. The integration time-step was 2 fs and atomic positions 
were saved every 500 steps (1 ps). The software VMD381 was used to compute 
backbone root mean square deviation (RMSD) and to render videos of the 
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simulations. Analysis of radius of gyration changes over trajectories were carried out 
with ptraj382. 
MD simulations made use of time on the ARC2 supercomputer facility at the 
University of Leeds, and time on ARCHER granted via the UK High-End Computing 
Consortium for Biomolecular Simulation, HECBioSim. 
2.20 Microscale thermophoresis (MST) binding experiments 
2.20.1 Labelling of tOmpA with Alexa Fluor 488 
An N-terminal cysteine residue was introduced in the tOmpA sequence in pET11a 
by site-directed mutagenesis (using the Q5 site-directed mutagenesis kit as per 
manufacturers’ instructions), to create Cys-tOmpA-pET11a (prepared by Tom 
Crosskey, University of Leeds)361. Cys-tOmpA was expressed and purified as 
detailed in Section 2.3.1 (Tom Crosskey, University of Leeds) and covalently 
labelled with Alexa Fluor 488 dye via maleimide chemistry. Alexa Fluor 488 C5 
maleimide (Thermo Fisher Scientific, UK) dissolved in DMSO (10 mg/ml) was added 
to a sample containing 50 M Cys-tOmpA, 6 M GuHCl, 0.5 mM TCEP 25 mM Tris-
HCl, pH 7.2, to a final concentration of 0.5 mM. The total sample volume was 500 l. 
The labelling reaction was left overnight at 4 ºC then was loaded onto Superdex 
Peptide 10/300 column equilibrated with 6 M GuHCl, 25 mM Tris-HCl, pH 7.2 to 
remove the excess free dye. Samples were collected every 1 ml and peak protein 
fractions tested for dye labelling using a Nanodrop 2000 (Thermo Fisher Scientific, 
UK). The labelling efficiency was estimated as ~50%. Cys-tOmpA was created, 
expressed and purified by Tom Crosskey. 
2.20.2 MST protocol 
From a 200 M SurA stock solution in 50 mM glycine-NaOH, pH 9.5, a series of 
two-fold serial dilutions were performed to obtain sixteen 15 l samples. Labelled 
Cys-tOmpA was buffer exchanged into 8 M urea, 50 mM glycine-NaOH, pH 9.5, to a 
concentration of 1.6 M. This stock was diluted 16-fold to a concentration of 100 nM 
with 50 mM glycine-NaOH, pH 9.5, then immediately added to the sixteen SurA-
containing samples in 15 l aliquots (30 l total sample volume). Therefore, the final 
concentrations in the samples were 50 nM Cys-tOmpA, 100 M – 3 nM SurA, 0.25 
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M urea, 50 mM glycine-NaOH, pH 9.5. Samples were rapidly added to capillaries by 
capillary action then read using a Monolith NT.115 MST machine (NanoTemper, 
Germany).  
2.20.3 MST data fitting to a quadratic binding equation 
The observed signal (Sobs) in the MST experiment arises from contributions from 
both the unbound and bound fraction of labelled tOmpA molecules (FB and Fu). 
Therefore: 
 𝑆𝑜𝑏𝑠 =  𝐹𝐵 𝑆𝐵  ×  𝐹𝑈 𝑆𝑈  (2.11) 
Where SB and SU are the signals from the bound and free states, respectively. As 
the sum of the bound and unbound fractions must equal 1 we can write: 
 𝐹𝑈 =   1 − 𝐹𝐵 (2.12) 
Substituting (2.12) into (2.11) gives: 
 𝑆𝑜𝑏𝑠 =  𝐹𝐵 𝑆𝐵  × (1 − 𝐹𝐵 )𝑆𝑈  (2.13) 
Expanding and rearranging: 
 𝑆𝑜𝑏𝑠 =  𝐹𝐵 𝑆𝐵 +  𝑆𝑈 −   𝐹𝐵 𝑆𝑈  
 𝑆𝑜𝑏𝑠 =  𝑆𝑈 + (𝑆𝐵 −  𝑆𝑈) 𝐹𝐵  (2.14) 
The equilibrium dissociation constant 𝐾𝑑 is defined as: 
 
𝐾𝑑 =  
[ 𝐴𝑓𝑟𝑒𝑒][𝐵𝑓𝑟𝑒𝑒]
[𝐴𝐵]
 
(2.15) 
where [Afree] is the concentration of one binding partner (fluorescently labelled 
tOmpA) and [Bfree] is the concentration of the other binding partner (SurA). 
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 [𝐴0] =  [ 𝐴𝑓𝑟𝑒𝑒] + [𝐴𝐵]   
 [𝐵0] =  [ 𝐵𝑓𝑟𝑒𝑒] + [𝐴𝐵]   
where [A0] and [B0] are the total concentrations of A and B, respectively. Therefore: 
 [ 𝐴𝑓𝑟𝑒𝑒] = [𝐴0] − [𝐴𝐵]  (2.16) 
  [ 𝐵𝑓𝑟𝑒𝑒] = [𝐵0] − [𝐴𝐵]  (2.17) 
Substituting (2.16) and (2.17) into (2.15) gives: 
 
𝐾𝑑 =  
([ 𝐴0] − [𝐴𝐵])  ×  ([𝐵0] − [𝐴𝐵])
[𝐴𝐵]
 
(2.18) 
Expanding and rearranging:  
 𝐾𝑑[𝐴𝐵] =  [ 𝐴0] [𝐵0] −  [ 𝐴0][𝐴𝐵] − [𝐴𝐵][𝐵0] +  [𝐴𝐵]
2
  
  0 =  [ 𝐴0] [𝐵0] −  [ 𝐴0][𝐴𝐵] − [𝐴𝐵][𝐵0] −  𝐾𝑑[𝐴𝐵] +  [𝐴𝐵]
2
  
  0 =   [𝐴𝐵]2 − [𝐴𝐵]([ 𝐴0] − [𝐵0] − 𝐾𝑑) + [ 𝐴0] [𝐵0] (2.19) 
Equation (2.19) is of the form ax2 + bx + c = 0 therefore using the quadratic formula: 
  
𝑥 =
−𝑏 ± √𝑏2 − 4𝑎𝑐
2𝑎
 
(2.20) 
  
[𝐴𝐵] =  
([ 𝐴0] + [𝐵0] +  𝐾𝑑)±]√([ 𝐴0] + [𝐵0] +  𝐾𝑑)2 − 4[𝐴0][𝐵0]
2
 
(2.21) 
The fraction bound is defined as: 
  
𝐹𝐵 =
[𝐴𝐵] 
𝐴0
 
(2.22) 
Substituting (2.14) and (2.22) into (2.21) gives: 
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𝑆𝑜𝑏𝑠 =  𝑆𝑈 + (𝑆𝐵 −  𝑆𝑈) × 
([ 𝐴0] + [𝐵0] + 𝐾𝑑)  ± √([ 𝐴0] + [𝐵0] + 𝐾𝑑)2 − 4[𝐴0][𝐵0]
2[𝐴0]
 
   (2.23) 
Equation (2.23) was fitted to MST data for SurA (molecule B) binding to 
fluorescently labelled tOmpA (molecule A) to obtain a Kd for the interaction. Data 
fitting was carried out using IgorPro 6.0 (Wavemetrics, Oregon, USA). 
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3 Development of a fluorescence assay for the study of OMP 
folding kinetics in low urea concentrations 
3.1 Introduction 
To aid understanding of the pathways and physicochemical principles of OMP 
folding over the last 25 years in vitro studies have measured OMP folding into a 
wide variety of amphiphiles and surfactants383. Kinetic assays of OMP folding have, 
in the vast majority of cases, measured folding using cold SDS-PAGE gels298. This 
technique exploits the fact that folded and unfolded OMPs migrate at different 
apparent molecular weights if left unboiled in SDS-containing sample buffer prior to 
gel loading. SDS resistance of the native state (‘heat modifiability’), which has been 
known since the 1970s308-310, allows the direct quantification the fraction folded 
within a sample, due to the increased stability and compaction of the native state320. 
The technique can also allow the resolution of native dimers and trimers if these are 
present311,328. To measure folding kinetics, following initiation of a folding reaction a 
sample is taken at different time points to which SDS is added which rapidly binds to 
the OMP, and is thought to prevent any subsequent folding. The fraction folded at 
each time point is then quantified by gel densitometry320. Far-UV CD has also been 
used to measure OMP folding kinetics by quantifying the appearance of -sheet 
secondary structure53,348,365 (or additionally, in the case of PagP, native tertiary 
structure348). No studies have examined the kinetics of OMP folding in the presence 
of additional folding factors by CD, likely due to the complication that the secondary 
structure of folding factors also contributes to the CD signal. 
The work in this chapter describes efforts to obtain conditions suitable for monitoring 
the in vitro folding kinetics of a range of different OMPs using intrinsic fluorescence, 
as a first step towards comparing how the influence of cellular factors on folding 
kinetics varies with OMP substrate. An important factor influencing OMP folding 
efficiency is the final OMP concentration on dilution from denaturant, as higher OMP 
concentrations increase the rate of aggregation relative to the folding rate. The 
assay developed here, based on intrinsic tryptophan fluorescence, allows real-time 
monitoring of folding at much lower OMP concentrations (sub-M) than normally 
used in CD or cold SDS-PAGE based studies (low M concentrations). 
Fluorescence-based kinetic assays are complementary to cold SDS-PAGE assays, 
the latter, although a discontinuous assay, and limited as to the number of points per 
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transient, provides a read out of the absolute fraction of folded SDS-resistant 
molecules at any point. In some cold SDS-PAGE based studies, notably those 
involving autotransporters or OMPs folding in the presence of the whole BAM 
complex136,239 (Section 1.5.2), western blotting has been used to detect folded 
populations, allowing low concentrations to be used (e.g. 0.1 M for the 
autotransporter EspP239 and 0.5 M for FLAG-tagged BamA, respectively136,283). 
A key problem in the experimental tractability of OMPs is their aggregation 
propensity. Denaturants, most commonly urea, help to maintain OMPs in a soluble 
folding-competent form. Depending on the OMP under study, and the nature of the 
folding environment, a high final denaturant concentration may be required to 
achieve high folding efficiency. For example, the Neisserial OMP Opa60 required 4 M 
urea to fold at >95% efficiency in DDPC (diC10:0PC) vesicles at pH 12
384. Further, a 
highly aggregation-prone His-tagged PagP construct has been shown to fold into 
DLPC (diC12:0PC) LUVs with the greatest efficiency in 7 M urea
348. In subsequent 
work on an untagged PagP construct, a high folding efficiency with exponential 
kinetics was observed into DLPC LUVs in the presence of 2 M urea, allowing the 
investigation of the effects of the chaperones Skp and SurA on PagP folding152. 
While it was shown that SurA was stable in conditions ≤ 2 M urea, this was not the 
case for Skp, although Skp-PagP complexes formed in a low urea concentration 
(0.24 M) were resistant to subsequent addition of 2 M urea152. The addition of high 
concentrations of denaturant does not appear to perturb synthetic liposomes 
structure; Rayleigh-Gans-Debye (RDG) scattering experiments showed that DLPC 
LUVs remained intact in titrations of up to 6 M GuHCl333. However, it is less clear 
how the inclusion of molar concentrations of urea may affect the activity of proteins 
involved in assisting OMP folding, therefore a low urea concentration (0.24 M) was 
used in the assay developed here. 
Structurally, OMPs generally have short turns on their periplasmic side between the 
-strands of their barrels (with TolC a notable exception80), and longer loops on their 
extracellular side81,89,385. OMPs have a wide variety of sizes, with known barrel sizes 
ranging from 8 to 26 -strands89,386. They may also have non-membrane embedded 
domains on either side of the membrane89. All this structural diversity is necessary 
for the multitude of functions OMPs perform. It influences OMP stability and 
dynamics, and also the folding kinetics, pathways, and mechanisms en route to the 
native state. Detailed explorations of the in vitro folding mechanisms of OMPs 
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initially focused almost exclusively on OmpA383,387, limiting opportunities for 
comparing and contrasting the folding behaviour of different OMPs. In recent years 
the in vitro folding behaviour of other OMPs have been studied, including the 8-
stranded OMPs PagP152,313,323,332,336,348 and OmpX300,313,318,388, the 10-stranded 
OmpT313, the 12-stranded OmpLA333,335,389,  the 14-stranded OMPs FomA319,320 and 
OmpG390, the 16-stranded OmpF311,313 and BamA136,283, and the 19-stranded 
mitochondrial OMP, hVDAC1293. However, conditions in OMP folding studies often 
need to be optimised for each protein studied limiting opportunities for direct 
comparison322, and relatively few studies have looked at the in vitro influence of 
folding factors on OMP folding136,152,153,233,239,283,299,300. In particular, no studies have 
compared the effects of chaperones on the in vitro folding behaviour of a range of 
OMPs. 
A study of the aggregation propensity of eight different OMPs in their unfolded 
aqueous (UAQ) state using sedimentation velocity analytical ultracentrifugation 
(AUC) revealed variation in the amount of self-association between different 
OMPs164. Interestingly, some of these variations do not have any obvious 
explanations. While it could be expected that OMPs which have an additional 
soluble domain (OmpA and BamA) would exhibit less self-association, it is unclear 
why OmpT, which has a large extracellular region, has a much greater tendency to 
self-associate than FadL, which has a particularly low folding efficiency in vitro313. 
PagP required the greatest addition of urea (5 M) to remain monomeric at the low 
micromolar concentrations used164. The addition of salt (KCl) increased the levels of 
OMP self-association164, consistent with experiments on Opa50 and Opa60 from 
Neisseria gonorrhea, which showed that salt lowers folding efficiency by favouring 
aggregation384. For this reason, no salt titrations were performed when optimising 
the kinetic assays described in this chapter. High pH was shown to reduce self-
association between all OMPs164, consistent with the notion that at a pH level far 
from the theoretical pI of E. coli OMPs (pI ~4-6), solubility is maintained by the 
increased negative charge on the protein. This also provides an explanation as to 
why high pH also increases OMP folding efficiency in vitro313,391,392; decreased 
aggregation allows a greater percentage of molecules to fold164. Consistent with this, 
in the assay developed here using PagP, it was also found that higher pH increased 
folding efficiency (Sections 3.1.1 and 3.1.2). In vivo the periplasm is at a similar pH 
to the extracellular environment49,84 as the OM is porous to small ions such as 
protons, providing an additional reason why OMPs are heavily dependent on the 
proper functioning of the periplasmic chaperone network (Section 1.3)393.  
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In the work described in this chapter OmpF was cloned, expressed and purified by 
A. N. Calabrese, and OmpT was cloned and produced by L. M. McMorran and T. G. 
Watkinson, respectively. 
3.1.1 Expression and purification of PagP 
To develop a kinetics assay for the study of the folding of multiple OMPs in the 
presence of folding factors, the system was first optimised for the 8-stranded OMP 
PagP. PagP, lacking its N-terminal signal sequence, was expressed as insoluble 
inclusion bodies, which were isolated, solubilised in denaturant, then further purified 
by gel filtration in its denatured state (6 M GuHCl, 25 mM Tris-HCl, pH 8.0, Section 
2.3.1). A typical A280 trace from PagP gel filtration is shown in Figure 3.1a, with SDS-
PAGE of peak fractions indicating highly pure PagP (Figure 3.1b). 
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Figure 3.1: Purification of PagP. (a) Purification of PagP by gel filtration 
(Superdex 75 HiLoadTM 26/60 column) following isolation from inclusion 
bodies. (b) SDS-PAGE gel lane of pooled peak fractions from gel filtration of 
solubilised PagP inclusion bodies (elution volumes ~110-140 mL in (a)). (c) 
Crystal structure of PagP (PDB: 3GP6345). Residues involved in exiton 
formation leading to a positive peak in the native far-UV CD spectra at 232 
nm, Y26 and W66349, are shown as magenta and red spheres, respectively. 
The native structure is tilted approximately 25° to the normal of the membrane. 
Black lines indicate approximate location of the membrane. 
To verify that PagP, purified in an unfolded stated, could fold to its native state three 
techniques were used to examinine the relative populations of folded and unfolded 
OMPs in a sample: fluorescence emission spectroscopy, CD spectroscopy and cold 
SDS-PAGE band shift assays. These experiments were performed with previously 
published conditions332,348 in 100 nm DLPC liposomes, 50 mM sodium phosphate, 
pH 8.0, with an LPR of 3200:1 at 25 ºC. The fluorescence emission spectrum for 
folded PagP is blue-shifted with a max at a lower wavelength and higher intensity 
compared to that of unfolded PagP, with a maximum difference at ~335 nm (Figure 
3.2a). The CD spectrum of unfolded PagP is consistent with a random coil set of 
conformations, while the CD spectrum of folded PagP has a negative maximum at 
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218 nm, typical of -sheet secondary structure394 (Figure 3.2b). An additional 
positive peak at 232 nm, which has been attributed to a ‘Cotton effect’ between 
residues W66 and Y26349 (Figure 3.1c), indicates the formation of native PagP 
tertiary structure. Overnight PagP folding experiments were performed under the 
same conditions in the presence of urea concentrations between 1 and 8 M and the 
fraction of folded protein assessed by a band-shift assay (Figure 3.2c). The results 
demonstrate that at high urea concentrations (6-8 M) the vast majority (>90%) of 
PagP is folded, while at lower urea concentrations (1-3 M) most of PagP is unfolded 
(>80%). 
 
Figure 3.2: Characterisation of PagP folding in DLPC liposomes at pH 
8.0. (a) Fluorescence emission spectra of folded and unfolded PagP. (b) CD 
spectra of folded and unfolded PagP. (c) Folding yields of PagP by SDS-
PAGE band shift assay at concentrations of urea between 1 M and 8 M. 
Folded and unfolded samples in (a) and (b) contained 7 M and 10 M urea, 
respectively. The concentrations of PagP in (a), (b) and (c) were 0.4 M, 
10 M and 5 M, respectively. All samples were folded overnight in 50 mM 
sodium phosphate, pH 8.0, at 25 ºC. 
3.1.2 Effects of lipid chain length on PagP folding yields in PC 
liposomes 
Evidence in the literature suggests that the in vitro folding efficiency of OMPs varies 
greatly with liposome composition, with a general trend of increasing efficiency with 
decreasing acyl chain length for folding into phosphatidylcholine LUVs53,313. Previous 
work by Dr. Alice I. Bartlett (University of Leeds)395 demonstrated that PagP folds 
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with the greatest efficiency at pH 9.5 (4 M PagP, 1 M urea, 10 mM glycine-NaOH, 
DLPC liposomes, LPR 3200:1, 37 ºC). Accordingly, this pH was used to investigate 
the impact of decreasing the acyl chain lengths on PagP folding efficiency. Further, 
the LPR was kept at the high value of 3200:1 as increasing the lipid:OMP ratio 
correlates with increased folding efficiency53, presumably by increasing the 
likelihood of interaction between OMPs and a membrane surface, compared with 
self-association and potentially aggregation.  
Overnight PagP folding experiments were performed in the presence of differing 
concentrations of urea (0.24-8 M) with liposomes composed of DDPC (diC10:0PC), 
DUPC (diC11:0PC) or DLPC (diC12:0PC) (Figure 3.3). The results showed that in high 
urea concentrations (7-8 M) PagP folding efficiency is high (>90%) regardless of 
lipid type (Figure 3.4). However, at low urea (0.24-1 M) the majority of PagP is 
unfolded (>60%) when folded into DLPC liposomes (Figure 3.4c). By contrast, when 
liposomes are composed of lipids with a reduced acyl chain length (DDPC or DUPC, 
Figure 3.4a,b) at low urea concentrations (1 M) the majority of PagP remaining in 
solution is folded (>80%). PC lipids with a chain length of lower than C9 form 
micellular structures396, and as the folding efficiency for DDPC liposomes was close 
to 100%, PC lipids with an acyl chain length of C9 were not investigated. 
 
Figure 3.3: Phosphatidylcholine lipids used in folding assay 
optimisation. Chemical structures of (a) 1,2-di-decanoyl-sn-glycero-3-
phosphocholine, diC10:0PC (DDPC), (b) 1,2-di-undecanoyl-sn-glycero-3-
phosphocholine, diC11:0PC (DUPC), and (c) 1,2-di-lauroyl-sn-glycero-3-
phosphocholine, diC12:0PC (DLPC). 
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Figure 3.4: PagP folding yields in PC liposomes of different acyl chain 
lengths as a function of urea concentration. SDS-PAGE band shift assay 
in concentrations of urea between 0.24 M and 8 M urea in liposomes 
composed of (a) DDPC, (b) DUPC, and (c) DLPC. Samples containing 4 M 
PagP, 50 mM glycine-NaOH, pH 9.5 were folded overnight at 37 ºC. 
3.1.3 Effects of lipid chain length on PagP folding kinetics in PC 
liposomes 
Next, fluorescent spectroscopy was used to examine the effects of acyl chain length 
on PagP folding kinetics in the presence of a low urea concentration (0.24 M) 
(Figure 3.5). Folding into DLPC liposomes was incomplete over a 2 h time-course 
(Figure 3.5c), consistent with previous observations152. An exponential fit of this data 
could not be made over this time period. By contrast, PagP folding into DDPC was 
rapid with the reaction mostly complete within a few minutes, and the data well 
described by a double exponential function (Figure 3.5a). However, a previous 
comparative study of the folding kinetics of nine different OMPs indicated that PagP 
is a relatively slow folding OMP313. The aim of the present study was to compare the 
folding behaviour of PagP with that of much faster folding OMPs such as OmpA and 
OmpF313 in the presence of folding factors which may increase their folding rate. 
Therefore, it was likely that the folding of some OMPs under these conditions using 
DDPC liposomes would be too fast to be measurable by manual mixing. However, 
PagP folding into DUPC liposomes was also well described by a double exponential 
function and occurred on a substantially slower timescale (Figure 3.5b). 
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Therefore, the results show that very small changes in lipid composition (the 
additional of a single carbon atom to the acyl chain of phosphatidylcholine lipids) 
dramatically alters the in vitro efficiency and kinetics of PagP folding, consistent with 
previous results313,323. Further, for measuring the folding kinetics of multiple OMPs it 
appears that the bilayer thickness of LUVs made from PC lipids with a chain length 
of C11 are ideal under the conditions employed, in that PagP folding was not ‘too 
fast’ or ‘too slow’ to measure the rates reliably. Therefore, this lipid was selected for 
further studies to compare the folding rate constants of a variety of OMPs under the 
same conditions. 
 
Figure 3.5: PagP folding kinetics in PC liposomes of different acyl chain 
lengths in 0.24 M urea. (a) DDPC, (b) DUPC, and (c) DLPC. Samples 
contained 0.4 M PagP, 1.28 mM lipids, 0.24 M urea, 50 mM glycine-NaOH, 
pH 9.5, at 37 ºC. Fits to a double exponential equation are shown as black 
dotted lines in (a) and (b). 
3.2 Extension of the OMP folding kinetics assay to additional OMPs 
3.2.1 OMP selection 
Having optimised the assay conditions for measuring the folding kinetics of PagP, 
additional OMPs were selected to compare their folding behaviour under identical 
conditions. OMPs were selected according to the following criteria: (1) a crystal 
structure is available, (2) each OMP had been previously folded in vitro, (3) all are 
found in the OM of E. coli, (4) they are structurally and functionally distinct, and (5) 
they cover a range of barrel sizes (from 8 to 16 -strands). Details of the OMPs 
chosen are given in Table 3.1 and their three-dimensional structures are shown in 
Figure 3.6.  
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OMP  
No. of 
-
strands 
Molecular 
weight* 
(kDa) 
Function Reference 
tOmpA 8 18.875 Adhesin/invasin/evasin Pautsch et al. (1998)397 
PagP 8 19.110 Acyl transferase Hwang et al. (2002)343 
OmpT 10   35.284ǂ Protease 
Vandeputte-rutten et al. 
(2001)398 
FadL 14 46.038 Fatty acid transporter 
Van den Berg et al. 
(2004)399 
OmpF 16 37.216 Porin Cowan et al. (1992)400 
tBamA 16 43.240 Insertase/secretase Noinaj et al. (2013)11 
 
Table 3.1: Model OMPs investigated have a range of functions, sizes and 
number of -strands. *Molecular weight of the mature OMP sequences, 
lacking their cleavable N-terminal signal sequences. ǂMolecular weight for the 
OmpT construct used here including an N-terminal hexahistidine tag and a 
TEV protease cleavage site. 
The OMPs tOmpA (Figure 3.6a) and PagP (Figure 3.6b) and tBamA (the 
transmembrane domain of BamA, Figure 3.6f) have already been described in 
Sections 1.5, 1.5.1, and 1.4.1, respectively. 
OmpT is a 10-stranded endoprotease with specificity for paired basic residues401. It 
is used as a defence against colicin-mediated attack402 and is also implicated in 
bacterial pathogenicity403. OmpT is involved in processing proteins of the 
autotransporter family, and cleaves the antimicrobial peptide proteamine, which is 
secreted by urinary tract epithelial cells403. The crystal structure of OmpT398 (Figure 
3.6c) revealed a 10-stranded -barrel with a large extracellular region including long 
loops which contain the active site residues404. 
FadL is a 14-stranded OMP involved in the transport of fatty acids405,406. FadL shows 
selectivity for long chain fatty acids (LCFAs); it was found to bind myristic acid 
(C14:0) with an order of magnitude lower Kd than the low M affinity observed for 
oleic acid (C18:1) and palmitic acid (C16:0)407. LCFAs acquired from the 
environment via FadL serve as sources of carbon and energy408. Additionally, 
removal of proinflammatory host LCFAs implicates FadL in immune evasion409. 
FadL was selected for study on the basis that, in the absence of additional factors, it 
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folds with a particularly poor folding yield in vitro (~25% in DDPC LUVs) compared 
to eight other OMPs folded under the same conditions (all >60% in DDPC LUVs)313. 
It was reasoned that FadL may be a useful model for studying the improvement in 
folding mediated by, for example, periplasmic chaperones. Similar to OmpT, a 
substantial percentage of the FadL barrel is not membrane-embedded and extends 
into the extracellular space (Figure 3.6d). 
 
Figure 3.6: Three-dimensional structures of OMPs used in this study. (a) 
tOmpA (PDB:1G90410), (b) PagP (PDB:1THQ344), (c) OmpT (PDB:1I78398), (d) 
FadL (PDB:1T16399) (e) OmpF (PDB:2ZFG411), and (f) tBamA (PDB:4N75287).  
All structures are to scale. OmpF is a functional trimer; for clarity only one 
subunit is coloured and the other two are shown in grey. The OM is 
represented in pale green, and approximate positions of OMPs within the 
membrane are judged by the position of residues in the ‘aromatic girdles’ at 
either side of the membrane412. 
OmpF is a trimeric porin and is one of the most abundant E. coli OMPs with an 
estimated ~100,000 copies per cell49,83. Each OmpF monomer forms a narrow, 
slightly cation selective pore85, that allows the passage of hydrophilic molecules of 
<600 Da across the OM. It is important in multidrug resistance (MDR) as antibiotics, 
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such as the -lactams and fluoroquinines, enter cells via the OmpF pore413. OmpF is 
also used as the entry point for toxins produced by other bacteria; following initial 
binding of colicin E9 to BtuB, intrinsically disordered colicin regions are threaded 
through two pores of an OmpF trimer in opposite direction to aid translocation of the 
cytotoxic colicin domain414.   
Expression plasmids for tOmpA, PagP, OmpT and OmpF were obtained from 
previous work. However, the project required the cloning of plasmids for the 
expression of FadL and tBamA, details of which are given below. 
3.2.2 Subcloning of FadL 
A codon-optimised gene encoding the mature sequence of E. coli FadL was 
synthesised by Eurofins Genomics, Germany. The synthetic gene was delivered in 
Eurofins Genomics’ standard high-copy number PEX-K4 plasmid360, and therefore 
required subcloning into a suitable expression vector. To obtain the expression 
vector backbone, a midiprep of PagP-pET11a was performed and ~5 μg of the 
resulting DNA was double digested with NdeI and BamHI restriction enzymes. Next, 
the vector was dephosphorylated and the reaction was run on an agarose gel, 
together with non-digested and singly digested controls, and the double digested 
bands gel extracted (Figure 3.7a). The FadL-PEX-K4 plasmid was also midiprepped 
and ~20 μg of the DNA produced was double digested and run on an agarose gel. 
The band corresponding to the FadL gene was gel extracted (Figure 3.7b). An 
overnight ligation reaction was performed between extracted, double digested 
pET11a backbone and the extracted FadL gene. This was then transformed into 
competent DH5 cells and the resulting colonies midiprepped and sent for 
sequencing to confirm the presence of the FadL gene. 
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Figure 3.7: Subcloning of FadL. (a) Restriction digests of pET11a-PagP. 
Lane L: 100 bp ladder. Lane 1: Undigested PagP-pET11a. Lane 2: BamHI 
digest of pET11a. Lane 3: NdeI digest of pET11a. Lane 4,5: NdeI/BamHI 
double digest of pET11a. The success of the double digestion reaction is 
indicated by the different gel mobility of the double digest reaction (lanes 4,5) 
compared to that of the digests with a single restriction enzyme (lanes 2,3). 
Additionally, bands corresponding to the PagP insert size (~500 bp) are 
present in the double digest reaction lanes (indicated by green arrows), which 
are not present in the lanes containing the vector digested with a single 
restriction enzyme (lanes 2,3). The bands corresponding to the double 
digested pET11a vector backbone (indicated by red arrows) were gel 
extracted for subsequent ligations. (b) NdeI/BamHI double digest of the FadL-
PEX-K4 vector. The band corresponding to the FadL gene (~1300 bp, 
indicated by a yellow arrow) was gel extracted for subsequent ligation. The 
two bands above this at ~3500 bp and ~2500 bp correspond to undigested 
vector and digested vector backbone, respectively. 
3.2.3 Cloning of tBamA 
To clone the gene for tBamA PCR primers were designed for the region 
encompassing residues 425-810 of BamA, and a PCR reaction performed (Section 
2.2.6), using the BamAB-pETDUET-1 vector as a template (Table 2.4). The PCR 
reaction was run on an agarose gel and the product gel extracted and digested with 
NdeI and BamHI restriction enzymes (Section 2.2.9). The digested tBamA product 
was run on an agarose gel, gel extracted, and subsequently ligated into the pET11a 
vector backbone, digested with NdeI and BamHI, obtained above (Section 2.2.12). 
Following transformation of the ligation reaction into supercompetent XL1-Blue cells, 
DNA minipreps were obtained from eight colonies. These eight minipreps were 
analysed by restriction digestion (Figure 3.8) and those containing an insert of the 
correct size (1169 bp) were sent for sequencing. 
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Figure 3.8: Cloning of tBamA into pET11a. Agarose gel analysis of double 
digests (NdeI/BamHI) of plasmid DNA obtained from colonies transformed 
with a ligation reaction between a PCR product of the mature tBamA gene 
sequence and pET11a.  Clones in lanes 1-5 and 7 contained an insert of the 
approximately correct size (1169 bp). Sequencing confirmed the correct 
tBamA sequence was present in the clone in lane 1. 
3.3 Expression and purification of additional OMPs 
The pET11a expression vectors containing the sequences for tOmpA, PagP, OmpT, 
FadL and tBamA were transformed into competent BL21(DE3) cells (Section 2.2.4) 
and expressed as detailed in Section 2.3. All OMPs were subsequently successfully 
purified from inclusion bodies to a purity of >95% (Figure 3.9) as outlined in Section 
2.3. 
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Figure 3.9: Purification of tOmpA, OmpT, OmpF, tBamA and FadL. SDS-
PAGE analysis of additional OMPs studied following purification by inclusion 
body isolation and gel filtration. 
3.4 Kinetic assays in the absence of lipids 
To verify that the fluorescence transients obtained for the six OMPs studied 
represent insertion and folding into a membrane environment, and not some other 
process that may give rise to a fluorescence change, control assays were performed 
in the absence of liposomes. For the 8-stranded OMPs tOmpA and PagP, and the 
16-stranded OMPs OmpF and tBamA no change in Trp fluorescence was observed 
on dilution from 8 M to 0.24 M urea (Figure 3.10). Further, there are no increases in 
noise and/or decreases in signal over time, which would provide evidence of 
aggregation, indicating the formation of a stable soluble form, as previously 
reported152,160. 
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Figure 3.10: OMP folding transients in the absence of lipids.  Example 
kinetic traces for (a) tOmpA, (b) PagP, (c) OmpF, and (d) tBamA, in the 
absence of lipids, monitored by fluorescence emission spectroscopy. Assays 
were performed with OMP concentrations of 0.4 µM, in 0.24 M urea, 50 mM 
glycine-NaOH, pH 9.5, at 25 ºC. At least three replicates are shown for each 
protein. 
However, in the cases of OmpT and FadL folding transients were observed in the 
absence of lipids (Figure 3.11a,b), with good fits to the data obtained with single or 
double exponential functions, respectively. In the case of OmpT this presumably 
reflects folding of the large extracellular domain which contains three tryptophan 
residues (Figure 3.11c). Similarly, FadL contains two tryptophan residues which are 
located beyond the membrane on the extracellular side (Figure 3.11d) that may 
contribute to the observed fluorescence change. Additionally, FadL has three short 
N-terminal helices which plug the barrel in the native state398 (Figure 3.6d) which 
possibly aid the formation of partially folded soluble conformations. Therefore, 
kinetic studies of OmpT and FadL folding into liposomes were not pursued due to 
the difficulty of separating and interpreting changes in fluorescence caused by 
membrane insertion and folding, and those observed in the absence of lipids.  
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Figure 3.11: Folding transients for OmpT and FadL in the absence of 
lipids. Kinetic folding traces for (a) OmpT, and (b) FadL, in the absence of 
lipids, monitored by fluorescence emission spectroscopy. The data for OmpT 
and FadL are well described by a single and double exponential, respectively, 
indicated by black dashed lines. Assays were performed with OMP 
concentrations of 0.4 µM, 50 mM glycine-NaOH, pH 9.5, at 25 ºC, in either in 
0.24 M or 2 M urea (in (a) and (b), respectively). At least three replicates are 
shown for each protein. (c) Crystal structure of OmpT (PDB:1I78398). (d) 
Crystal structure of FadL (PDB:1T16399). Tryptophan residues are shown in 
stick representation and highlighted in red.  
3.5 Highly reproducible exponential kinetics for tOmpA, PagP, 
OmpF and tBamA under identical conditions 
Finally, folding experiments into liposomes were performed for the substrates 
tOmpA, OmpF and tBamA using conditions identified for PagP (Section 3.1.3) 
(0.4 µM OMP, 50 mM glycine-NaOH, 0.24 M urea, LPR 3200:1, pH 9.5, 25 ºC). 
Exponential folding transients could be measured for these three OMPs under these 
conditions (Figure 3.12). The data for tOmpA could be fitted to a single exponential, 
while the data for PagP, OmpF and tBamA required an additional exponential term. 
In each experiment, four samples were run concurrently. A minimum of three of 
these transients were globally fitted, forcing them to share the same rate constant, 
 
 
112 
but allowing their amplitudes to vary. The amplitude data was not considered further 
due to the variability introduced by stochastic variation in the amount of aggregation 
in folding experiments, and between the results acquired on different days. The 
extracted folding rate constants show very minor variation between liposome 
batches (Table 3.2). 
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Figure 3.12: The OMPs tOmpA, PagP, OmpF and tBamA fold with highly 
reproducible exponential kinetics. Folding transients for (a) tOmpA, (b) 
PagP, (c) OmpF, and (d) tBamA, folding into DUPC liposomes monitored by 
fluorescence emission spectroscopy (left). Residuals for fits to a single 
(middle) or double (right) exponential function are shown. Assays were 
performed with OMP concentrations of 0.4 µM, in 0.24 M urea, 50 mM glycine-
NaOH, LPR 3200:1, pH 9.5, at 25 ºC. At least three replicates are shown for 
each protein. Exponential fits to the data (a single exponential for tOmpA (a) 
and double exponentials for PagP, OmpF and tBamA (b)-(d)) are indicated by 
black dashed lines. 
 
 
114 
OMP  k1 (x10
-3 s-1)  k2 (x10
-3 s-1)  A1 (range) A2 (range) 
tOmpA 15.7 ± 0.6 N/A -27300, -51081 N/A 
PagP 3.8 ± 0.8 0.8 ± 0.1 -13587, -30984 -28220, -46976 
OmpF 10.5 ± 0.6  0.5 ± 0.2 -5728, -43673 -4448, -61239 
tBamA 12.8 ± 2.4 1.6 ± 0.3 -11272, -35841  -11307, -37961 
 
Table 3.2: Measured rate constants for OMP folding into DUPC 
liposomes. Data are shown as the mean ± the standard deviation of the rate 
constants obtained from three separate folding experiments, each using 
independently prepared batches of liposomes. For each batch of liposomes at 
least three folding transients were fitted globally to obtain the rate constants 
shown. Amplitude data was variable and shown as a range between minimum 
and maximum values. N/A: The kinetic traces for tOmpA were adequately 
described by a single exponential. 
Several alterations to the method previously used in our laboratory for the storage 
and preparation of DLPC liposomes152 were made, which aided the reproducibility of 
experiments with DUPC liposomes: (1) purchased solid lipids were dissolved in 
80:20 ethanol:methanol, aliquoted, and stored in solution, instead of being stored in 
solid form and weighed out for each liposome batch; (2) an additional step was 
added to the protocol for making liposomes. Following resuspension of lipid films an 
additional step of 5x freeze/thaw cycles was performed to aid resuspension prior to 
extrusion (Section 2.11); and (3) DUPC liposomes were used within 48 h of 
preparation. 
3.6 Discussion 
This chapter presents the first examination of the in vitro folding kinetics of multiple 
OMPs using fluorescence spectroscopy. OMP folding behaviour is highly dependent 
on the properties of the lipid bilayer53, and here LUVs made from saturated PC lipids 
were used as the folding environment. Studies examining the principles of OMP 
folding often employ PC lipids53,298,313,320, despite the fact that Gram-negative 
bacteria contain no PC34. The positive spontaneous curvature of bilayers formed 
from PC lipids may be the physical reason for the high OMP folding efficiencies 
achieved in these lipids32,415. Liposome size, as well as composition, influences in 
vitro OMP folding efficiency and kinetics53,297,313. LUVs are made by extrusion 
through filters 100-400 nm in size, while SUVs (~40-50 nm) are generally made by 
sonification of LUVs322. OMP folding efficiency is generally higher in SUVs which 
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have a greater elastic curvature than LUVs313,416. This may be due the increased 
stress within SUVs leading to bilayer defects, which exposes hydrophobic surfaces 
thereby aiding OMP folding320. Early work found that OmpA could not fold in LUVs 
composed of DMPC (diC14:0PC) under the conditions used, but would readily fold into 
SUVs of PC lipids with chain lengths of up to C18297,391. However, this effect is OMP 
dependent as liposome size had no influence on the yield of folded OmpF trimers311. 
The liposomes employed here were 100 nm LUVs. LUVs were selected as opposed 
to SUVs, due to their lower curvature strain. However, given the typical dimensions 
of an E. coli cell (~2-4 m x ~1 m417) the average curvature of the OM in vivo is 
likely much lower. Indeed, recently it was found that nascent OMPs are inserted into 
the central region of the OM in E. coli, the spatial location of the OM which exhibits 
the lowest curvature37,290. 
Examination of the effects of lipid chain length on PagP folding demonstrated that 
thinner bilayers promote greater folding yields and faster kinetics (Figure 3.4 and 
Figure 3.5), likely due to increased fluidity in the membrane322. This is consistent 
with previous folding experiments in which OMPs are diluted from denaturant313, and 
with experiments which used a cell-free transcription-translation system392. 
A low protein concentration (0.4 M) and a high LPR (3200:1) was used throughout 
this chapter to decrease the probability of aberrant protein-protein interactions, 
which may decrease yields. The kinetics of OMP folding are strongly dependent on 
the concentration of liposomes, following a second order rate law, with increased 
LPR resulting in faster folding (as demonstrated for OmpA folding into DLPC 
liposomes)53. 
There are clear differences in the kinetic behaviour of the four OMPs compared here 
(Figure 3.12). This variation does not correlate with protein size, consistent with 
previous results313; while the 8-stranded tOmpA folds faster (~2-times) than the 16-
stranded OMPs, tBamA and OmpF in DUPC LUVs, the 8-stranded PagP folds ~2-
times more slowly than the 16-stranded OMPs. Differences in folding behaviour 
likely results from variations in states along the pathway(s) to the native state. The 
structural diversity of the four OMPs in the native state may be reflected in their 
ensemble of denatured states. For the 8-stranded OmpX NMR studies found that 
the urea unfolded state (in 6.5 M urea) contains regions of structure, including a 
helical segment (residues 73-82) and a hydrophobic cluster (residues 137-145) both 
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of which were present in ~25 % of molecules418, with these results supported by MD 
simulations419. Different levels and types of structure in the denatured states may 
result in variation between OMPs in collapsed misfolded (UAQ) states on dilution 
from denaturant. In turn, differences in UAQ states may affect interaction with lipid 
bilayers, all of which may affect folding rates. 
Additionally, it is not obvious why the kinetics of tOmpA folding under the conditions 
employed here can be adequately fitted to a single exponential model, while the 
kinetics of PagP, OmpF and tBamA folding require a second exponential term 
(Figure 3.12 and Table 3.2). Where multiple exponential kinetics are seen in folding 
transients, this may reflect the formation of on- or off-pathway folding 
intermediates314,383, or be due to parallel folding pathways319-321,323. It is also possible 
that the slow folding phase observed for OmpF (Figure 3.12c) is the result of 
trimerisation311. In vivo experiments determined that monomers of the trimeric 
transporter LamB stably fold into the OM prior to trimerisation123, and folded dimers 
as well as trimers have been identified in OmpF folding experiments in vitro311,313. 
However, a further complication in interpreting fluorescence data for OmpF is that it 
contains only two tryptophans which exhibit different fluorescence properties in the 
native state420. One of these tryptophans (W61) is located at the trimer interface421, 
consistent with the notion that the slow folding phase observed is the result of 
trimerisation. Future work could investigate the origins of this multiphase kinetic 
behaviour, and the reasons for differences between OMPs.  
A key finding in this chapter is that the use of tryptophan fluorescence is not 
appropriate for monitoring the folding status of all OMPs. Importantly, the assay 
developed here does not report directly on the formation of secondary or tertiary 
structure, but on the change in polarity of OMP Trp residues. The underlying 
assumption is that changes in observed fluorescence are due to interactions with 
and/or burial within the bilayer. Accordingly, it was found for OmpA folding into 
DLPC liposomes that the kinetics of Trp burial were faster than those of secondary 
and tertiary structure measured by CD and cold SDS-PAGE53. Available evidence 
suggests that on dilution from denaturant OMPs undergo a rapid collapse to a 
misfolded or partially folded state160,173,391 occurring in the dead time of the manual 
mixing experiments performed here. The presence of a folding transient when 
monitoring the OmpT and FadL in the absence of lipids (Figure 3.11b) suggests a 
structural rearrangement from the collapsed state which gives rise to signal changes 
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independent of lipid interaction, thereby limiting the usefulness of intrinsic 
fluorescence as a probe for bilayer folding and insertion for these OMPs. 
In summary, here it is demonstrated that folding kinetics could be reliably measured 
for set of OMPs with different molecular weights, functions and number of -strands 
(Table 3.1) under identical conditions into DUPC liposomes using fluorescence 
spectroscopy. This allows the influence of folding factors on folding to be directly 
compared and contrasted for different OMPs, which is the focus of the following 
chapter. 
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4 Skp is a multivalent chaperone of outer membrane proteins 
4.1 Introduction 
The final folded location of -barrrel OMPs in the OM is distal to their site of 
synthesis in the cytosol422, and OMPs are inherently aggregation prone due the 
patterns of alternating hydrophobic and hydrophilic residues in their sequences81. 
Therefore, chaperones are required at all stages of OMP assembly to prevent OMP 
self-association164, and to maintain unfolded OMPs in a soluble, folding-competent 
state359. It has been reported that poly(Val-Lys) peptides form stable -sheet 
containing structures423, and that de novo designed peptides with alternating polar 
and non-polar residues have a high propensity to form amyloid-like fibres114. 
Accordingly, it was recently found that OMPs, which contain similar alternating polar 
and non-polar residues, can also form amyloid-like fibres, as judged by EM, and 
binding of the amyloid-specific dye Thioflavin T (ThT) to OmpA aggregates in the 
absence of chaperones424. As fibrillar protein species are strongly associated with 
cellular toxicity425, this further highlights the importance of chaperones in controlling 
OMP assembly pathways. 
Following synthesis and translocation across the inner membrane, OMPs must 
traverse the periplasm (~165-210 Å17,22,426) before reaching the OM, where they are 
folded and inserted by the -barrel Assembly Machinery (BAM) complex9,13,68,152 
(Section 1.4). In assisting OMPs across the periplasm chaperones prevent aberrant 
interactions, which could lead to aggregation, and maintain OMPs in a folding-
competent state. Additionally, in the case of some OMPs, such as OmpA, attached 
soluble domains within the same polypeptide chain can fold independently and act 
to chaperone the -barrel domain427. Recent kinetic modelling studies suggest that 
OMPs may make many hundreds of interactions with chaperones as they traverse 
the periplasmic space124. The thermodynamics and kinetics of chaperone-OMP 
complexes, as well as the synthesis and degradation rates of all components, must 
be finely balanced to ensure the correct flux in the system and the maintainance of 
OM homeostasis17,124,336. Despite the availability of crystal structures for the 
chaperones implicated in OMP assembly (Skp, SurA, FkpA, and DegP10) the 
mechanism(s) by which they bind and release substrates, in the absence of 
ATP21,428, is poorly understood10. 
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In the case of the trimeric ‘holdase’152 chaperone Skp, OMPs are sequestered within 
a hydrophobic cage to prevent their misfolding and aggregation during transport 
across the periplasm (Section 1.3.1). Skp has broad substrate specificity
155, with 
reported affinities for its substrates in the low nanomolar range160,336. Skp is a 
functional homotrimer (referred to herein as Skp) with a ‘jellyfish’-like 
architecture149,150 (Figure 4.1), consisting of three α-helical ‘legs’ that extend 60 Å 
away from the ‘body’ domain; a 9-stranded β-barrel which mediates 
trimerisation149,150.  
 
Figure 4.1: Dimensions of the Skp chaperone. Crystal structure of Skp 
(PDB: 1U2M150) from (a) the side, (b) the bottom. Missing residues in chains B 
and C were modelled from chain A using PyMOL. Residues in chains A, B, 
and C are shown in green, blue and yellow, respectively. 
The three subunits of Skp form a hydrophobic cavity inside which OMP clients are 
bound150,155,161,171, with previous studies suggesting a 1:1 stoichiometry for all 
Skp:OMP complexes156,160,166. These 1:1 stoichiometries have been proposed in 
studies using tryptophan fluorescence (Skp complexes formed with tOmpA (19 
kDa)160, NalP (32 kDa)160, OmpG (33 kDa)160, OmpA (35 kDa)160 and BamA (89 
kDa)160), SEC-MALS (OmpA (35 kDa)170), NMR (OmpX (16 kDa) and tOmpA (19 
kDa)171) and fluorescence correlation spectroscopy (OmpC (38 kDa)156). The Skp 
hydrophobic cavity has been estimated to be able to accommodate folded proteins 
of ~25 kDa150, but many OMPs known to interact with Skp are considerably larger 
(e.g. the 22-stranded BtuB and the 26-stranded LptD are 66 kDa and 87 kDa, 
respectively)12. Therefore, this raises the question of what are the structural 
alterations that must occur for Skp to accommodate its larger substrates? 
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To investigate the mechanism by which Skp sequesters OMPs of different sizes, this 
chapter presents kinetic studies of OMP folding, complemented with electrospray 
ionisation-ion mobility spectrometry-mass spectrometry (ESI-IMS-MS) analyses, 
computer modelling and molecular dynamics simulations. The interactions are 
examined between Skp and five diverse OMPs introduced in the previous chapter: 
(1) tOmpA, the 8-stranded transmembrane domain of OmpA387; (2) PagP, an 8-
stranded acyl transferase enzyme342; (3) OmpT, a 10-stranded protease398; (4) 
OmpF, a 16-stranded trimeric porin411; and (5) tBamA, the 16-stranded 
transmembrane domain of the BamA OMP insertase16 (Figure 3.6, Table 3.1).  
The mass spectrometry experiments described were performed and analysed by Dr 
A. N. Calabrese (University of Leeds). The in vacuo molecular dynamics simulations 
of Skp were initiated by P. W. A. Devine (University of Leeds). All simulations were 
performed and analysed by B. Schiffrin, with the exception of one replicate of the 
Skp-tOmpA simulations in explicit solvent (Section 4.6) which was carried out by Dr 
S. A. Harris (University of Leeds). The work presented in this chapter has been 
published in: Schiffrin, B., Calabrese, A. N. et al., Skp is a multivalent chaperone of 
outer membrane proteins, Nature Structural & Molecular Biology, 23, 786-793, 
2016173. 
4.2 Higher Skp:OMP ratios are required to prevent folding of larger 
OMPs 
The work presented in Chapter 3 determined optimised conditions for measuring 
exponential folding kinetics for PagP and successfully extended the assay to the 
OMPs tOmpA, OmpF and tBamA (Section 3.5). Here, this approach was exploited 
to compare the kinetic behaviour of these OMPs in the presence of Skp. 
To verify that the OMPs selected for study are indeed folded at the end of the 
observed transients (Figure 3.12), fluorescence emission spectra of each OMP were 
measured in 8 M urea and compared with spectra of membrane inserted (folded) 
OMP obtained at the end point of the folding reaction (Figure 4.2, red and grey 
spectra). Spectra of tOmpA, PagP, OmpF and tBamA folded into liposomes show a 
characteristic blue-shift in λmax and increase in fluorescence intensity compared with 
spectra of the unfolded proteins in 8 M urea, indicating that a substantial fraction of 
all four OMPs fold successfully into the 100 nm DUPC liposomes. Next, to 
determine whether the OMPs are able to interact with Skp under the experimental 
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conditions selected, fluorescence emission spectra of each OMP were measured in 
0.24 M urea in the absence of liposomes with or without a two-fold molar excess of 
Skp (Figure 4.2, cyan and purple spectra). In the presence of Skp, the spectra of 
tOmpA, OmpF and tBamA show decreases in λmax and/or increases in fluorescence 
intensity compared with spectra of these OMPs in buffer alone, demonstrating that 
these unfolded OMPs interact with Skp. For PagP, no change in fluorescence is 
observed in the presence of Skp compared with buffer alone, however previous 
work, using pull-down experiments, has shown that these proteins do interact under 
these conditions152. The unusual fluorescence emission spectrum for PagP in buffer 
alone may be due to the presence of the 19-residue N-terminal helix which contains 
two Trp residues348. 
 
Figure 4.2: tOmpA, PagP, OmpF and tBamA interact with Skp and fold 
into DUPC liposomes under selected conditions. Fluorescence emission 
spectra of OMPs folded in DUPC liposomes (red lines), unfolded in 8 M urea 
(grey lines), in buffer alone in the absence of lipids (purple lines), and in the 
presence of a 2-fold molar excess of Skp (cyan lines) for (a) tOmpA, (b) PagP, 
(c) OmpF, and (d) tBamA. Final OMP concentrations were 0.4 µM, with a 
molar lipid:protein ratio of 3200ː1 (in folded samples), in 0.24 M urea, 50 mM 
glycine-NaOH, pH 9.5, at 25 ºC. 
The effect of Skp on OMP folding kinetics was next investigated. In the absence of 
Skp, all four OMPs fold with single or double exponential kinetics (Figure 4.3, left), 
allowing extraction of the folding rate constants (k1 and k2) (Figure 4.3, right, Table 
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4.1). The folding kinetics of OMPs that had been pre-incubated with Skp at molar 
ratios ranging from 1:1 to 4:1 (chaperone:client) (where Skp concentrations are in 
trimer equivalents) were then measured by adding the pre-formed complexes to 
DUPC liposomes and monitoring OMP folding by fluorescence spectroscopy (Figure 
4.3, left, Figure 4.4). Concentrations of Skp are given as trimer equivalents as AUC 
experiments have shown that at the concentrations utilised here, Skp is in a 
dynamic equilibrium between folded monomer subunits and trimers163.  The results 
show that at a substrate concentration of 0.4 µM, a 2-fold molar excess of Skp is 
sufficient to prevent tOmpA and PagP folding into DUPC liposomes (Figure 4.3a,b, 
Figure 4.4a,b). It has been shown previously that while incubation of Skp with PagP 
at a 2:1 molar ratio prevents OMP folding over a 2 h timescale, overnight incubation 
with liposomes allows OMP release and folding to the equivalent yields as in the 
absence of Skp152. For both of the 8-stranded OMPs tOmpA and PagP, a 1:1 
Skp:OMP ratio retards folding, while a 2:1 ratio prevents folding over the timescale 
of the experiment. By contrast, pre-incubation of OmpF and tBamA with a 2-fold 
excess of Skp decreases the folding rate, but does not prevent folding (Figure 
4.3c,d, Figure 4.4c,d). However, pre-incubation with a 4-fold excess of Skp inhibits 
folding of these larger proteins over the timescale of the experiment (Figure 4.3c,d, 
Figure 4.4c,d. right). As the Kd for Skp binding is similar for all OMPs measured (0.3 
- 83 nM)160, the results suggest, therefore, that complete sequestration of larger 
OMP barrels requires the binding of more than one copy of Skp.  
 
 
123 
 
Figure 4.3: Different Skp:OMP ratios are required to sequester OMPs and 
inhibit folding. Folding data for (a) tOmpA, (b) PagP, (c) OmpF, and (d) 
tBamA. (left) Kinetic traces for the folding of OMP alone into DUPC liposomes 
(red lines), and in the presence of Skp at a 1:1 molar ratio (tOmpA and PagP, 
green lines, parts a and b), a 2:1 molar ratio (cyan lines, parts a–d), a 4:1 
molar ratio (OmpF and tBamA, orange lines, parts c and d), or in the absence 
of lipids (purple lines).  Single or double exponential fits to the data are shown 
as dotted lines. (right) Rate constants for OMP folding in the absence or 
presence of Skp at the OMP:Skp ratio indicated. Where the data were best 
described by a double exponential fit, the rate constants for the second, 
slower, phase are not shown, but are given in Table 4.1. A star indicates a 
Skp:OMP ratio where folding did not occur on the timescale of these 
experiments. Data are shown as mean ± s.d. of three independent 
experiments using three separate liposome batches. 
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Figure 4.4: 16-stranded OMPs require pre-incubation with a greater 
molar excess of Skp than 8-stranded OMPs to inhibit folding into 
synthetic liposomes. Example kinetic folding data for (a) tOmpA, left panel 
and tOmpA in the presence of a 1:1, centre panel, or 2:1, right panel, molar 
ratio of Skp:tOmpA; (b) PagP, left panel and PagP in the presence of a 1:1, 
centre panel, or 2:1, right panel, molar ratio of Skp:tOmpA; (c) OmpF, left 
panel and OmpF in the presence of a 2:1, centre panel, or 4:1, right panel, 
molar excess of Skp; (d) tBamA, left panel and tBamA in the presence of a 
2:1, centre panel, or 4:1, right panel, molar excess of Skp. Pre-incubated Skp-
OMP complexes were added to DUPC liposomes and OMP folding was 
monitored by fluorescence spectroscopy.  Final OMP concentrations were 0.4 
µM, with a molar lipid:protein ratio of 3200ː1, in 0.24 M urea, 50 mM glycine-
NaOH, pH 9.5. A minimum of three transients are shown in each panel. 
Exponential fits to the data are indicated by black dashed lines. 
 
 
125 
Table 4.1: Measured rate constants for OMP folding into liposomes after 
pre-incubation with varying molar ratios of Skp.  Data are shown as the 
mean ± the standard deviation of the rate constants obtained from three 
separate folding experiments, each using independently prepared batches of 
liposomes. For each batch of liposomes at least three folding transients were 
fitted globally to obtain the rate constants shown. N/A: The kinetic traces for 
the condition were adequately described by a single exponential. 
4.3 ESI-MS reveals differing Skp:OMP stoichiometries according to 
OMP size 
The experiments described above suggest that the binding of more than one Skp is 
necessary to prevent the folding of larger OMPs. To gain insights into the 
architectures of these complexes, ESI-MS coupled with IMS was used to analyse 
different Skp:OMP assemblies within multicomponent mixtures. Skp complexes with 
tOmpA, PagP, OmpT, OmpF and tBamA were prepared in the absence of detergent 
or lipid (Section 2.17) and, following buffer exchange into a MS-compatible buffer, 
ESI-MS spectra were acquired using carefully tuned instrumental conditions 
(Section 2.17), allowing non-covalent interactions to be retained in vacuo (non-
covalent or “native” MS)370,429,430 (Figure 4.5, Table 4.2). The results show that the 
complexes of all five OMPs with Skp are sufficiently stable to survive the ESI 
process and be transferred into the gas phase for analysis. Binding to Skp maintains 
the solubility of these OMPs prior to mass spectral analysis, which is typically 
OMP OMP:Skp ratio k1  (x10
-3
 s
-1) k2 (x10
-3
 s
-1) 
tOmpA OMP alone 15.7 ± 0.6 N/A 
  1:1 11.1 ± 1.4 1.3 ± 0.1 
  1:2 No folding No folding 
PagP OMP alone 3.8 ± 0.8 0.8 ± 0.1 
  1:1 1.2 ± 0.3 0.1 ± 0.02 
  1:2 No folding No folding 
OmpF OMP alone 10.5 ± 0.6  0.5 ± 0.2 
  1:2 1.8 ± 0.2 N/A 
  1:4 No folding No folding 
tBamA OMP alone 12.8 ± 2.4 1.6 ± 0.3 
  1:2 7.6 ± 0.6 1.4 ± 0.4 
  1:4 No folding No folding 
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achieved by solubilising with detergents or other media431,432, or by using harsh 
denaturing conditions433,434. 
Several reports have suggested that Skp binds unfolded OMPs ranging from 16-89 
kDa (8-16 β-strands in the native state) with a 1:1 stoichiometry156,160,166,171. By 
contrast, the ESI mass spectra shown in Figure 4.5 reveal that the stoichiometry of 
these assemblies is dependent on the size of the OMP client, consistent with the 
kinetic traces shown in Figure 4.3. Thus, tOmpA and PagP (8-stranded OMPs) bind 
only one Skp, whilst the larger OMPs, OmpT, OmpF and tBamA (10- and 16-
stranded OMPs) bind up to two copies of Skp, at least as suggested by ESI-MS. 
Peaks corresponding to monomeric Skp subunits were also observed in the spectra 
at m/z ~2000 (Figure 4.5), indicating either that some dissociation of the assembly is 
occurring in-source, and/or reflecting a population of monomeric Skp subunits in 
solution163,167. Interestingly, a 2:1 assembly is the predominant complex observed in 
the spectrum for the largest 16-stranded OMP studied, tBamA (Figure 4.5f), despite 
being formed by mixing Skp with tBamA at a 1:1 molar ratio. To investigate whether 
the absence of the POTRA domains in tBamA alters complex formation, the 
interaction of Skp with full-length BamA was also investigated (Figure 4.6). This 
sample also displays a 2:1 Skp:OMP stoichiometry in addition to a 1:1 complex, 
which has been reported previously160. Interestingly, the 1:1 stoichiometry previously 
reported for Skp in complex with full-length BamA was obtained using fluorescence 
studies160. This suggests that the binding of additional copies of Skp does not 
increase OMP fluorescence, which is saturated at a 1:1 Skp:OMP ratio. 
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Figure 4.5: Skp:OMP complexes have different stoichiometries. ESI mass 
spectra of (a) Skp (5 μM) and Skp pre-incubated in the presence of 5 μM (b) 
tOmpA, (c) PagP, (d) OmpT, (e) OmpF and (f) tBamA. OMPs were diluted 
from a denatured state (in 50 mM glycine-NaOH pH 9.5, 8 M urea) into Skp-
containing solutions (final OMP and urea concentrations of 5 μM and 0.2 M, 
respectively), and incubated at room temperature for 5 min before buffer 
exchange into 200 mM ammonium acetate, pH 10. Spectra are annotated with 
red circles (●) (Skp), green squares (■) (1:1 Skp:OMP) and blue triangles (▲) 
(2:1 Skp:OMP). The most abundant charge state is labelled for each 
distribution. Observed masses for the complexes are summarised in Table 
4.2. Complementary IMS data are displayed in Table 4.3. 
 
Figure 4.6: BamA forms complexes with Skp with a 2:1 stoichiometry. 
ESI mass spectra of Skp (5 μM) pre-incubated in the presence of BamA 
(5 μM). Experiments were performed, and peaks labelled, as detailed in 
Figure 4.5. 
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Table 4.2: Observed and expected masses for the complexes studied. 
For mass measurements, mass spectrometry conditions were optimised 
empirically for each sample to decrease peak widths, by increasing the cone 
voltage and trap collision energy, (typically 100 V and 40 V, respectively), 
relative to the gentler conditions used to acquire IMS data. 
4.4 Insights into the structure and dynamics of Skp:OMP complexes 
using ESI-IMS-MS 
The folding kinetics and non-covalent mass spectrometry data described above 
provide evidence that Skp binds its OMP clients of larger size by increasing the 
Skp:OMP stoichiometry. Next, ESI-IMS-MS was used to study the structures and 
dynamics of the complexes identified. IMS measures the mobility of ions through an 
inert gas-filled chamber under the influence of a weak electric field, with the drift 
time (the time taken to traverse the ion mobility cell) of an ion dependent principally 
on its size and charge370,371. Conceptually, a useful analogy is with gel 
electrophoresis, in which differences in size and charge of different species are used 
for their separation and measurement, based on their mobility through a medium435. 
Similar to the manner in which a marker lane of protein standards is used for 
calibration to obtain the masses of observed bands in a gel electropherisis 
experiment, here, using travelling wave IMS-MS370,371 calibration of drift time data 
using a set of globular standards allowed rotationally averaged collision cross-
sections (CCSs) for each ion in the ESI mass spectra to be obtained. The CCS 
parameter is a measure of the interaction area between an ion and the buffer gas, 
which is related to the conformation of an ion, as well as its structure436,437. From a 
Complex Expected Mass (Da) Observed Mass (Da) 
Skp 47,075 47,125 ± 10 
1:1 Skp:tOmpA 65,818 65,898 ± 12 
1:1 Skp:PagP 66,185 66,208  ± 15 
1:1 Skp:OmpT 82,355 83,304 ± 20 
2:1 Skp:OmpT 129,430 130,542 ± 14 
1:1 Skp:OmpF 84,220 84,210 ± 18 
2:1 Skp:OmpF 131,295 131,337 ± 11 
1:1 Skp:tBamA 90,315 90,183 ± 5 
2:1 Skp:tBamA 137,390 137,303 ± 8 
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Protein Data Bank (PDB) file containing the complete structural information for a 
protein or protein complex a theoretical CCS value can be calculated, here using the 
software IMPACT375. For globular assemblies, the error between measured CCS 
values and theoretical CCS values calculated from atomic coordinates has been 
estimated to be below 3%438. Hence, CCS data from IMS were acquired for Skp and 
all Skp-OMP complexes identified (Figure 4.7, Table 4.3), and compared with the 
theoretical CCS value of the Skp crystal structure, or with CCS values for models of 
the Skp:OMP complexes for which there are no high resolution structural data 
(Section 4.5). 
Figure 4.7 displays the CCS distributions of the observed ions originating from Skp 
and 1:1 Skp:OMP complexes, normalised to spectral intensity (a representative 
dataset is shown from three independent experiments). The modal CCSs are also 
plotted as a function of charge state in Figure 4.7g (Table 4.3). Interestingly, the 
CCSs of the Skp ions (black squares in Figure 4.7g) are substantially smaller than 
expected based on the published crystal structure (the modal CCS at the lowest 
observed charge state, which is least affected by Coulombic repulsion439, was 
37.9 nm2, approximately 25 % lower than the expected value of 45.7 nm2 derived 
from the crystal structure (red dotted line (ii) in Figure 4.7g)). To investigate this, 
molecular dynamics simulations of apo-Skp in vacuo were performed (Figure 4.8), 
revealing that the assembly collapses in the gas phase, presumably due to the 
large, empty central cavity present in the structure. The CCS of the structure at the 
end of the simulation, 37.3 ± 1.9 nm2 (black dotted line (i) in Figure 4.7g) is in 
excellent agreement with the CCS measured by IMS (37.9 nm2, Table 4.4) 
Binding of Skp to the 8-stranded OMPs tOmpA and PagP (red and green circles in 
Figure 4.7g) results in ions with increased CCS compared with Skp alone. The 
CCSs of the ions observed (45.6 nm2 and 45.8 nm2 for Skp-tOmpA and Skp-PagP, 
respectively, at the lowest observed charge state) are similar to the CCS predicted 
from the crystal structure of Skp alone (45.7 nm2), supporting the notion that these 
assemblies are specific complexes in which the OMP is located within the central 
Skp cavity161,171, preventing collapse of the chaperone in the gas phase. Consistent 
with this, these Skp:OMP complexes sample a narrower conformational ensemble 
when compared with Skp alone, measured by the width at half height of the mobility 
peaks observed440,441,  (Figure 4.7a-c). The data suggest that the formation of a 
complex with tOmpA and PagP packs the hydrophobic cavity of Skp resulting in a 
narrower conformational ensemble. This is consistent with NMR experiments, which 
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have demonstrated that Skp binding to tOmpA and OmpX results in stable NMR-
visible complexes with reduced Skp flexibility when compared with Skp alone171. 
The 1:1 Skp:OMP assemblies of the larger OMPs studied (OmpT, OmpF and 
tBamA) (orange, blue and purple circles in Figure 4.7g) have increased CCSs 
(51.4-54.2 nm2) compared with the Skp:tOmpA/PagP assemblies (~46 nm2). These 
data, together with mismatch between the volume of Skp’s cavity and the volume 
likely to be occupied by larger OMP clients in the ‘fluid globule’ state171, suggest that 
the central cavity expands in size to encapsulate these species, consistent with 
recent SANS data172. However, given that increased Skp:OMP ratios are required to 
prevent folding of these larger OMPs (Figure 4.3), and that 2:1 Skp:OMP complexes 
are detected by IMS-MS, these data also indicate that Skp expansion is insufficient 
to fully sequester these larger OMPs in a 1:1 complex. 
The increase in CCS as a function of molecular weight for Skp and all complexes, 
including 2:1 Skp:OMP assemblies, is plotted in Figure 4.7h. This data can be fitted 
to a globular model (Section 2.17), irrespective of client size, with the complexes 
exhibiting an effective gas phase density375 of 0.33 Da.Å-3. This value is similar to 
those reported for other protein complexes371, and is consistent with recent 
calculations of the CCSs of globular proteins in the PDB375. 
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Figure 4.7: Collision cross-section distributions of Skp and Skp:OMP 
complexes. CCS distributions (peak heights normalized to MS peak intensity) 
of (a) Skp and 1:1 Skp:OMP complexes with (b) tOmpA, (c) PagP, (d) OmpT, 
(e) OmpF and (f) tBamA. The width at half height (normalized for spectral 
intensity) for each distribution is indicated (dashed lines)440,441, as well as the 
charge states which are represented by each CCS distribution. (g) Plot of 
observed CCSs of the assemblies as a function of charge state (mean of three 
replicates shown, note that standard deviation values are smaller than the 
symbol size used): Skp, black squares; 1:1 Skp:tOmpA, red circles; 1:1 
Skp:PagP, green circles; 1:1 Skp:OmpT, orange circles; 1:1 Skp:OmpF, blue 
circles; 1:1 Skp:tBamA, purple circles; 2:1 Skp:OmpT, orange open squares; 
2:1 Skp:OmpF, blue open squares; 2:1 Skp:tBamA, purple open squares. 
Dashed lines indicate CCSs estimated from (i) the collapsed structure of Skp 
from the MD simulation (black) (Figure 4.8), (ii) the crystal structure of Skp 
(red), (iii) a model 1:1 Skp:OMP complex with an expanded central cavity 
(orange), (iv) a model 2:1 Skp:OMP complex comprising two interlocking Skp 
molecules (green) and (v) a model (Skp)2:OMP complex arranged in a side-
by-side fashion (pink) (Figure 4.9). (h) Plot of the lowest measured CCS of 
each assembly as a function of molecular weight (symbols as in (g)). The line 
represents the expected CCSs for globular proteins with an amino acid density 
of 0.33 Da.Å-3. 
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Table 4.3: Experimentally determined modal collision cross-sections 
(CCSs) (nm2) for the observed charge states (z) of Skp and Skp:OMP 
complexes. CCS values are shown as mean ± standard deviation of three 
independent measurements. 
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Figure 4.8: In vacuo molecular dynamics simulations of Skp. (a) 
Theoretical CCS, and (b) backbone RMSD (red line) and radius of gyration 
(Rg) (light blue line) calculated for the initial 10 ns of the 100 ns simulation in 
the absence of solvent. (c) The starting model Skp structure used for the MD 
simulation (PDB: 1U2M150, with missing residues in chains B and C modelled 
from chain A). Skp subunits are coloured green, blue and yellow. (d,e) 
Structures of Skp after a simulation time of (d) 0.2 ns and (e) 10 ns. The CCS 
of the collapsed Skp structure after a simulation time of 100 ns simulation 
(37.3 ± 1.9 nm2, Table 4.4) agrees favourably with the modal CCS of Skp at 
the lowest observed charge state (37.9 ± 0.6 nm2). 
4.5 Modelling of larger OMPs in complex with two copies of Skp 
gives structures with different architectures 
To investigate the architecture(s) of Skp complexes with OmpT, tBamA or OmpF, 
four different models were constructed and the theoretical CCSs of the resulting 
structures compared with the experimentally determined CCS. As a starting point, 
encapsulated tOmpA was modelled as a sphere with a radius of 20 Å (Figure 4.9a) 
which has a volume of 33,500 Å3, consistent with previous estimates from the 
crystal stucture150, and with NMR data for the 8-stranded OmpX in complex with 
Skp171. It was assumed that the amino acid density for non-native OMPs bound to 
Skp is independent of the mass of the OMP studied, consistent with the MS data 
presented above (Figure 4.7h). Therefore, to model a 16-stranded OMP, a spherical 
volume of ~67,000 Å3 was assumed giving a radius of ~25 Å, and generated a Skp 
model with its three subunits surrounding a sphere of this size (Figure 4.9b). The 
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theoretical CCS of the resulting structure (50.4 nm2) (orange dotted line (iii) in Figure 
4.7g) is in good agreement with the measured CCS values for 1ː1 
SkpːOmpT/OmpF/tBamA complexes (51.4, 51.8 and 54.2 nm2, respectively) (Table 
4.3). The results suggest, therefore, that 1:1 Skp:OMP complexes with larger OMPs, 
involve an expanded Skp cavity. 
Next, models were generated of the 2:1 Skp:OMP complexes with theoretical CCS 
values consistent with those measured by IMS. It was theorised that Skp could 
arrange in a side-by-side configuration, in either a parallel or antiparallel 
arrangement (Figure 4.9c,d), with the OMP represented by a capsule with a cylinder 
height of 37 Å and cap radii of 20 Å. The theoretical CCSs of these assemblies were 
determined to be 79.1 and 78.2 nm2, respectively (green dotted line (iv) in Figure 
4.7g). Alternatively, a model in which the OMP substrate (represented by a sphere 
with a radius of ~25 Å) may be encapsulated by two interlocked copies of Skp 
(Figure 4.9e) was considered, which results in a complex with a theoretical CCS of 
73.5 nm2 (pink dotted line (v) in Figure 4.7g). All three values are in good agreement 
with the measured CCS values for 2:1 Skp:OmpT/OmpF/tBamA complexes (71.7, 
71.2 and 72.8 nm2, respectively) (Table 4.3).  
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Figure 4.9: Possible architectures of Skp:OMP complexes. Side (left) and 
bottom (right) view surface representations of models of (a) Skp (yellow) 
(based on the published crystal structure (PDB: 1U2M150) with missing 
residues modelled by molecular replacement), bound to an 8-stranded OMP 
represented by a grey sphere of radius 20 Å, (b) Skp with an expanded central 
cavity surrounding a 16-stranded OMP represented by a grey sphere of radius 
25 Å, (c,d) 2:1 Skp:OMP structures (Skp coloured in yellow and green) 
arranged side-by-side in a (c) parallel or (d) antiparallel arrangement, with the 
16-stranded OMP substrate represented by a grey capsule with cylinder 
height of 37 Å and cap radii of 20 Å, (e) 2:1 Skp:OMP complex with an 
interlocked trimer architecture with the 16-stranded OMP represented by a 
grey sphere of radius 25 Å, and (f) the hexameric eukaryotic chaperone 
prefoldin (PDB: 1FXK174), with chains A, B and C of the crystal structure 
shown in green, cyan and yellow, respectively. 
4.6 Investigation of Skp:OMP complex models by molecular 
dynamics simulations 
To model these Skp:OMP complexes further, and aid their visualisation, a series of 
molecular dynamics simulations were performed. A simulation of apo-Skp in explicit 
solvent over 100 ns demonstrated that the individual subunits are highly dynamic 
and flexible. Each subunit undergoes a transition to an ‘open’ state, in which subunit 
helices splay from the central axis, resulting in an expanded central cavity, 
consistent with previous MD studies156,172 (Figure 4.10). The average radius of 
gyration (Rg) of Skp from the simulation (31.5 Å) is in good agreement with 
published SANS data (~33 Å)172.  This Rg value is ~10 % higher than predicted from 
the crystal structure, indicating that dynamic motions of the Skp subunits observed 
in the simulation likely reflect those observed in solution. In the two Skp crystal 
structures solved to date149,150, the lower section of one of the subunits is 
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unresolved, indicating flexibility, and the angles with which the Skp subunits extend 
away from the ‘body’ domain are different for each of the subunits in the two 
structures149,150. The individual subunits in the crystal structure of the 
heterohexameric eukaryotic chaperone prefoldin (Figure 4.9f) also make different 
angles with respect to the multimerisation domain, which has also been suggested 
to indicate conformational flexibility that may be functionally relevant174. 
Next, models were generated of tOmpA (8-stranded) and tBamA (16-stranded) 
alone in an unfolded, extended conformation, and their behaviour simulated in 
solvent (mimicking the situation in which OMPs are diluted from 8 M urea). In each 
case, the OMPs collapse rapidly to an approximately globular form (Figure 4.10d,e).  
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Figure 4.10: Molecular dynamics simulations of Skp, tOmpA and tBamA 
in solvent. (a) Starting structure used for explicit solvent MD simulation of Skp 
(PDB: 1U2M150, with missing residues in chains B and C modelled from chain 
A), shown from the side (left) and bottom (right). (b) Example structure of Skp 
in an ‘open’ conformation (t = 7.5 ns), shown from the side (left) and bottom 
(right). Skp subunits in (a) and (b) are coloured green, blue and yellow. (c) 
Radius of gyration of Skp over the course a MD simulation in explicit solvent. 
Structural collapse of initially extended chains of (d) tOmpA and (e) tBamA 
simulated with an implicit solvent model (Section 2.19). 
A model of the 1:1 Skp:tOmpA complex was then generated by placing the 
collapsed tOmpA structure within the cavity of Skp in an ‘open’ conformation from 
the simulation of apo-Skp (Figure 4.10b) and relaxing the resulting structure in 
vacuo. In the simulation, the subunits of Skp collapse rapidly around the tOmpA 
substrate resulting in a structure with a CCS value (43.7 ± 1.2 nm2) in excellent 
agreement with that measured by ESI-IMS-MS (45.6 ± 0.1 nm2), suggesting that, at 
least in the gas phase, Skp “clamps” around the substrate  (Figure 4.11a,b). To 
provide insight into the potential atomistic structure of the 2:1 Skp:OMP complexes 
observed using ESI-MS (Figure 4.5), and to aid visualisation of the size of Skp 
relative to its 16-stranded OMP clients, a model for the gas-phase 2:1 Skp:tBamA 
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complex was created by placing the collapsed tBamA structure in the hydrophobic 
cavity formed by two copies of Skp in their ‘open’ conformations. A side-by-side 
parallel orientation (Figure 4.9c) was chosen based on the striking resemblance of 
this model to the structure the eukaryotic prefoldin chaperone174 (Figure 4.9f). The 
size of the collapsed tBamA model clearly exceeds the maximal dimensions of the 
cavity of a single Skp observed in an ‘open’ conformation (Figure 4.11c). Simulation 
of the 2:1 Skp:tBamA complex in vacuo showed that the Skp subunits also rapidly 
“clamp” around the tBamA substrate creating a complex with a CCS value (74.4 ± 
1.4 nm2) again in good agreement with the IMS data (72.8 ± 0.2 nm2) (Figure 4.11d). 
Therefore, the CCS data obtained from both experiment and simulation (Table 4.4) 
are consistent with a model in which multivalent Skp binding is necessary to 
sequester OMPs that exceed the dimensions of the Skp cavity, to prevent their 
aggregation. 
 
Figure 4.11: In vacuo molecular dynamics simulations of 1:1 and 2:1 
Skp-OMP complexes. (a) Starting model of a 1:1 Skp:tOmpA complex used 
for MD simulations, and (b) the structure obtained after 10 ns of in vacuo 
simulation. (c) Starting model of a 2:1 Skp:tBamA complex used for MD 
simulations, with the two copies of Skp arranged in a side-by-side parallel 
orientation (Figure 4.9c), and (d) the structure obtained after 10 ns of in vacuo 
simulation. Views from the (i) side and (ii) bottom are shown. Skp (green/blue) 
is shown in cartoon representation. OMPs (yellow) are shown in surface 
representation 
To provide evidence that a similar “clamping” motion of Skp around its OMP 
substrates could occur in solution, analogous MD simulations of Skp:tOmpA and 2:1 
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Skp:tBamA complexes were performed in explicit solvent. In these simulations Skp 
subunits are also observed wrapping around their OMP substrates (Figure 4.12a,b), 
with ‘clamping’ movements similar to those observed in the gas-phase simulations 
(Figure 4.11). The complexes formed are stable over 100 ns (Figure 4.12c,d) and 
have larger calculated CCS values (56.5 ± 0.3 nm2 and 101.2 ± 6.0 nm2 for Skp-
tOmpA and 2:1 Skp-tBamA, respectively) than those following gas-phase simulation 
(43.7 ± 1.2 nm2 and 74.4 ± 1.4 nm2 for Skp-tOmpA and 2:1 Skp-tBamA, 
respectively). These data are consistent with a model in which the subunits of Skp 
are dynamic, resulting in expansion of the hydrophobic cavity that allows entry of 
substrates of varying sizes, prior to the Skp subunits ‘wrapping’ around the 
sequestered client to protect it from aggregration until folding into the bilayer can 
take place. 
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Figure 4.12: Molecular dynamics simulations of 1:1 and 2:1 Skp:OMP 
complexes in explicit solvent. (a) (i) Starting model of a 1:1 Skp:tOmpA 
complex used for MD simulations, and (a) (ii) the structure obtained after 100 
ns of simulation in explicit solvent. (b) (i) Starting model of a 2:1 Skp:tBamA 
complex used for MD simulations, with the two copies of Skp arranged in a 
side-by-side parallel orientation (Figure 4.9c), and (b) (ii) the structure 
obtained after 100 ns of simulation in explicit solvent. (c,d) Backbone RMSDs 
calculated for the 100 ns simulations of (c) 1:1 Skp:tOmpA, and (d) 2:1 
Skp:tBamA in explicit solvent, demonstrating that the complexes are stable 
over this timescale. 
 
Table 4.4: Comparison of CCS values from MD simulations and IMS-MS 
measurements. CCS values from IMS-MS are shown as the mean ± standard 
deviation of the modal value of the lowest charge state ion from three 
independent measurements.  CCS values from the simulations are the mean ± 
standard deviation for the endpoint structures at 100 ns from three 
independent simulations. For globular assemblies, the error between 
measured CCS values and those computed from atomic coordinates has been 
estimated to be below 3%438.    
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4.7 Discussion 
Major advances in the understanding of the roles of molecular chaperones and 
folding catalysts involved in OMP biogenesis have been made in recent years17, yet 
the molecular details of how OMPs are bound by molecular chaperones, transported 
across the periplasm and assembled into the outer membrane, all without using the 
energy of ATP binding/hydrolysis, remain unclear10,14,16. In this chapter, new insights 
have been provided into how Skp is able to chaperone its broad array of OMP 
clients, including substrates which are too large to be accommodated within its 
hydrophobic cavity. The results show that Skp utilises subunit dynamics to expand 
the size of its client binding cavity and demonstrate that Skp can function as a 
multivalent OMP chaperone in order to sequester and prevent aggregation of its 
larger OMP clients. Further, ESI-IMS-MS was used to gain structural insight into the 
1:1 and 2:1 Skp:OMP complexes identified. Using kinetic refolding and ESI-IMS-MS 
data, combined with MD simulations, models consistent with the experimental 
results have been presented, in which Skp sequesters larger OMPs by binding in a 
multivalent arrangement (side-by-side parallel or anti-parallel, and/or via an 
interlocking structure) (Figure 4.9c-e). Interestingly, the parallel side-by-side model 
(Figure 4.9c) bears a striking resemblance to the structure of the non-homologous 
chaperone prefoldin (Figure 4.9f)174. The precise orientation(s) of Skp molecules in 
these multivalent complexes cannot be extracted from the experimentally obtained 
CCS values obtained. Indeed, the models of 2:1 Skp:OMP complexes generated 
(Figure 4.9c-e) are not mutually exclusive and given the dynamic nature of Skp and 
the wider range of CCS values obtained for Skp in complex with larger OMPs 
(Figure 4.4d-f) it is possible many different configurations exist in solution. Additional 
information from further studies, for example using cross-linking experiments 
followed by MS/MS, will be required to obtain a more complete structural picture. 
Nevertheless, the kinetic, MS and MD results in this chapter indicate that the ability 
of Skp to chaperone substrates ranging from 35-43 kDa in size requires both subunit 
dynamics and its ability to function as a multivalent chaperone. Skp has been shown 
in vivo to interact with much larger substrates than those investigated here (19-43 
kDa), including BtuB (66 kDa), FhuA (79 kDa) and LptD (87 kDa) which form β-
barrels composed of 22, 22, and 26 β-strands, respectively155,178. It is likely these 
proteins also form multivalent complexes with Skp, and indeed recent experiments 
on a Skp:FhuA complex, using analytic SEC, are consistent with a greater than 1:1 
Skp:OMP stoichiometry97. 
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The results presented have implications for understanding how OMPs are 
chaperoned by Skp in the periplasm, including the mechanisms of substrate binding 
and release. The atomistic MD trajectories of apo-Skp show that it exists in a wide 
range of open conformations with large differences in the area of the cavity entrance 
formed between the tips of its three subunits (Figure 4.10a-c). Such conformational 
flexibility has been implicated in the mechanisms of other ATP-independent 
chaperones168,442. Therefore, in rescuing aggregation-prone proteins145 Skp could be 
thought of as analogous to a pair of ‘callipers’, sampling open conformations prior to 
capture of its client, allowing it to adjust the volume of its central cavity.  In this 
model once the substrate has entered the Skp cavity, the Skp subunits ‘clamp down’ 
to protect the exposed hydrophobic surfaces of the protein, in a mechanism similar 
to those of other chaperones such as Trigger Factor or Hsp90443, as observed in the 
simulations of Skp:tOmpA and Skp:tBamA complexes (Figure 4.12). For those 
substrates which are too large to be accommodated within the Skp substrate cavity, 
additional copies of Skp recognise and engulf sections of the substrate not already 
encapsulated. In vivo cross-linking evidence suggests that Skp can interact with 
OMPs as they emerge from the SecYEG translocon148. Thus it is possible that 
during translocation of larger OMPs, the substrate is fed directly into the cavity of 
Skp and the chaperone’s maximum binding capacity would then be reached before 
the complete polypeptide chain is translocated. Subsequent polypeptide chain 
emerging from the translocon would then be bound by a second or more Skp(s), 
ensuring sequestration of the entire polypeptide sequence so that periplasmic 
aggregation is prevented. 
Recent equilibrium sedimentation experiments of Skp in the absence of substrate 
have demonstrated a dynamic equilibrium between folded subunit monomers and 
trimers at physiological concentrations163. Therefore, a possible alternative in vivo 
pathway to Skp-OMP complex formation may involve sequential binding of 
monomer subunits to OMP substrates, with Skp trimerisation linked to (and indeed 
driven by) subunit binding to substrate. Sandlin et al. raise the possibility that more 
diverse species of Skp could form around an unfolded OMP163. However, for the 
complexes studied here only Skp:OMP complexes containing monomeric Skp 
subunits in multiples of three are observed (Figure 4.3), suggesting that either the 
trimeric unit is the OMP binding species, or that complexes between OMPs and non-
trimeric Skp subunits are unstable in the gas-phase. 
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It has been proposed that transient exposure of the C-terminal OMP targeting 
sequence129,444 (Section 1.2.2), and its recognition by the BAM complex136, triggers 
substrate release from Skp171. The space between Skp subunits (∼25 Å in the 
crystal structure150) and/or the inherent dynamics of the complex may facilitate the 
transient solvent-exposure of regions of the OMP substrate, permitting β-signal 
recognition. Consistent with this, a study found that the presence of BamA in DUPC 
liposomes relieves the in vitro folding inhibition of OmpA by Skp299. Interestingly, in 
all 2:1 Skp:OMP models proposed here there remains a substantial distance (>20 Å) 
between the Skp subunits, which would permit exposure of sections of the substrate 
polypeptide required for BAM signalling and/or membrane insertion. The release of 
the OMP from Skp is likely to be driven by the increased thermodynamic stability of 
the folded OMP relative to the chaperone-bound state445, and for OMPs that are 
bound to more than one Skp, it is possible that individual copies of Skp are released 
sequentially in a process driven by the free energy of OMP folding. Kinetic modelling 
of the flux of OMPs through the periplasm suggested that the population of Skp-
OMP complexes is dynamic124. Association rates (kon) between Skp and its OMP 
clients are diffusion limited, and dissociation rates (koff) are on the millisecond time-
scale, much shorter than the time taken for an OMP to cross the periplasm (~2 
min)123,124. The authors suggest that rapid binding and unbinding of Skp to its OMP 
clients may promote conformations which favour folding, and disfavour 
aggregation124. Single molecule force spectroscopy (SMFS) experiments in which 
FhuA was refolded in the presence or absence of Skp or SurA also suggested that 
periplasmic chaperones have a role in modulating the folding pathway to promote 
folding97.  
Chaperones utilise two general strategies to protect substrates from misfolding and 
aggregation.  In the first, substrates are chaperoned by sequential binding and 
release of exposed hydrophobic surfaces along an extended polypeptide chain. This 
‘beads on a string’ model is typified by chaperones such as the Hsp70s and Trigger 
Factor446,447. Alternatively, aberrant interactions may be prevented by sequestration 
of the substrate from the cellular environment within an enclosed space, as is the 
case for the ‘cage-like’ chaperonins such as GroEL/ES and TriC446,447. The data 
presented here suggest that Skp operates with a ‘hybrid’ mechanism, employing 
both of these strategies to bind and encapsulate its OMP clients, thereby preventing 
their aggregation and facilitating their delivery to the OM.   
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In summary, the combined results in this chapter provide a new understanding of 
how Skp is able to bind, chaperone and release substrates that vary dramatically in 
size, with expansion of the binding cage and/or formation of multivalent complexes 
allowing the chaperone to adapt to the demands of its clients. It also introduces 
native-MS as a new method for studying membrane protein-chaperone complexes. 
This technique has exciting prospects for examining the structure and dynamics of 
other MP-chaperone systems, particularly when, as here, it is used in combination 
with MD simulations. The following chapter considers the next stage in the OMP 
biogenesis pathway, when OMPs are released by periplasmic chaperones, such as 
Skp, and subsequently interact with the BamA folding catalyst. 
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5 Effects of periplasmic chaperones and membrane thickness 
on BamA catalysed OMP folding 
5.1 Introduction 
In the previous chapter the interactions and effects on in vitro folding of a single 
folding factor (the Skp chaperone) with a number of substrate OMPs was 
investigated. Here, work is described which takes the complementary approach of 
considering a single substrate, tOmpA, and examining the influence of multiple 
folding factors on its folding kinetics. Since this thesis commenced, several SDS-
PAGE based studies have shown that BamA alone is able to accelerate OMP 
folding in vitro299,300,302. This chapter will begin by recapitulating this result using 
fluorescent spectroscopy. It then examines the effects of the periplasmic 
chaperones Skp and SurA on BamA-catalysed folding reactions. Finally, the effects 
of the hydrophobic thickness of the bilayer environment on BamA activity are 
analysed. 
The molecular details of how OMPs are transported across the periplasm and 
delivered to the BAM complex remain unresolved10. Genetic studies suggest that the 
two major OMP chaperones in E. coli, Skp and SurA, operate in parallel 
pathways145,147. However, while Skp has been cross-linked at the inner 
membrane148, no direct in vivo cross-linking of Skp to BAM components has been 
reported. By contrast, SurA is readily cross-linked to BAM components145,187,188, 
supporting the notion that Skp and SurA may cooperate in a sequential pathway in 
which Skp interacts early in the pathway and hands over substrates to SurA for 
delivery to BAM68,176. An alternative pathway in which Skp delivers substrates 
directly to the OM is supported by in vitro data which have shown that the highly 
positively charged Skp can deliver OMPs directly to negatively charged 
bilayers152,153, and recent data which suggest that Skp can deliver substrates into 
membranes in vivo154. By systematically examining the effects on tOmpA folding of 
combinations of chaperones and BamA, the data in this chapter suggest that Skp 
may directly deliver substrates to BAM, and provides evidence against a sequential 
model for the Skp and SurA chaperones. 
Many studies have shown that OMPs are able to spontaneously fold and insert into 
lipid bilayers298, and that the folded state is highly stable448. However, in vivo the 
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kinetics of spontaneous folding into the membrane environment of the OM is too 
slow to be biologically relevant and therefore a dedicated catalyst, the BAM complex 
is required15. Therefore, the role of the BAM complex in vivo is to modulate the 
kinetics of an already thermodynamically favourable process445. So what are the 
factors that increase the kinetic barriers to OMP folding? In vitro evidence points to a 
role for the physicochemical properties of the lipids themselves, as OMP folding 
kinetics and efficiency in vitro are influenced by lipid curvature, the degree of 
saturation in acyl chain lengths, the nature of lipid head groups, and the hydrophobic 
thickness of the membrane322. BamA, in the absence of the other BAM lipoproteins, 
was first shown to accelerate OmpA folding in DLPC (diC12:0PC) bilayers
299. 
Subsequently, it was demonstrated that the presence of prefolded BamA in DDPC 
(diC10:0PC) liposomes containing a mole percentage of 20% DDPE (diC10:0PE) or 
DDPG (diC10:0PG) leads to a much greater difference in OMP folding kinetics 
between the catalysed and uncatalysed folding reactions300. Therefore, it was 
proposed that one function of BamA is to overcome the kinetic barrier to folding 
imposed by native lipid head groups300. 
Another kinetic barrier to OMP folding is imposed by the hydrophobic thickness of 
the membrane, and it as been suggested that the decreased thickness of the OM 
compared to the IM may be one mechanism by which OMPs are sorted to the 
correct membrane in vivo53,336. The results in Chapter 3 showed that the OMP PagP 
folds fastest in thinner bilayers, which follows the same trend as that observed for 
other OMPs313. The acyl chain lengths of lipids in the OM are mostly longer (C14-
C1834) than commonly used in in vitro studies, and accordingly, most OMPs cannot 
be folded directly into liposomes composed of E. coli polar lipid extract300,313. For 
those OMPs which are able to fold into these native lipids, folding does not occur on 
biologically relevant timescales300,313. Therefore, it is likely that one strategy by 
which BAM aids OMP folding in vivo is to locally thin the bilayer. In support of this, 
the crystal structure of BamA revealed an asymmetric -barrel, with a thinner 
aromatic girdle on the side of the barrel closest to the 1-16 seam (Figure 5.1)11. 
By contrast, OmpA, BtuB and the Omp85 family member FhaC have a similar 
hydrophobic thickness all the way around the barrel (Figure 5.1). 
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Figure 5.1:  The BamA -barrel has a reduced hydrophobic thickness on 
one side close to the 1 and 16 interface.  (a) The location of aromatic 
girdle residues (Trp, Tyr and Phe, highlighted in blue) in BamA (H. ducreyi, 
PDB: 4K3C11), OmpA (E. coli, PDB: 1QJP303), FhaC (B. pertussis, PDB: 
2QDZ449) and BtuB (E. coli, PDB: 1NQE450), (b) the same structures rotated 
180º around the y-axis. Image reproduced from Noinaj et al. (2013)11. 
Further, a simulation of the -barrel domain of BamA from N. gonorrhoeae in a 
DMPE bilayer, exhibited dramatic membrane thinning of 16 Å close to 1611. 
However, in recent simulations of full-length E. coli BamA in an atomistic outer 
membrane, thinning of only a few angstroms was observed, and this was not always 
localised to the 1-16 interface262. Additionally, a similar extent of membrane 
thinning was observed in simulations of E. coli OmpLA in an all-atom native 
membrane451. Membrane thinning of lipid bilayers by clusters of BamA molecules 
was proposed to have been observed by negative stain EM452. However, very few 
EM images were shown of the notches and distortions in BamA-containing 
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liposomes suggested to be caused by BamA, and no quantitative analysis was 
presented452. 
Related to the membrane thinning hypothesis is the idea that BAM may act as a 
‘disruptase’ creating areas of local defects within the membrane to enhance folding 
rates445. A study on the permeation of small ions (protons and potassium ions) 
through bilayers composed of unsaturated PC lipids concluded that the diffusion of 
ions is aided by the creation of transient pores, but only if the membrane is 
sufficiently thin (acyl chain lengths of <C18 and <C22 were required for the 
permeation via pores of potassium ions and protons, respectively)453. Further, 
atomistic simulations showed that the free energy penalty for pore formation was 
much lower in shorter DLPC bilayers (C12) than those composed of DMPC (C14) or 
DPPC (C16)454. Direct evidence that membrane defects accelerate OMP folding was 
recently provided by experiments in which the kinetics of folding of tOmpA into 
DMPC LUVs was monitored at, or close to, the transition temperature (Tm) of the 
bilayer365. AFM studies have shown that at the DMPC Tm (24 ºC) liquid and gel 
phase domains coexist455,456, thus creating defects in the membrane and increasing 
its permeability365. The kinetics of tOmpA were substantially faster (>10-fold) at the 
Tm than at a temperature 2 ºC higher
365. It was proposed that this effect is due to the 
hydrophobic mismatch between lipids at the boundaries of these two phases 
creating transient defects and pores, which OMPs utilise to aid insertion and 
folding365. These hypothesised ‘membrane-based’ mechanisms of OMP folding 
catalysis are not mutually exclusive with other proposed models of BAM function. 
For example, they do not provide evidence for or against the currently favoured 
‘BamA-budding’ and ‘BamA-assisted’422 models (Section 1.4.7), which are both 
consistent with a role for BAM in altering membrane properties to aid folding445. 
In this study it was decided to examine the effects of the central component BamA in 
assisting OMP folding in the absence of the other BAM lipoproteins for several 
reasons: (1) BamA is the central platform for the other BAM components16; (2) it has 
been shown that BamA can be refolded in vitro from inclusion bodies129,313; (3) there 
is evidence of direct interaction of BamA with substrates in vitro129,444; (3) a catalytic 
effect on OMP folding has been demonstrated for BamA in the absence of other 
BAM subunits299,300,302; and (4) BamA is the only BAM complex member for which 
homologs have been found in all known Gram-negative bacterial genomes224,457. 
BamB-E have varying degrees of conservation across Gram-negative bacteria224; no 
homologs of BAM lipoproteins have been found in Thermus thermophilus224,243, or in 
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the cyanobacterium Thermosynechococcus elongates224,244. Interestingly, the BamA 
homologue from T. thermophilus appears to be able to aid assembly of one of its 
substrates (TtoA) in vitro in the absence of other factors444,458.  
In this chapter a systematic and stepwise strategy is taken towards gaining 
understanding of the function of BamA using kinetic assays. The results presented 
for BamA, in combination with different chaperones, and in liposomes of different 
composition, also lay a foundation for future work involving the remaining BAM 
lipoproteins. 
In the work presented in this chapter the N-terminal cysteine tOmpA mutant used in 
microscale thermophoresis (MST) experiments was mutated, expressed and purified 
by Tom Crosskey (University of Leeds). The temperature denaturation of BamA was 
performed by Anna Higgins (University of Leeds). 
5.2 BamA has a catalytic effect on OMP folding in DUPC liposomes 
Cold SDS-PAGE based studies have demonstrated that BamA alone can increase 
the kinetics of OmpA folding in DLPC LUVs299, and of tOmpA, OmpA, OmpX, and 
OmpLA folding in LUVs composed an 80:20 DDPC:DDPE mix300,302. Therefore, 
whether BamA could also accelerate the folding of tOmpA into DUPC liposomes 
was first investigated, using the fluorescence assay developed in Chapters 3 and 4. 
To examine the effects of BamA on tOmpA folding in vitro three separate BamA 
constructs were produced: (1) the soluble POTRA domains of BamA (residues 21-
424), (2) the -barrel domain of BamA (tBamA) (residues 425-810), and (3) full-
length BamA (residues 21-810) (Figure 1.15). Initially, the POTRA domains were 
cloned into pET11a, however this construct could not be expressed despite trials in 
BL21(DE3), BL21(DE3)Star, BL21-CodonPlus(DE3)-RIPL, BL21(DE3) BLR(pLysS), 
and Rosetta-2(DE3)pLysS expression strains (data not shown). The addition of an 
N-terminal His-tag allowed expression, but this construct was unable to be bound by 
Ni2+ beads or His-Trap columns, despite numerous attempts (data not shown). It is 
likely that self-association of the POTRA domains obscured the His-tag, consistent 
with previous observations of in vitro self-association of full-length BamA129. Finally, 
the BamA POTRA domains were cloned and expressed as a fusion with maltose-
binding protein (MBP) (Section 2.4), and pure protein obtained following removal of 
MBP by TEV cleavage (Section 2.4, Figure 5.2a, upper). To compare the effects of 
BamA on OMP folding in the presence of chaperones, His-tagged constructs of Skp 
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and SurA were expressed and purified (Sections 2.6 and 2.7, respectively, Figure 
5.2b,c, upper). Far-UV CD spectra indicated the BamA POTRA domains, Skp and 
SurA have native-like secondary structure under the conditions used in kinetic 
experiments (Figure 5.2, lower). 
 
Figure 5.2: Purification of BamA POTRA domains, Skp and SurA. SDS-
PAGE purification gels (top) and CD spectra (bottom) for (a) BamA POTRA 
domains 1-5, (b) Skp, and (c) SurA. CD spectra where acquired in 50 mM 
glycine-NaOH, pH 9.5, at 25 ºC. Protein concentrations in CD samples for 
BamA POTRA domains, Skp and SurA were 5 M, 3 M (trimer equivalent), 
and 5 M, respectively. CD spectra of Skp and SurA are of constructs lacking 
a His-tag. 
To ensure that any effect on tOmpA folding kinetics by the presence of BamA was 
specific to BamA and not simply due the presence of a prefolded OMP in the bilayer, 
full-length OmpA was also expressed and purified for use as a control. OmpA was 
selected for several reasons: (1) OmpA, like BamA, has a periplasmic domain that 
makes up ~50% of the protein; (2) OmpA has been shown to fold into liposomes in 
an orientation in which the soluble domain faces outwards297, as has also been 
demonstrated for BamA299; and (3) OmpA and BamA have similar theoretical pIs 
(5.59 and 4.87 for OmpA and BamA, respectively364), and (4) OmpA and BamA 
have been shown to fold in PC containing LUVs with similar efficiencies313. To verify 
that BamA, tBamA, OmpA, and the substrate tOmpA, are able to fold into DUPC 
liposomes under the experimental conditions used, fluorescence emission spectra 
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were acquired for each OMP either unfolded in 8 M urea, or in 0.24 M urea following 
a folding reaction in the presence of DUPC LUVs (LPR 3200:1) (Figure 5.3). The 
spectra of each OMP following folding exhibit characteristic decreases in max and 
increases in fluorescence intensity compared with spectra acquired for the OMPs in 
an unfolded state, indicating that a substantial fraction of each OMP was 
successfully folded. To confirm and quantify this result, SDS-PAGE band shift 
assays were performed for BamA, tBamA and OmpA (Figure 5.4). The results show 
that BamA and OmpA fold with similar efficiencies (~80%) while tBamA has a 
slightly lower folding efficiency (~70 %), as quantified by densitometry. 
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Figure 5.3: Fluorescence emission spectra of folded and unfolded OMPs. 
(a) BamA, (b) tBamA, (c) OmpA, and (d) tOmpA. Folded samples (red) 
contained 0.24 M urea, 1.28 mM DUPC (LPR 3200:1), 50 mM glycine-NaOH, 
pH 9.5. Samples were folded for >1.5 h. Unfolded samples (blue) contained 8 
M urea, 50 mM glycine-NaOH, pH 9.5. Fluorescence was excited at 280 nm 
and emission measured between 290-400 nm. The OMP concentrations were 
0.8 M in (a-c) and 0.4 M in (d), and all spectra were acquired at 25 ºC.  
 
Figure 5.4: Substantial fractions of BamA, tBamA and OmpA are folded 
in DUPC liposomes. Semi-native SDS-PAGE band shift assays for (a) BamA, 
(b) tBamA, and (c) OmpA. Samples were folded for >1.5 h at 25 ºC and 
contained 0.24 M urea, DUPC liposomes (LPR 1600:1), in 50 mM glycine-
NaOH, pH 9.5. Samples were run with or without prior boiling, indicated by ‘+‘ 
and ‘-’ symbols, respectively. 
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To further characterise and compare the folding behaviour of BamA and OmpA in 
DUPC liposomes, SDS-PAGE band shift assays for folding reactions in increasing 
concentrations of urea (0.24 – 8 M) were performed (Figure 5.5a-c). The results 
show that BamA and OmpA exhibit similar folding efficiencies when diluted to 
different final urea concentrations from an unfolded state in 9 M. The urea 
concentration at which 50% of molecules are folded (apparent Cm) was ~3.5 M for 
both BamA and OmpA (Figure 5.5c). The apparent Cm is slightly higher than that 
obtained for OmpA in DLPC liposomes (~2.5 M) using a fluorescence-based 
assay416. By contrast, the unfolding behaviour for BamA and OmpA when denatured 
by heat is markedly different (Figure 5.5d). Fluorescence based temperature ramp 
experiments showed that while folded OmpA is resistant to thermal denaturation at 
temperatures up to 95 ºC, BamA begins to unfold at ~70 ºC with a denaturation 
midpoint (apparent Tm) of ~75 ºC. This apparent instability of BamA compared with 
OmpA may be due to the incomplete hydrogen bonding between the first and last -
strands of the BamA barrel11,287 (Figure 1.15), potentially making the structure more 
unstable at higher temperatures. 
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Figure 5.5: Effects of urea on BamA and OmpA folding efficiency in 
DUPC liposomes. Cold SDS-PAGE band shift assays in DUPC liposomes for 
concentrations of urea between 0.24 M and 8 M urea for (a) BamA, and (b) 
OmpA. (c) Quantification of gels in (a) and (b) by densitometry. Samples 
contained 1.5 M BamA or 4 M OmpA, in 50 mM glycine-NaOH, pH 9.5, and 
were folded overnight at 25 ºC. (d) Thermal denaturation of BamA and OmpA 
prefolded overnight in DUPC liposomes. Samples contained 0.8 M OMP, 
0.24 M urea, 50 mM glycine-NaOH, pH 9.5, and were folded overnight at 
25 ºC prior to heat denaturation. Data for OmpA were fitted to a linear model, 
while data for BamA was fitted to a two-state thermal denaturation model 
(Section 2.16). 
Having gathered these reagents the effects of a two-fold molar excess of each 
folding factor on tOmpA folding kinetics was next analysed systematically. OmpA 
prefolded in liposomes marginally lowered the folding rate constant compared with 
tOmpA alone (Figure 5.6a,b), while preincubation of tOmpA with BamA POTRAs 
had no effect on tOmpA folding kinetics (Figure 5.6c). A slightly higher folding rate 
constant was observed in the presence of prefolded tBamA (Figure 5.6d), and this 
was the same when tOmpA was preincubated with BamA POTRAs and then added 
to liposomes containing prefolded tBamA (Figure 5.6e). However, when tOmpA was 
folded in the presence of prefolded BamA, the kinetics of tOmpA folding were 
increased, and the folding behaviour was altered, with transients requiring an 
additional exponential term for adequate fitting (Figure 5.6f). The rate constant for 
the faster phase (k1) was ~2-fold faster than that measured for tOmpA alone. These 
results are summarised in Table 5.1. 
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Figure 5.6: Effects of BamA and its constituent domains on the folding 
kinetics of tOmpA in DUPC liposomes. Kinetic folding traces for (a) tOmpA 
alone, and with (b) prefolded OmpA, (c) preincubation with BamA POTRA 
domains, (d) prefolded tBamA, (e) prefolded tBamA and preincubation with 
BamA POTRA domains, and (f) prefolded BamA (full-length). Samples 
contained 0.4 M tOmpA, 1.28 mM DUPC (LPR 3200ː1), 0.24 M urea, 50 mM 
glycine-NaOH, pH 9.5. A two-fold molar excess (0.8 M) of OmpA, POTRAs, 
tBamA and BamA was used. A minimum of three transients are shown in each 
panel. Fits to a single exponential, (a-e), and double exponential function, (f), 
are indicated by dashed black lines (Table 5.1). 
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Table 5.1: Measured rate constants for tOmpA folding into DUPC 
liposomes in the presence of BamA constructs or OmpA. Data are shown 
as the mean ± the standard error of the mean (s.e.m.) of the rate constants 
obtained from separate folding experiments, each using independently 
prepared batches of liposomes. For each batch of liposomes at least three 
folding transients were fitted globally to obtain the rate constants shown. Data 
are from three independent experiments, except for conditions indicated by an 
asterisk for which the data are from two experiments. N/A: The kinetic traces 
for the condition were adequately described by a single exponential. 
5.3 Release and folding of tOmpA from its complex with Skp is 
dependent on the -barrel domain of BamA 
The results in Chapter 4 demonstrated that tOmpA is prevented from folding into 
DUPC liposomes when preincubated with a two-fold molar excess of Skp, at least 
on a timescale of 2 h (Figure 4.3a). Here, experiments were carried out to determine 
whether BamA could release tOmpA from Skp, as this may recapitulate an in vivo 
assembly pathway (Figure 5.7). When Skp-tOmpA was added to liposomes 
containing the prefolded OmpA control, similarly to Skp-tOmpA alone, no folding 
was observed (Figure 5.7a,b). By contrast, on addition of Skp-tOmpA to liposomes 
containing prefolded BamA, a folding transient is observed (Figure 5.7c), with a 
folding rate constant ~15-fold lower than for tOmpA alone (1.1 ± 0.2 and 14.9 ± 0.3 x 
10-3 s-1 for tOmpA folding from Skp in the presence of BamA, and tOmpA alone, 
respectively). Therefore, release and folding of tOmpA from Skp is specifically 
dependent on BamA. This dramatic result is consistent with previous work in which 
the retardation of OmpA folding into 80:20 DLPC:DLPE liposomes by Skp was 
relieved by the presence of prefolded BamA299. 
Folding reaction k1  (x10
-3
 s
-1) k2 (x10
-3
 s
-1) 
tOmpA alone 14.9 ± 0.3 N/A 
 tOmpA + OmpA 14.1 ± 0.8 N/A 
tOmpA + POTRAs  15.9 ± 0.1 N/A 
 tOmpA + tBamA* 20.1 ± 0.2 N/A 
 tOmpA + tBamA + POTRAs 16.9 ± 0.9 N/A 
  tOmpA + BamA* 33.6 ± 6.0 0.8 ± 0.1 
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Next, the effect of the N-terminal and C-terminal domains of BamA on Skp-tOmpA 
complexes were investigated separately to determine which part of BamA is 
responsible for the observed release of tOmpA from Skp. No folding was observed 
when premixed Skp and tOmpA were added to free POTRA domains in the 
presence of liposomes (Figure 5.7d), therefore the soluble domains of BamA alone 
are unable to release tOmpA from Skp. By contrast, when tOmpA preincubated with 
Skp was added to liposomes which contained prefolded tBamA a folding transient 
was observed (Figure 5.7e,f), indicating that the BamA -barrel domain is necessary 
and sufficient for substrate release from Skp. However, the tOmpA folding rate 
constant on release from Skp by tBamA was ~three-fold lower than for full-length 
BamA (0.4 ± 0.1 and 1.1 ± 0.2 x 10-3 s-1 for tOmpA folding from Skp in the presence 
of tBamA and BamA, respectively (Table 5.2)). Therefore, the most efficient release 
of tOmpA from Skp in the presence of prefolded BamA depends upon the 
connection between the BamA barrel and the POTRA domains at the membrane. 
 
Figure 5.7: The -barrel domain of BamA facilitates release and folding of 
tOmpA from its complex with Skp. Kinetic folding traces for (a) tOmpA-Skp 
alone, and with (b) prefolded OmpA, (c) prefolded BamA (full-length), (d) 
BamA POTRA domains, (e) prefolded tBamA, and (f) prefolded tBamA, first 
6000 seconds of data in (e) for comparison with data for BamA in (c). Samples 
contained 0.4 M tOmpA, 1.28 mM DUPC (LPR 3200ː1), 0.24 M urea, 50 mM 
glycine-NaOH, pH 9.5. A two-fold molar excess (0.8 M) of Skp, OmpA, 
POTRAs, tBamA and BamA was used. A minimum of three transients are 
shown in each panel. Global fits to a single exponential are indicated by 
dashed black lines (Table 5.2). 
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Table 5.2: Measured rate constants for tOmpA folding into DUPC 
liposomes from its complex with Skp in the presence of BamA 
constructs, OmpA or SurA. Data are shown as the mean ± the standard 
error of the mean (s.e.m.) of the rate constants obtained from separate folding 
experiments, each using independently prepared batches of liposomes. For 
each batch of liposomes at least three folding transients were fitted globally to 
obtain the rate constants shown. Data are from three independent 
experiments, except for conditions indicated by an asterisk for which the data 
are from two experiments. N/A: The kinetic traces for the condition were 
adequately described by a single exponential. 
5.4 SurA cannot release tOmpA from its complex with Skp 
Few studies have investigated the effects of SurA on in vitro OMP folding. SurA has 
been shown to increase the in vitro folding efficiency of OmpT233,301 and BamA283 in 
the presence BAM-containing native lipid proteoliposomes. In the latter case, SurA 
could be functionally replaced with urea, suggesting that its role could be that of a 
passive solubility agent in these experiments283. A study investigating the effects of 
chaperones on in vitro PagP folding in the absence of BAM components found SurA 
had no effect on in vitro PagP folding efficiency or yield14,152. Here, the effect of SurA 
on tOmpA folding in the presence and absence of Skp was investigated. First, 
kinetic experiments were performed in which tOmpA was preincubated with a two-
fold molar excess of SurA, in the absence of Skp. These experiments showed that 
SurA had little effect on the folding rate constant (Figure 5.8a, Table 5.2), consistent 
with previous results for PagP152. Next, tOmpA was preincubated with a two-fold 
excess of Skp, prior to mixing with liposomes in the presence of a two-fold excess of 
Folding reaction k1  (x10
-3
 s
-1) k2 (x10
-3
 s
-1) 
tOmpA alone 14.9 ± 0.3 N/A 
tOmpA-Skp No folding No folding 
 tOmpA-Skp  + OmpA No folding No folding 
tOmpA-Skp + BamA 1.1 ± 0.2 N/A 
 tOmpA-Skp + POTRAs No folding No folding 
 tOmpA-Skp  + tBamA* 0.4 ± 0.1 N/A 
tOmpA-Skp  + SurA No folding No folding 
  tOmpA + SurA 12.7 ± 0.5 N/A 
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SurA (Figure 5.8b). No folding was observed, demonstrating that SurA is unable to 
release tOmpA from its complex with Skp to allow folding. 
 
Figure 5.8: SurA is unable to release tOmpA from its complex with Skp. 
Kinetic folding traces for (a) tOmpA preincubated with SurA, and (b) tOmpA 
preincubated with Skp, then added to liposomes in the presence of SurA. 
Samples contained 0.4 M tOmpA, 1.28 mM DUPC (LPR 3200ː1), 0.24 M 
urea, 50 mM glycine-NaOH, pH 9.5. A two-fold molar excess (0.8 M) of Skp 
and SurA, was used. A minimum of three transients are shown in each panel. 
Global fits to a single exponential in (a) are indicated by dashed black lines 
(Table 5.2). 
Interestingly, the addition of SurA had no effect on the folding of tOmpA, with or 
without Skp, yet the SurA protein purified was pure (Figure 5.2c, upper) and far-UV 
CD indicated that it was correctly folded to the native state (Figure 5.2c, lower). To 
verify that SurA interacts with tOmpA under the experimental conditions employed, 
an assay for SurA binding to full-length OMPs was developed using microscale 
thermopheresis (MST) (Section 2.20). In this technique one of the binding partners 
is fluorescently labelled and kept at a constant low (nM) concentration, and its 
movement in a temperature gradient monitored in the presence of different 
concentrations of its potential binding partner459. An N-terminal cysteine mutant of 
tOmpA was produced and labelled via maleimide chemistry with AlexaFluor 488 dye 
(Section 2.20.1) for use in the MST assay. The results demonstrate that this 
technique works very well for OMP binding studies, likely due to the relatively low 
OMP concentrations (50 nM) that can be used compared with other binding analysis 
techniques such as ITC (in which normally ~10 M is required460,461). The MST data 
in Figure 5.9 demonstrate conclusively that SurA binds tOmpA under the 
experimental conditions used in the kinetic assays above, with the observed binding 
affinity (Kd: 1.4 ± 0.4 M) in agreement with literature values
186,197,198. 
 
 
160 
 
Figure 5.9: Binding of SurA to tOmpA measured by microscale 
thermopheresis. Samples contained 50 nM tOmpA labelled with AlexaFluor 
488, 0.003-100 M SurA, in 0.24 M urea, 50 mM glycine-NaOH, pH 9.5. Data 
were fitted to a quadratic tight binding equation (Section 2.20.3). Error 
indicated is the error in the fit to this model. 
5.5 The catalytic effect of BamA is dependent on membrane 
thickness 
Next, to investigate the hypothesis that the mismatch between the hydrophobic 
thickness of the membrane and the BamA barrel domain is important in the BamA 
mechanism, the effect of BamA on the folding of tOmpA in bilayers with different 
hydrophobic thicknesses was compared. PC lipids with different acyl chain lengths, 
DLPC (C12), DTPC (C13) and DMPC (C14), were selected. While the exact 
hydrophobic thickness of the OM is not known53,462, the six acyl chains of LPS 
molecules contain predominantly myristoyl (C14) acyl chains53,56, while 
phospholipids in the inner leaflet are mostly composed of lipids with C16 and C18 
acyl chain lengths34,39. X-ray scattering experiments have shown that the 
hydrophobic thickness of PC bilayers is linearly dependent on acyl chain length463, 
with DMPC bilayers most closely matching the expected hydrophobic thickness of 
the OM (Figure 5.10), as judged by the average hydrophobic thickness of a set of 24 
OMP structures464. OMPs have an average hydrophobic thickness of 23.7 ± 1.3 Å464, 
while DMPC bilayers have a hydrophobic thickness of 23.0 ± 1 Å463. 
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Figure 5.10: Hydrophobic thickness of PC bilayers varies linearly with 
acyl chain length. (a) Plot of hydrophobic thicknesses of PC bilayers 
composed of lipids with different acyl chain lengths obtained using X-ray 
scattering data from Lewis and Engelman (1983)463. Literature values are 
shown as green squares, and calculated values for DLPC and DTPC based 
on a line of best fit for the data (black line) are shown as red squares. (b) 
Table of hydrophobic thicknesses of the PC bilayers used in the current study 
from data in (a). 
To verify that any observed differences in BamA behaviour in different lipids were 
not due to differences in folding yield, semi-native SDS-PAGE band shift assays129 
were performed to assess the fraction of folded BamA in DLPC, DTPC and DMPC 
liposomes (Figure 5.11a, Table 5.3). The results show that BamA folds with similar 
efficiencies in each case (62.7 ± 2.0, 57.3 ± 2.9 and 51.7 ±1.7 %, for DLPC, DTPC 
and DMPC, respectively), with a slight trend of decreasing folding yield with 
increasing acyl chain length, consistent with previous results313 (Figure 5.11b). Far-
UV CD data also indicated successful BamA folding into liposomes of each lipid type 
with a similar folding efficiency (Figure 5.11c). These data are consistent with 
previous CD data for BamA from Thermus thermophilus243 and imply that both the 
BamA barrel and POTRA domains have been successfully folded to the native state. 
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Figure 5.11: BamA folds with similar efficiencies into DLPC, DTPC and 
DMPC liposomes. (a) Semi-native SDS-PAGE band shift assay of BamA 
folding efficiency in DLPC (C12), DTPC (C13) and DMPC (C14) liposomes. 
Samples were run with or without prior boiling, indicated by ‘+‘ and ‘-’ symbols, 
respectively. (b) Quantification of data in (a) by densitometry. Error bars 
represent the standard deviation from three independent experiments. (c) CD 
spectra of BamA in DLPC, DTPC and DMPC LUVs. Samples for semi-native 
SDS-PAGE contained 0.8 M BamA 1.28 mM lipids (LPR 1600:1), 0.24 M 
urea, 50 mM glycine-NaOH, pH 9.5. Samples for CD contained 1.5 M BamA, 
1.2 mM lipids (LPR 800:1), 0.24 M urea, 50 mM glycine-NaOH, pH 9.5. All 
samples were folded overnight at 25 ºC. 
 
 
 
Lipid type 
Acyl chain 
length 
BamA folding 
efficiency (%) 
DLPC C12 62.7 ± 2.0 
DTPC C13 57.3 ± 2.9 
DMPC C14 51.7 ± 1.7 
Table 5.3: BamA folding efficiencies in DLPC, DTPC and DMPC 
liposomes. Data shown are the mean ± the standard deviation of the folding 
efficiencies obtained from three separate folding experiments, each using 
independently prepared batches of liposomes. 
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Next, experiments were performed in which tOmpA folding was monitored by 
fluorescence spectroscopy into DLPC, DTPC or DMPC liposomes, in the presence 
or absence of prefolded BamA in the bilayer. Folding of tOmpA alone in each of the 
three lipid types was characterised by a lag phase in the transients, giving a 
sigmoidal shape suggestive of the presence of folding intermediates (Figure 
5.12a,c,e)365. Despite the small change in lipid structure, the addition of a single 
methylene group to the acyl chain has a dramatic effect on the folding of tOmpA, 
such that folding was much slower (~six-fold) in DTPC than in DLPC LUVs (Table 
5.4). Similarly, tOmpA folding into DMPC liposomes was substantially slower 
(~seven-fold) than in DTPC liposomes (Table 5.4). The addition of a two-fold molar 
excess of prefolded BamA to the bilayer prior to folding of tOmpA removed the lag 
phase observed in the absence of BamA (Figure 5.12b,d,f). The data for tOmpA 
folding into DLPC or DTPC LUVs in the presence of BamA could be fitted to a single 
exponential, but required a double exponential function to fit the data for folding 
reactions in DMPC (Figure 5.13a,b,c). 
As tOmpA exhibited nonexponential kinetics in the absence of BamA, the kinetics of 
folding were compared using the time taken to achieve 50% of the total observed 
fluorescence change (t50) (Table 5.4, Section 2.14.2). In DLPC liposomes a ~two-
fold decrease in t50 occurred in the presence of BamA, compared with in its absence. 
By contrast, in DTPC liposomes a ~six-fold decrease in t50 was observed. 
Dramatically, the presence of BamA in DMPC liposomes led to a ~ten-fold decrease 
in t50 (Figure 5.13d,e). Thus, as the hydrophobic thickness of the bilayer increases, 
and is closer to that of the OM464, the folding rate enhancement of tOmpA mediated 
by BamA increases substantially. 
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Figure 5.12: Example raw kinetic traces of tOmpA folding in the presence 
or absence of BamA in DLPC, DTPC and DMPC liposomes. Folding 
kinetics of tOmpA alone (upper) and in the presence of BamA (lower) into 
liposomes composed of (a) DLPC, (b) DTPC, or (c) DMPC liposomes. 
Samples contained 0.4 M tOmpA, 1.28 mM DUPC (LPR 3200ː1), 0.24 M 
urea, 50 mM glycine-NaOH, pH 9.5. A two-fold molar excess (0.8 M) of 
BamA was used. For samples containing BamA, exponential fits to the data 
are shown as black dotted lines. Four transients for each of three liposome 
batches (12 in total) were used for calculation of the average T50 value for 
each condition. These experiments were performed at 30 ºC to be well above 
the Tm for DMPC (24 ºC)
365. 
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Figure 5.13: BamA accelerates tOmpA folding more effectively in 
liposomes with longer acyl chain lengths. Comparison of tOmpA folding in 
the presence and absence of BamA in LUVs composed of (a) DLPC, (b) 
DTPC, or (c) DMPC. Fits to a sigmoidal function (-BamA) or an exponential 
function (+BamA) are shown to guide the eye. (d) Comparison of t50 values for 
tOmpA folding into DLPC, DTPC or DMPC LUVs in the presence or absence 
of BamA. (e) Fold change in t50 values between tOmpA folding into DLPC, 
DTPC or DMPC LUVs in the presence or absence of BamA. Samples 
contained 0.4 M tOmpA, 1.28 mM DUPC (LPR 3200ː1), 0.24 M urea, 50 mM 
glycine-NaOH, pH 9.5, at 30 ºC. A two-fold molar excess (0.8 M) of BamA 
was used.  
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Table 5.4: Measured t50 values for tOmpA folding into DLPC, DTPC or 
DMPC liposomes in the presence or absence of BamA. Data are shown as 
the mean ± the standard error of the mean (s.e.m.) of the t50 values obtained 
from three separate folding experiments, each using independently prepared 
batches of liposomes. Fold change errors are the propagated s.e.m. from 
folding reactions in the presence or absence of BamA  (Section 2.14.2). 
One explanation for these results is that BamA function is impaired by the increase 
in hydrophobic mismatch between the side of its barrel domain opposite to the 1-
16 seam and the bilayer as it is placed in thinner membranes. Membrane proteins 
as well as lipids may adjust to ensure the optimum hydrophobic matching465, and it 
could be that deformations in BamA in shorter chain lipids impair its catalytic activity. 
However, available evidence suggests that to prevent the exposure of hydrophobic 
surfaces to hydrophilic environments, lipids more readily adapt to OMPs than vice 
versa, due to the high stablility of -barrel OMP structures11,292,331. Therefore, it is 
likely that the increase in hydrophobic mismatch between BamA barrel in the 1-16 
seam region and the membrane as the chain length is lengthened from C12-C13-
C14 leads to local increases in lipid disorder, which may be the origin of the 
increased BamA catalytic effect in longer chain LUVs. The results thus suggest that 
the hydrophobic mismatch between the BamA and the OM plays an important role in 
the overall BAM catalytic mechanism.  
5.6 Discussion 
While an increasing number of OMP folding studies have been carried out in the 
presence of folding factors298, a systematic study of the combined effects of Skp, 
SurA and BamA on the kinetics of OMP folding was lacking. The results in this 
chapter confirmed that BamA alone can enhance the rate of folding of OMPs 
Lipid 
type 
Folding reaction 
t50 value 
(min) 
Fold change 
 (+/- BamA) 
DLPC 
tOmpA alone 7.0 ± 0.3 
1.9 ± 0.1 
 tOmpA + BamA 3.7 ± 0.1 
DTPC 
tOmpA alone 41.0 ± 2.2 
6.2 ± 0.6 
 tOmpA + BamA 6.6 ± 0.6 
DMPC 
tOmpA alone 276.0 ± 6.0 
9.8 ± 0.6 
 tOmpA + BamA 28.1 ± 1.6 
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(specifically tOmpA) in vitro (Figure 5.6) and showed that this effect was fairly 
modest (~two-fold) in short chain (C11) lipids, in the absence of additional factors 
(Table 5.1). However, when the selected substrate tOmpA is preincubated with Skp 
(at a 2:1 Skp:tOmpA molar ratio), folding is prevented on the experimental timescale 
used. The results then showed that BamA is able to release tOmpA from Skp, 
allowing it to fold (Figure 5.7). Experiments involving the two halves of BamA 
separately expressed and purified demonstrated that the BamA barrel domain 
(tBamA) is predominantly responsible for this activity (Figure 5.7). Interestingly 
tOmpA release from Skp by tBamA was much less efficient than that observed for 
full-length BamA. These differences are unlikely to be explained by these constructs 
folding with different orientations in the bilayer, i.e. with the periplasmic side of the 
barrel facing out from or in to liposomes in different ratios for BamA and tBamA. 
Trypsin digest experiments demonstrated that full-length BamA and a tBamA 
construct comprising residues 404-810 both exhibit orientated folding into PC 
liposomes with the periplasmic side of the barrel facing out from liposomes299. 
Additionally, the results are consistent with previous experiments in DLPC LUVs 
which showed that tBamA enhanced the folding rate constant of OmpA less than 
full-length BamA299. Further, a construct consisting of the BamA barrel and POTRA 
5 (BamAP1-4) was less able than wild-type BamA to accelerate the folding kinetics 
of tOmpA and OmpX in 80:20 DDPC:DDPE liposomes300. A two-fold difference in 
folding efficiencies between BamA and BamAP1-4 was reported, but the difference 
in apparent rates of the folding reactions they assisted was five-fold, leading the 
authors to speculate that BamAP1-4 has a reduced specific activity compared with 
wild-type BamA300. This study concluded that the catalytic activity, in terms of 
reduction of the kinetic barrier imposed by PE headgroups, was located at the 
membrane and required the -barrel domain and POTRA domain 5300. Subsequent 
NMR studies have shown that in a BamAP1-4 construct POTRA 5 remains in an 
unfolded state in the absence of its N-terminal four POTRA domains466,467, therefore 
is unlikely contribute to activity. The results presented here show that POTRA 5 is 
not required for tBamA to assist tOmpA folding at the membrane. 
One explanation for the observed differences between the kinetics of tOmpA release 
from Skp by BamA and tBamA could be differences in BamA and tBamA folding 
efficiencies in DUPC under the conditions employed. However, as shown in Figure 
5.4, when BamA and tBamA are added at a concentration of 0.8 M they fold with 
similar efficiencies (~80% and ~70% for BamA and tBamA, respectively) (Figure 
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5.4a,b). The concentration difference between folded BamA and tBamA in the 
membrane (0.64 - 0.56 = 0.08 M or ~10%) is unlikely to explain the ~four-fold 
difference in tOmpA folding rate. Therefore, the results suggest that the POTRA 
domains contribute to the efficient release of tOmpA from Skp when attached to the 
BamA -barrel domain. Recent atomistic molecular dynamics simulations of BamA 
in a native outer membrane showed that the POTRA domains are highly dynamic 
when attached to the BamA barrel and were able to interact with the membrane 
independently of the barrel domain262. Insertion into the membrane of the two 
tryptophan residues in POTRA domain 3 was observed in a conformation which was 
consistent with the known arrangement of BamB and BamD in the complex262. 
Consistent with these results, in the recent cryo-EM structure of the BAM complex 
these two tryptophan residues are observed inserted in the detergent micelle (Figure 
1.27a)232. This may be a stabilising interaction to anchor POTRA 3 during the BAM 
catalytic cycle (Section 6). However, it is possible the POTRA domains, as well as 
the BamA barrel may be involved in modulation of the membrane to aid catalysis, 
and attachment of the POTRA domains close to the membrane may facilitate this. 
The POTRA domains may provide an additional electronegative surface close to the 
membrane. A key factor in the release of tOmpA from Skp by tBamA may be the 
electrostatic interaction between the positively charged tips of the Skp subunits and 
the electronegative patches at the periplasmic side of the BamA barrel (Figure 
5.14a). It has been proposed that the POTRA domains may be instrumental in the 
release of substrates from their complex with Skp, due to the interaction of the 
highly basic Skp (pI ~9.5) with negatively charged patches on the POTRA domains 
(Figure 5.14b)383. Therefore, although the data in Figure 5.7 shows that the POTRA 
domains are insufficient on their own to release tOmpA from Skp, the electrostatics 
of the POTRA domains may still play an important role in substrate release from Skp 
in the context of full-length BamA. 
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Figure 5.14: The BamA barrel and POTRA domains have electronegative 
regions which may be involved in release of substrates from Skp.  
Electrostatic surface representations of (a) tBamA, (b) the BamA POTRA 
domains, and (c) Skp. Regions of blue and red represent areas of 
electropositive and electronegative surface potential, respectively. Structure of 
BamA from the cryo-EM structure of the E. coli BAM complex (PDB: 5JLO232). 
Structure of Skp from PDB: 1U2M150, with missing residues from chains B  and 
C modeled from chain A using MODELLER191. Electrostatic surface 
representations (-2 kT/e to +2 kT/e) were created using the APBS plugin for 
PyMOL151. 
A further possibility is that the presence of both the membrane and soluble BamA 
domains allows cooperative behaviour between them. Several studies have 
implicated functional cooperation between the periplasmic and barrel domains of 
BamA. Genetically, substitutions in the BamA barrel can restore viability to the 
conditional synthetic lethal phenotype of a BamBBamE strain468, with four of the 
six rescuing mutations located in the L6 loop. Another study also found that 
mutations in BamA L6 could ablate the SDS-sensitivity of a mutation (E373A) in 
BamA POTRA 5469. Further, domain swap experiments in which the E. coli BamA 
barrel or POTRA domains were individually substituted with those from other 
species showed that efficient OMP assembly depends upon precise alignment of the 
two domains254. 
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Whether the release of OMP substrates to BAM via Skp occurs in vivo is still under 
question, and evidence of a genetic interaction is lacking445. However, in vitro 
studies have shown that Skp can deliver substrates to negatively charged 
bilayers152,153. Further, recent data in which induction of the Cpx envelope stress 
response470 caused downregulation of Skp, thus preventing toxicity due to OMP 
mislocalisation in the IM, suggested that Skp is able to fold OMPs directly into 
membranes in vivo154. While SurA has been cross-linked to BamA in vivo145,187, Skp 
has only been cross-linked in vivo to BAM components indirectly via the passenger 
domain of the EspP autotransporters111. 
There is a discussion in the literature as to whether or not Skp and SurA act in 
sequential68,227 or parallel pathways145,147. The kinetic data presented here for SurA 
suggest that this chaperone cannot release tOmpA from Skp which is consistent 
with recent competitive affinity assays for the 22-stranded substrate FhuA97. The low 
micromolar Kd obtained from MST experiments (Figure 5.9) is consistent with 
previous results for SurA binding to peptides186,197,198, and with that obtained for 
SurA binding to the full-length OMPs, OmpF and OmpG using a peptide competition 
assay197. However, tighter binding (Kd of ~0.1 M) was observed for SurA binding to 
the 16-stranded OmpC in fluorescence-based experiments162. The differences in 
affinity for OMP substrates between Skp and SurA (low nanomolar and low 
micromolar for Skp160,162,336 and SurA186,197,198, respectively) also appears to argue 
against a handover mechanism. However, transport proteins participate in an 
inherently non-equilibrium process, due to flux through the system. Thus, although 
Skp and SurA are present in approximately the same quantities in vivo (~6600 and 
~3900 molecules/cell for Skp and SurA, respectively83) the amount of free 
chaperone at any point will be dependent upon the flux through the pathway. If the 
rate of depletion of SurA-OMP complexes by substrate handover to the BamA 
POTRA domains is very rapid, the pool of available SurA may be much higher than 
that of Skp. 
The results show that the BamA POTRA domains free in solution have no effect on 
in vitro tOmpA folding kinetics. POTRA domains are proposed to chaperone OMP 
substrates en route to the membrane247,256. Possibly, the edges of POTRA -strands 
weakly bind the -strands of incoming OMP substrates by -augmentation allowing 
processive sliding motions towards the BamA barrel12,471. However, no direct binding 
of a full-length OMP to the POTRA domains has yet been reported. Here, POTRA-
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tOmpA binding was unable to be demonstrated by MST (data not shown), in sharp 
contrast to the binding data obtained for SurA-tOmpA (Figure 5.9). 
The work described in Section 5.5 demonstrates the importance of hydrophobic 
mismatch between the membrane environment and the BamA barrel in the BamA 
mechanism. This may be due to an increase in bilayer defects and/or disorder in the 
membrane11,365. The effects of increasing the dynamics and fluidity of membranes 
on OMP folding was recently dramatically demonstrated in experiments in which 
~100% folding efficiency for OmpX and OmpA could be achieved by ‘heat shock’ of 
lipid membranes at 70 ºC472. The results in this chapter also highlight the importance 
of lipid:protein interactions in OMP folding383, and support the view that BamA is a 
very unusual kind of catalyst in that it has two substrates, both proteins and lipids300. 
In summary, a systematic approach was used in this chapter to investigate the 
effects of periplasmic chaperones and lipid chain length on BamA-assisted tOmpA 
folding in vitro. The results obtained, together with a consideration of currently 
available literature, suggest a new ‘barrel elongation’ model for the assembly of 
OMPs in Gram-negative bacteria by the BAM complex, which is proposed in the 
following chapter. 
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6 Conclusions and final thoughts 
Unlike the spontaneous protein folding observed in dilute solutions473, protein folding 
in the cell is complicated by the high concentration of other proteins with which 
aberrant interactions can be made474. This can lead to aggregation, the 
accumulation of toxic species and cell death, therefore cells expend considerable 
effort to maintain unfolded proteins in a folding-competent state446. In the case of 
OMPs, folding is complicated by the fact that the site of synthesis in the cytosol is far 
from the location of their final folded state in the OM68. Therefore, a network of 
folding factors is important in ensuring OMP proteostasis, which becomes 
particularly important under stress conditions10,18. The work presented in this thesis 
has investigated OMP biogenesis by purifying the major folding factors involved, and 
trying to recreate aspects of the pathway in vitro. In this final chapter the major 
findings are summarised, and in conclusion, a new model is presented for the 
mechanism of OMP assembly by the BAM complex, which is consistent with the 
results obtained here, as well as with the currently available literature. 
In this work, the mechanisms by which chaperones aid OMPs on their perilous 
journey across the aqueous periplasmic space has been investigated. The first 
assay to compare the kinetics of OMP folding between different OMPs using 
fluorescence spectroscopy was developed (Chapter 3). This was then used, 
together with IMS-MS and MD simulations, to compare the interaction of Skp with 
OMPs of different sizes (8- to 16-stranded). It was shown that Skp is able to function 
as a multivalent chaperone with mechanistic similarities to both the ‘beads on a 
string’ chaperones, such as Trigger Factor, and ‘Anfinsen cage’ chaperones, such 
as the chaperonins173,446 (Chapter 4).  
Evidence has been provided that SurA does not release OMPs from Skp, which 
argues against a sequential handover mechanism for these chaperones (Chapter 5). 
This is consistent with the notion that, rather than due to a specific interaction 
between Skp and SurA, the movement of substrates between the Skp and SurA 
chaperones depends upon (1) the relative kon and koff rates between the chaperones 
and unfolded OMPs, and (2) the relative concentrations of Skp and SurA (Chapter 
5). This is consistent with genetic studies which suggest that Skp and SurA function 
in partially redundant parallel pathways, with SurA as the main pathway and the 
Skp/DegP more important in times of stress145. Recent kinetic modelling of the flux 
of OMPs through the periplasm also supports this hypothesis124. Therefore, it 
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appears there is no predefined sequential chaperone pathway; instead OMP 
proteostasis is controlled by the kinetics and thermodynamics of interactions 
between unfolded OMPs and chaperones in the periplasm17. Given that kinetic 
modelling suggests that OMPs make hundreds of separate interactions with 
chaperones on their way across the periplasm124, conceptually thinking about OMPs 
following particular chaperone ‘pathways’ may be misleading. 
The results in Chapter 5 suggest that Skp may deliver substrates to the BAM 
complex, as has been previously suggested171,299,383. Kinetic experiments showed 
that prefolded BamA can specifically release tOmpA from its complex with Skp, 
suggesting that this may be a relevant in vivo pathway (Chapter 5). There is no in 
vivo cross-linking data to support this, but it is striking that tOmpA is efficiently 
released from Skp by prefolded BamA, whereas prefolded OmpA has no effect. The 
presence of Skp in an in vitro reconstitution of autotransporter assembly assay, 
which included the BAM complex and SurA, slowed the kinetics of EspP folding239. 
However, this may be due to Skp binding to the EspP soluble passenger domain 
slowing its precession across the membrane111. 
Further, the results in Chapter 5 suggest that the BamA POTRA domains and the 
BamA -barrel act cooperatively, as release and folding of tOmpA from its complex 
with Skp was more efficient (~3-fold) with prefolded BamA than with prefolded 
tBamA  (Section 5.3). This is consistent with in vivo data which showed genetic 
interactions between BamA POTRA 5 and extracellular loop 6 (L6) in BamA469. The 
results are also consistent with previous in vitro studies, in the absence of Skp, 
which showed faster OMP folding in the presence of prefolded BamA compared with 
tBamA299 or a BamA construct lacking POTRA domains 1 to 4 (BamAP1-4)300. 
Further, Cys mutations designed to cross-link BamA POTRA 5 to the BamA barrel in 
the ‘lateral open’ conformation were lethal, but could be rescued by the addition of 
reducing agent221.  
How might the cooperativity observed between the BamA barrel and POTRA 
domains function in the context of the full BAM complex? A striking feature of the 
now available structures of the complete221,222,232 and near-complete221,223 BAM 
complex is that the POTRA domains and BAM lipoproteins form a ring structure in 
the periplasm (Figure 1.25). Where protein complexes have ring-like structures 
these can be involved in cooperative behaviour in which movements are propagated 
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around the ring475,476. Examples of this include the GroEL chaperonin, which 
displays cooperativity of ATP binding and hydrolysis around the heptameric subunits 
in each of its two rings446, and also the AAA (ATPases Associated with diverse 
cellular Activities) unfolding and degradation machine ClpX477. Thus, I propose a 
model in which the binding of nascent OMPs to BamD, and possibly simultaneously 
to BamA POTRA 5, causes a conformational change which is propagated around 
the periplasmic ring to the BamA -barrel domain. In the recent cryo-EM model of 
the BAM complex, BamD exhibits a rigid body hinge movement between TPRs 3 
and 4 when compared with other BAM structures232. Binding of an OMP could 
trigger this movement of the N-terminal three BamD TPR domains away from the C-
terminus of BamD. This movement would then be propagated to POTRAs 1 and 2 
through their interaction with the BamD N-terminal TPR domains. This interaction, 
between the BamD N-terminal TPR domains and the BamA N-terminal region, is 
structurally slightly different in all BAM structures, suggesting it is a dynamic 
region232. The BamD-POTRAs interaction in turn would lead to ‘concertina-like’ 
movements in the POTRA domains, with the major POTRA hinge motion, the 
narrowing of the angle between POTRAs 2 and 3, aided by BamB. Finally, the 
conformational change would be transmitted through BamA POTRA 5, to the BamA 
-barrel, ensuring that BamA barrel 1 and 16 are in the ‘lateral open’ state, which 
is assumed here to be the ‘acceptor’ state (Figure 6.1). The two consecutive 
tryptophans in BamA POTRA 3 are observed inserted into the detergent micelle in 
the recent cryo-EM structure of the BAM complex in a ‘lateral open’ state232 (Figure 
1.27a), as seen previously in MD simulations of BamA alone in a native outer 
membrane262. These two residues are in a similar location in the two structures of 
the BAM complex in the ‘lateral closed’ state221,222. Therefore, it may be that the role 
of this loop is to anchor POTRA 3 in position to assist the transfer of conformational 
movement around the periplasmic ring between POTRAs 1-2, and POTRA 5. This 
model provides an explanation as to why BamD is an essential protein; it is required 
to transmit the information that a nascent OMP has entered the BAM periplasmic 
ring to trigger the BamA -barrel domain into an ‘active’ state, ready for insertion 
and folding. The recently observed loop in BamD, which makes contact with the 
detergent micelle in the cryo-EM structure (Figure 1.27b)232, may not be involved in 
signalling to the membrane. Rather, its importance could be due to stabilising the C-
terminal BamD TPRs (4-5) to allow the N-terminal TPRs (1-3) to make the rigid body 
movement which is propagated around the ring. Note that in this model the minor 
conformational changes in BamD eventually lead to a major allosteric 
conformational change in the BamA barrel, due to mechanical propagation around 
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the ring. It may be that despite the major structural differences observed in the two 
states so far captured in structural studies of the BAM complex221-223,232, there is not 
a large energetic barrier between them. 
 
Figure 6.1: Movements in the N-terminal TPR domains (1-3) of BamD 
propagate around the periplasmic ring to the BamA barrel in the ‘barrel 
elongation’ model. BAM in a ‘lateral closed’ conformation (PDB: 5D0O221) 
and the ‘lateral open’ cryo-EM structure (PDB: 5LJ0232) are shown aligned on 
TPRs 4-5 of BamD (residues 160-241). The small movement between the N-
terminal TPRs 1-3 of BamD in the two structures (a maximum displacement of 
6 Å232 is correlated with larger rearrangements in the BamA POTRA domains, 
the position of BamB, and the open/closed status of the BamA barrel. BamA, 
BamB and BamD in the ‘lateral open’ structure are shown in green, light blue, 
and yellow, respectively. BamA, BamB and BamD in the ‘lateral closed’ 
structure are shown in pink, dark blue, and red, respectively. For clarity, BamC 
and BamE are omitted. Image created with PyMOL. 
This model may also explain why the C-terminal sequence of OMPs is so important 
for assembly in vivo128,478. It may initiate the conformational change in BamD which 
places BamA into the ‘active’ (‘lateral open’) state. The structural similarity of BamD 
to the TPR domains of PEX5, which binds peroxisomal targeting sequences281, first 
suggested that BamD may be involved in recognition of OMP targeting signals270. 
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BamD can be cross-linked to peptides containing OMP targeting sequences in 
vitro235, and peptides containing the -signal of BamA were shown to bind BamD in 
an in vitro pull-down assay136. Bacterial genetic studies282 and in vivo cross-linking of 
EspP112, and LptD479, also suggest that BamD binds substrates separately from 
BamA (Section 1.4.4).  
The trigger for completion of the reaction cycle may be the release of the C-terminal 
OMP sequence from BamD, allowing restoration of the ‘resting’ (‘lateral closed’) 
state. BamE may assist in this return to the initial state; genetic evidence suggests 
that BamE may be involved in returning BamA to the ground state through 
regulation of BamD276,469. In this model, the ‘scissor-like’ motion of the 1-6 strands 
of the BamA barrel through ~65º, suggested by the structures of BamA in the ‘lateral 
open’ and ‘inward open’ states (Figure 6.2b), may be key to breaking the interaction 
between 1 of the BamA barrel and the final -strand (1) of the nascent OMP. This 
would allow the barrel of the nascent OMP to close and complete folding, and the 
restablishment of the interaction between BamA 1 and 16. Note that in this model 
the OMP ‘targeting sequence’ has an additional role other than targeting, and could 
be thought of as an ‘activating sequence’. The role of BamC in this proposed 
mechanism is unclear. However, given that its N-terminal region covers a wide 
surface area of BamD, its role seems likely to consist of assisting and/or regulating 
the function of BamD. However, the model does provide a clear explanation as to 
why OMP biogenesis is so impaired in bamB null mutants125,264. BamB is required to 
regulate the hinge movement at POTRAs 2 and 3 for efficient propagation of 
conformational changes around the ring from BamD. This is also suggested by the 
available crystallographic structures of BAM. All complete structures are in the 
‘inward open’ (‘lateral closed’) state221,222, while those lacking BamB are in the 
‘lateral open’ state221,223. 
Given that bamB and surA mutants are phenotypically identical123, and 
bamBsurA mutants are non-viable264, this strongly implicates SurA in also 
assisting in the movements in the POTRA domains required to promote the BamA 
barrel to the ‘active’ state. This most likely occurs through the known interaction of 
SurA with BamA POTRA 1187. 
The results in Chapter 5 also show that BamA functions much more effectively as an 
in vitro OMP folding catalyst when the hydrophobic thickness of the membrane 
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matches that of the OM. Therefore, local alteration of the lipid environment is clearly 
important in the BAM mechanism. These results are consistent with the ‘BamA-
assisted’ model of OMP assembly, in which BAM ‘primes’ the membrane for 
insertion and aids trafficking to the thinned/destabilised area of the membrane422. 
However, the results are also consistent with the ‘BamA-budding model’, in which, in 
addition to membrane destabilisation, BamA creates a ‘super-barrel’ or ‘hybrid 
barrel’ with incoming OMP substrates248,263,422. Also, these two models are not 
mutually exclusive and a ‘hybrid’ model in which both mechanisms are correct is 
possible. The results in Chapter 5 strongly support the BamA-assisted model. By 
contrast, the ‘hybrid barrel’ appears less likely for the following reasons: (1) the 
‘hybrid barrel’ model requires the making and breaking of large number of hydrogen 
bonds, each time a new -hairpin is inserted, which seems energetically implausible; 
(2) 16 of the BamA barrel is a short -strand, yet the BAM complex has to function 
with substrates with very different numbers of residues per -strand (as determined 
by the number of -strands in the barrel and the shear number)480,481; and (3) the 
model seems unnecessarily complex. Therefore, an alternative ‘barrel elongation’ 
model for the BAM complex mechanism is proposed here. In this model BamA is 
proposed to assist folding by affecting the local membrane environment due to the 
hydrophobic mismatch between the OM and side of the BamA barrel at the 1-16 
interface, as suggested previously11,300,365. In the ‘barrel elongation’ model the 
‘lateral open’ state is the OMP acceptor state (see above), with folding initiated by 
templating of the C-terminal strand of the nascent OMP by 1 of the BamA barrel. 
Thus, the BamA barrel is extended (‘elongated’) from the 1 strand by -
augmentation, but without a -augmentation interaction with BamA 16. Once this 
initial interaction is formed, successive -strands are templated onto the barrel, 
possibly in -hairpin units97, in a similar manner to the amyloid formation reactions 
observed for peptides with alternating polar and non-polar residues114. 
The word ‘elongation’ is deliberately chosen as a reference to the elongation phase 
of amyloid aggregation reactions. OMP assembly is viewed as a -sheet templating 
reaction similar to seeded amyloid aggregation reactions482. OMP folding via the 
BAM complex is therefore seen as an example of a highly controlled seeded 
aggregation reaction. In vitro studies of the kinetics of amyloid aggregation reactions 
have shown that the kinetics of fibril assembly are much faster if they are ‘seeded’ 
with small amounts of pre-formed amyloid fibres425,482. In the ‘barrel elongation’ 
model, a similar templating reaction to initiate the formation and association of 
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successive -strands, combined with membrane priming, is the origin of the BAM 
catalytic effect. 
One question for this model is how is the stability of the BamA -barrel maintained if 
16 is not involved in the formation of a hybrid barrel? In the structures of BamA 
alone11 and of the BAM complex in the ‘lateral-open’ conformation221,223,232, the 
BamA barrel can remain stably folded with very few (as low a 2) hydrogen bonds 
between 1 and 1611. Therefore, it is conceivable that the BamA barrel could 
remain stably folded without hydrogen bonds being sequentially formed and broken 
between 16 and the incoming substrate -strands. MD studies of the BamA barrel 
in DMPE bilayers also suggest that the BamA barrel can exhibit transient opening 
between 1 and 16 and still remain stably folded in the membrane11. Omp85 family 
members have a well-conserved VRGF/Y motif present in L6483. Mutation of the 
RGF residues in this motif to alanine all affect OMP assembly in vivo, with R661, the 
most conserved residue, the most critical484. The functional role of this motif is 
unknown. One reason why the VRGF loop is so-well conserved in BamA 
homologues could be that it is required to stabilise the BamA barrel as nascent 
OMPs are elongated from BamA 1 (Figure 6.2a), although experimental evidence 
for such a role is lacking. 
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Figure 6.2: The conserved VRGF motif maintains BamA barrel stability 
during catalysis in the ‘barrel elongation’ model. (a) The BamA barrel in 
the ‘lateral open’ conformation (PDB: 5EVK223). BamA barrel strands 1 and 
16 are highlighted in blue. In the model proposed in this chapter, the VRGF 
motif (red) stabilises the BamA barrel while the -strands of substrates are 
elongated by templating from the 1 strand of the BamA barrel. (b) Alignment 
of BamA barrel structures in the ‘lateral open’ (green) (PDB: 5D0Q221) and 
‘lateral closed’ (yellow) (PDB: 5D0O221) states. The opening of the barrel is 
proposed to allow the BamA barrel 1 strand to be available for templating the 
elongation reaction of the nascent OMP via -augmentation. The ~65º 
movement of strands 1-6 to return the BamA barrel to the closed state is 
proposed to sever the interaction between BamA 1 and the final -strand of 
the nascent OMP. This allows completion of nascent OMP folding by the 
association of its first and last -strands, and completes the BAM reaction 
cycle. Images created with PyMOL. 
How does the ‘barrel elongation’ model fit with the known role of the BAM complex 
in autotransporter assembly?107 As in the ‘hybrid barrel’ model, in the ‘barrel 
elongation’ model the BamA barrel also laterally opens, and therefore allows the 
secretion of the N-terminal passenger domains of autotransporters248. The trimeric 
autotransporters, such as YadA, which have 12-stranded -barrels with each 
subunit contributing four -strands, are also BAM-dependent478. The ‘barrel 
elongation’ model is consistent with their assembly, as incoming subunits could be 
involved in a sequential elongation reaction with the first subunit templated by 1 of 
BamA, 1 of the second subunit templated by 4 of the first subunit, and 1 of the 
third subunit templated by 4 of the second subunit. The model does not require that 
the -strands which form the -barrel of the nascent substrate enter the lumen of the 
BamA barrel, as proposed in the ‘hybrid barrel’ model263. However, to allow 
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secretion of autotransporters passenger domains, initiation of templating of the 
nascent -barrel by the BamA 1 strand must be coupled to movements which 
prevent POTRA 5 from blocking access to the BamA barrel lumen. This allows a 
route across the OM for autotransporter passenger domains, as well as extracellular 
OMP loops and domains, via the BamA ‘exit pore’ above the 1-16 lateral gate263.  
When the final -strand of the nascent OMP is elongated the reaction cycle must 
complete to allow BAM to catalyse the folding of its next substrate. This requires 
removal of interaction between the final -strand of the nascent OMP and 1 of 
BamA, to allow the first -strand to the substrate to interact with its last -strand to 
close the substrate OMP barrel, and allow dissociation from BamA. In the ‘barrel 
elongation’ model, this is caused by the scissor-like movement in the BamA barrel, 
linked to the 30º turn of the periplasmic ring (Figure 6.2b). The trigger for this 
movement could be the dissociation of the C-terminal sequence of the nascent OMP 
from BamD, and possibly BamA POTRA 5, assisted by BamE (see above). This 
trigger would then be propagated around the periplasmic ring to cause the 
conformational change in the BamA barrel required to complete the reaction cycle. 
Thus BAM is returned to the ‘ground state’, in the reverse process to that which 
mediated the transition to the ‘acceptor state’. The displacement of the final -strand 
of the nascent OMP from 1 of BamA may occur via a zip-in-zip-out mechanism 
similar to that proposed for donor strand exchange (DSE) in Gram-negative pilus 
assembly485. Note that if BamA 16 is not involved in the formation of a hybrid 
barrel, we would expect that it exhibits little structural change between the ‘lateral 
closed’ and ‘lateral open’ states, which is exactly what is observed (Figure 6.2b). 
One prediction from the mechanism outlined above is that the N- and C-termini of all 
OMPs in Gram-negative bacteria should be located in the periplasm, therefore 
restricting the number of -strands to multiples of two; this is in agreement with all 
structural data to date481,486. Therefore, the ‘barrel elongation’ model of the BAM 
mechanism involves intricate coordinated cooperative movements around the 
periplasmic ring. Another role for the ring structure, aside from coordinating the 
conformation of the BamA barrel, may be to provide a sequestered environment 
while templating occurs, to protect elongating OMPs from aberrant interactions. This 
would help to ensure intramolecular elongation rather than intermolecular 
aggregation. 
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Consistent with the ‘barrel elongation’ model, as well as preventing aggregation487, 
the role of chaperones is to localise unfolded OMPs to BAM through either non-
specific interactions in the case of Skp152,153, or specific interactions with the BamA 
POTRA domains in the case of SurA187. Chaperones may also modulate the folding 
pathway by biasing the unfolded ensemble towards conformations that lead to 
productive folding97. In the case of SurA, this may include keeping the nascent OMP 
in an extended conformation to favour the formation of -hairpins, and prevent 
hydrophobic collapse, which would require subsequent structural rearrangement. 
Consistent with the ‘barrel elongation’ model, SurA is a potent substoichiometric 
inhibitor of A40 amyloid formation in vitro (unpublished observations, B. Schiffrin, 
K. L. Stewart, and J. R. Humes (University of Leeds)). Further, A42 oligomers were 
recently reported to form membrane pores with a -barrel structure reminiscent of 
OMPs488. SurA may also be involved in modulating the conformation of BamA via its 
interaction with BamA POTRA 1 (see above), providing an additional reason for the 
severity of the surA phenotype145,147,180. 
At the present time we only have structures of BAM in essentially two 
conformations. While these structures must represent free energy minima, they do 
not exclude the possibility that other conformational changes can occur. Watching 
BAM in action will require techniques which monitor dynamic changes, such as 
NMR, AFM and FRET experiments, as well MD simulations489. Cross-linking studies 
during BAM-mediated folding are also likely to be vital in unpicking the 
conformational changes that occur during the BAM reaction cycle490-492. A promising 
future area of research will be the use of protection strategies, such as HDX318, 
coupled with either NMR or MS, or labelling strategies, such as FPOP (Fast 
Photochemical Oxidation of Proteins)493, to examine how the folding pathway of 
OMPs is altered by the presence of chaperones and the BAM complex, in residue-
specific detail. All these techniques will be useful in providing evidence for or against 
the ‘barrel elongation’ model proposed here. A structure of a stalled intermediate 
along the BAM-mediated OMP assembly pathway would be very useful in 
differentiating between different models for the BAM mechanism. Stalled 
intermediates have been important in elucidating the mechanism of pilus assembly 
by the FimD usher494, and efforts to obtain the structure of a BAM complex stalled 
intermediate are a logical next step479.  
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There is much still to be learned about the role that the membrane environment 
plays in modulating the folding of OMPs, but its importance has been highlighted 
recently by work which has shown that the trimeric porin OmpF has specific binding 
sites for LPS, which are essential for its biogenesis in vivo61. Specific interactions 
between MPs and lipids are increasingly recognised to have biological significance 
and studies examining the functional significance of lipid:protein interactions will 
likely gain importance in the OMP folding field. Recently, native mass spectrometry 
has emerged as a useful tool to identify the lipids bound to membrane proteins and 
their complexes285,495, and may prove invaluable in ascertaining whether BAM 
selectively binds particular lipids. 
Further, progress in the field is likely to come from the improvement of 
computational techniques. Vast amounts of data on protein sequences, structures 
and dynamics has been acquired in recent years. The full potential for mining this 
data is yet to be realised, but improvements have been made recently in 
computational tools to predict the topologies and structures of OMPs63,66,496, as well 
as their thermodynamic stabilities66. 
Greater understanding of OMP biogenesis pathways will lead to strategies for their 
inhibition. Complete inhibition of BAM complex function may not be required for 
drugs to be useful. Often the lack of effectiveness of an antibiotic is due to the low 
permeability of the Gram-negative OM49. Lowering the levels of functional BAM 
leads to an increase in outer membrane permeability, facilitating the entry of other 
antimicrobial drugs which find it difficult to cross the OM in normal circumstances497. 
Indeed bacterial genetic studies have used a strategy of reducing the permeability of 
the OM to toxic substances with mutations or deletions of proteins involved in OMP 
biogenesis, to gain insight into the process by looking for suppressor mutations498. 
Strategies which target BAM function to attenuate virulence without killing cells, may 
put pathogens under less selection pressure to evolve resistance274,275. If 
cooperativity around the periplasmic ring is important in the BAM mechanism, as 
proposed in the ‘barrel elongation’ model, this implies a multitude of potential areas 
in the complex which could be targeted by rational, structure-based drug design 
(SBDD)499. 
Overall, the results presented in this thesis provide valuable new insights into OMP 
folding mechanisms, and in particular the roles of cellular folding factors in OMP 
folding in vitro. The work in this thesis, together with consideration of the research 
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literature, has led to the new model for OMP assembly by Gram-negative bacteria 
proposed above. The beauty of modern molecular life science research is that there 
is an abundance of data from many different techniques, which provide different 
clues into biological processes. In this chapter I have attempted to collate all the 
available clues from genetic, biochemical and biophysical studies to provide a view 
of how the final stages of OMP biogenesis may occur. This offers testable 
hypotheses for future studies, which are likely to yield many more surprises. We are 
living through a golden age of stunning discoveries in the OM biogenesis field, and 
we can no doubt look forward to many more exciting results over the next few years. 
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